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 The obligate human pathogen Neisseria gonorrhoeae (gonococci) causes the 
sexually transmitted disease gonorrhea. Interactions between gonococci and human 
cervical epithelial cells that promote bacterial invasion and post-invasion survival were 
examined. The data showed that gonococci activated MAPK signaling in cervical 
epithelial cells prior to invasion. Gonococci triggered prolonged ERK phosphorylation 
(possibly through EGFR signaling), which could facilitate gonococcal invasion. 
Furthermore, gonococci expressing lacto-N-neotetraose LOS decreased JNK activation 
and elicited lower IL-8 production from host cells compared to variants expressing 
lactosyl LOS. I propose that gonococci can manipulate MAPK signaling to facilitate 
invasion into cervical epithelial cells and to evade the innate immune response. 
 To investigate gonococcal invasion, I expressed β-lactamase on the outer 
membrane of gonococcal strain FA1090 to generate the reporter strain FA1090 Φ(bla-
iga’). Utilizing a β-lactamase reporter assay, I demonstrated that FA1090 Φ(bla-iga’) 
only invaded a subpopulation of cervical epithelial cells. Nonviable FA1090 Φ(bla-iga’) 
did not invade host cells and failed to recruit F-actin to sites of adherence. Viable 
 
gonococci required pili expression but not Opa expression to invade susceptible host 
cells. These data suggest that viable gonococci elicit invasion-promoting interactions 
with host cells not triggered by nonviable gonococci.  
 Finally, the data demonstrated that gonococci realize different intracellular fates 
after entry into cervical epithelial cells. I developed a tannic acid survival assay to show 
that intracellular gonococci survived within host cells. Intracellular survival did not 
require catalase or the NfsB nitrogen reductase. A subpopulation of gonococci could 
escape from cells back into the extracellular milieu. Gonococci utilized an exocytosis 
pathway to escape after invasion that was blocked by treating cells with tannic acid, but 
not cytoskeletal inhibitors.  
 I propose a working scenario whereby gonococci undergo cycles of invasion into 
and escape from a susceptible subpopulation of cervical epithelial cells. Gonococci that 
survive within host cells may represent bacteria that progress into deeper host tissues to 
disseminate to secondary sites. Escaping gonococci could invade into other host cells and 
are well-positioned for transmission to another host. Gonococci interact with the cervical 
epithelium through invasion, intracellular survival, and escape to establish bacterial 
persistence in the female host. 
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Background and Significance 
 Neisseria gonorrhoeae (gonococci, or GC) is an obligate human pathogen that 
causes the venereal disease gonorrhea. People with GC infections are also commonly co-
infected with Chlamydia trachomatis and are predisposed to increased HIV transmission 
(148, 169, 213, 306). According to recent statistics from the Center for Disease Control 
and Prevention, gonorrhea is the second most common notifiable and sexually 
transmitted disease (STD) in the United States (1, 306). Nearly 340,000 cases were 
documented in 2005—the first increase in the incidence of gonorrhea since 1999—and an 
estimated 600,000 new GC infections occur each year (1, 306). Cephalosporins are the 
only remaining class of drugs recommended to treat gonorrhea.  The rise in 
fluoroquinolone resistant GC has eliminated this class of antimicrobials as a 
recommended treatment (1). GC are facultative anaerobes that are classically identified in 
infected individuals as Gram-negative diplococci within neutrophil-containing exudates 
(133, 306). GC express variable surface components and do not generate a productive 
adaptive immune response, which have prevented the development of a suitable vaccine 
to prevent GC transmission.  
 GC disease remains a major source of morbidity in the male and female genital 
tracts and many of the clinical symptoms and outcomes of disease are gender-specific. 
GC usually infect the male urethra or the female cervix, but they are capable of 
colonizing almost any mucosal surface, including the nasopharynx, conjunctiva of the 
eye, fallopian tubes, and rectum. Around 90% of men develop uncomplicated gonorrhea 
(UG) 2-5 days after GC exposure and realize few secondary complications after treatment 
 
 2 
(270). UG is a symptomatic disease characterized by local inflammation where 
neutrophils migrate to the site of infection to phagocytose GC and generate 
proinflammatory cytokines that damage the surrounding tissues (69). Tissue damage in 
the male urethra leads to the characteristic symptoms of GC disease in men—dysuria and 
the mucopurulent discharge of mucosal epithelial cells and neutrophils (239, 304).  
 In women, GC may cross the mucosal barrier by triggering bacterial-mediated 
endocytosis (invasion) into cervical epithelial or endothelial cells (69, 73, 261, 266, 288-
290). Invasion into host cells protects GC from components of the innate and humoral 
immune system to help GC avoid symptom elicitation (190, 192). Often in women, GC 
invade at a low-level without generating a substantial inflammatory response or creating 
recognizable symptoms (asymptomatic) during the initial stages of disease (306). 
Asymptomatic women do not realize they are infected and fail to seek treatment allowing 
GC to spread to secondary sites (62). GC can ascend into the normally sterile upper 
reproductive tract, including the fallopian tubes and uterus, to elicit severe tissue 
destruction, scarring, and chronic inflammation that leads to secondary complications, 
such as pelvic inflammatory disease (PID), ectopic pregnancy, salpingitis, and/or 
infertility (62, 119, 172, 202). GC can also transcytose through epithelial tissues into 
subepithelial regions where they encounter phagocytes (261). On rare occasions, GC can 
reach the bloodstream, become serum resistant, and disseminate throughout the body 
(291). Women are more susceptible to these disseminated gonococcal infections (DGI) 
that can lead to gonococcal arthritis, septicemia, or bacteremia in 1-3% of infected 




Role of Antigenic and Phase Variation in GC Pathogenesis 
 Phase variation (PV), turning on and off the expression of genes in response to 
environmental cues or due to mistakes in replication, and antigenic variation (AV), 
modifying the amino acid sequence/structural appearance of cellular components, provide 
GC with mechanisms to modify their cell surface. In other words, progeny derived from a 
single GC ancestor will be a mixed population of surface variants since each GC has the 
potential to express a unique combination of surface molecules due to PV and AV. GC 
can modulate the expression of several surface proteins, glycoproteins, and glycolipids by 
PV and/or AV. The generated variability allows GC to interact with various host cell 
types and take advantage of new environments encountered during infection. PV and AV 
result in GC expressing a repertoire of surface ligands that can bind to a variety of host 
cell receptors on different cell types (188, 190). Surface modifications due to PV and AV 
also permit GC to mimic host structures and avoid recognition by pathogen associated 
molecular pattern (PAMP) receptors, such as toll-like receptors (TLR) and cytosolic 
nucleotide oligomerization domain (NOD) proteins, in order to evade immune 
surveillance and persist in host tissues (190, 197). Pili, opacity proteins (Opa), and 
lipooligosaccharide (LOS) are three major GC surface components that undergo PV and 
AV and play important roles in adherence, invasion, intracellular fate, and innate immune 
evasion.  
 
GC Interactions with Epithelial Cells  
A. Overview of GC-Epithelial Cell Interactions and Host Defense Against Infection 
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 Upon transmission to a new host, GC encounter mucosal epithelial cells, an initial 
barrier of innate immune defense. Epithelial cells provide protection for underlying 
tissues and allow for secretion and absorption exchanges with the external environment. 
They can be ciliated or nonciliated, simple or stratified, and are classified into three 
general shape categories—columnar, cuboidal, and squamous. GC seem to preferentially 
colonize nonciliated mucosal epithelial cells, such as those found in the female cervix, 
endometrium, and fallopian tubes (177). 
 Our understanding of GC infection of human cells is derived from clinical human 
challenge, the estradiol-treated mouse model, and tissue culture cell models that support 
gonococcal interactions in vitro, including primary human organ or cell cultures and 
transformed cell lines (137, 250). When GC are transmitted to a new female host, 
cervical epithelial cells represent one of the initial cell types encountered and a primary 
location for GC to establish infection (232). In the data presented here, I primarily 
utilized the ME180 cervical carcinoma cell line as a model for GC infection of the 
cervical epithelium. ME180 cells were originally isolated from an omental metastasis in a 
patient exhibiting a rapidly spreading cervical carcinoma (276). This cell line maintains 
many of the morphological characteristics found in a typical differentiated epithelial 
layer, including desmosomes, tonofilaments, and epidermal filaments (277), suggesting 
these cells bear close resemblance to normal cervical epithelial cells. ME180 cells 
support GC attachment and invasion and are capable of proinflammatory cytokine 
production, which mimic the cellular responses to GC infections in primary cervical and 
endometrial cells (35, 42, 78, 104, 146, 266). Ultimately, natural human challenge studies 
in women are not possible due to the ethical restrictions imposed by the asymptomatic 
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and disseminating nature of GC disease in women. Therefore, I cannot be certain that the 
pathogenicity displayed by GC during infection of ME180 cells will completely reflect 
natural infections (60). However, several of the virulence factors GC utilize to infect 
ME180 cells, including pili, Opa, and LOS, have been shown to contribute to infection in 
human challenge studies with men, primary cell models, and other immortalized cell lines 
that support GC infection (42, 106, 138, 234, 253). Overall, ME180 cells can serve as a 
suitable model to investigate various aspects of GC infection of the human cervical 
epithelium.     
From in vitro models, such as ME180 cells, research has demonstrated that GC 
infection of epithelial cells occurs in several stages—initial attachment, intimate adhesion 
to the plasma membrane, invasion into the cell, intracellular survival and persistence, and 
transcytosis to the subepithelium or escape back into the extracellular environment (Fig. 
1). At each stage, GC must overcome the innate immune responses of host tissues and 
initiate signaling pathways in epithelial cells to orchestrate continued progression of the 
infection. GC establish persistence within the host at a low level where they do not elicit 
a profound proinflammatory response, yet are still transmitted readily within the 
population.  
 
B. Adherence: Attachment and Intimate Adhesion 
 Pili or fimbriae represent the most common adhesin utilized by pathogens, 
including GC, to make initial contact with host cells. Some bacteria possess nonpilus 
adhesins to secure attachment to cells. In general, one class of these adhesins bind to 




Figure 1—GC pathogenesis of the epithelial cell barrier.  Shown are the different 
stages of GC interaction with epithelial cells. Factors listed under (GC) indicate GC 
virulence factors utilized to accomplish each process. Factors listed under (Host) indicate 
host cell factors GC interact with or manipulate during each process. GC = black 
diplococci, pili = irregular-shaped thin lines, epithelial cells = white rectangular boxes, 
cell tight junctions = small black boxes adjoining adjacent epithelial cells to indicate the 
polarized nature of an epithelial cell barrier. GC initial attach to the apical side of the 
epithelial cells and transcytose towards the basolateral membrane. 
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 binding proteins, or M proteins from pathogenic Streptococci and Staphylococci spp. 
(31, 139, 256). Other adhesins include autotransporter proteins, such as the BabA protein 
in Helicobacter pylori or other surface expressed proteins, like Opa, with adhesive 
domains that bind to cellular receptors, such as integrin, cadherin, or selectin family 
molecules (9, 27, 223). In a unique case, enteropathogenic and enterohemorrhagic E.coli 
(EPEC and EHEC) encode for Tir, the translocated intimin receptor for their intimin 
adhesin, both of which are part of a TTSS. Once injected into the host, the Tir effector 
protein integrates into the plasma membrane where it binds intimin (150). In some cases, 
these bacterial adhesins induce host cell receptor phosphorylation and downstream 
signaling to recruit additional receptors, signaling molecules, and cytoskeletal proteins to 
the adherence site. This bacterial-directed recruitment can generate further host-pathogen 
adhesions and prepares cells to internalize the adherent bacteria. 
 In order to colonize mucosal epithelial cells, GC must attach to the cell surface. 
Epithelial cells possess a variety of defense mechanisms to prevent bacterial adherence. 
A flowing layer of mucus covers these cells, washing bacteria away before they can 
establish ligand-receptor interactions (47, 171). The mucoid layer also contains mucin, 
secretory IgA antibodies, and secreted antimicrobial molecules, such as defensins, 
cathelicidins, lysozymes, and phospholipases that can disrupt bacterial membrane 
integrity or block pathogen access to the cell surface (171, 232). Furthermore, GC must 
contend with normal commensal flora, like Lactobacillus spp. and Enterococcus spp., for 
attachment sites, especially in the female reproductive tract (232). GC that are able to 
overcome these defenses, must deal with pathogen-associated molecular pattern PAMP 
molecules, such as TLRs, that recognize bacterial components, such as LPS, 
 
 8 
peptidoglycan and deoxyribonucleic acid (DNA), from a variety of pathogens (8, 134). 
Binding these receptors triggers signaling pathways within epithelial cells that lead to the 
activation of transcription factors, such as nuclear factor-kappaB (NF-κB) and activator 
protein-1 (AP-1), and the expression of genes involved in defense responses. Part of this 
response includes the increased production of proinflammatory cytokines and 
chemokines. GC are known to elicit different levels of tumor necrosis factor alpha 
(TNFα), IL-1, IL-6, and IL-8 secretion from a variety of epithelial cell types, which 
results in tissue damage and the recruitment of phagocytes (3, 134, 311). Neutrophils and 
macrophages can engulf and destroy adherent GC, but some studies show a subset of GC 
may survive inside these cell types [for review see (239)] (168). 
 GC that overcome these extracellular innate defense mechanisms can make initial 
contact with the apical side of epithelial cells via their type-IV pili—long, filamentous 
protein appendages extending from the GC cell surface composed of individual pilin 
protein subunits (32, 274). GC possess several silent pilin genes (pilS) copies that can 
recombine into the pilin expression locus (pilE) to mediate AV (193, 194, 257). AV 
creates morphologically and immunologically distinct pilus structures that may allow GC 
to adhere to a greater variety of cell types and evade the immune response (29, 144, 243).  
 GC utilize their type-IV pili-associated PilC adhesin to attach to the CD46 
receptor on epithelial cells (147, 241, 243). GC can also adhere to epithelial cells with pili 
in the absence of cellular CD46 expression via complement receptor 3 (CR3) or integrins 
(68, 72, 152, 153), but these interactions are less well-characterized. Binding these 
receptors stimulates signal transduction pathways in mucosal epithelial cells. Pili trigger 
CD46 phosphorylation by the Src-family kinase c-Yes and the influx of calcium into the 
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host cell cytosol (146, 166). Pili-mediated signaling also triggers the accumulation of 
cortical plaques, which contain actin, actin-associated proteins, tyrosine phosphorylated 
proteins, and Opa receptors, that cluster beneath sites of gonococcal contact with host 
cells to facilitate gonococcal adherence and invasion (147, 166, 185, 187). GC retract pili 
powered by the ATPase motor protein, PilT (189). PilT-mediated retraction triggers the 
phosphatidyl inositol-3-kinase (PI3K)/Akt signaling pathway in epithelial cells and 
blocking this retraction-induced signaling inhibits subsequent GC invasion (167). 
Retractile forces also enhance mitogen-activated protein kinase (MAPK) activation 
during the early stages of infection and cause epithelial cells to release CD46 into the 
extracellular milieu (86, 123). GC twitching motility is driven by pilus retraction (189), 
which may allow GC to spread out or migrate as a microcolony on the cell surface and 
engage additional host receptors (117).  
 After making initial contact with host cells, GC establish more intimate adhesion 
with host cells through additional GC ligand-host cell receptor interactions. Most GC 
surface factors responsible for establishing intimate GC adhesion to epithelial cells also 
direct bacteria-mediated endocytosis (invasion) and are discussed in the next subsection. 
GC form microcolonies of tightly-associated bacteria on the surface of most 
nonphagocytic cells. GC microcolonies are formed through Opa-LOS interactions on 
neighboring GC and bacterial growth over time (24). GC also recruit host cell factors, 
such as kinases, adaptor molecules, and actin-associated factors to the adherence site to 
promote intimate adhesion, microcolony forming interactions, host cell signaling, and 
invasion (67, 117, 167, 185). Microcolonies may provide protection for GC sequestered 




C. Invasion: Mechanisms and Signal Transduction 
 Bacterial pathogens possess a diverse array of strategies to invade into 
nonphagocytic cells. The specifics of each pathway involve different host cell and 
bacterial factors that interact to orchestrate internalization, but overall invasion 
mechanisms can be divided into three general categories. Direct penetration occurs when 
a microorganism, like Borrelia burgdorferi or Clostridium perfringens, crosses the 
epithelial barrier due to a puncture, such as a tick-bite that delivers the pathogen into a 
subepithelial region, or an indirect injury to the tissue (121). Other bacteria utilize TTSS 
to inject effectors directly into the host cell cytosol where they interact with signaling 
molecules and actin cytoskeletal components. Bacteria utilizing this strategy invade by a 
“trigger” mechanism whereby the effectors provoke membrane ruffling. Those pathogens 
lacking TTSS gain entry by binding their invasin proteins to host cell receptors, which 
then triggers invasion-promoting signal transduction pathways that culminate in actin 
reorganization. Bacteria are internalized via a “zipper” mechanism where microvilli 
elongations surround and engulf the pathogen (50, 79). 
 MAPKs are activated by some invasive pathogens and are linked to cytoskeletal 
rearrangements. Tang, et al. were the first group to link MAPK activation to the invasion 
of epithelial cells when they demonstrated that extracellular signal regulated kinase-2 
(ERK-2) inhibition reduced Listeria monocytogenes invasion into HeLa cells via the 
internalin-E-cadherin “zipper” pathway (278). Since then, combinations of p38, Jun-N-
terminal kinase (JNK), and/or ERK signaling have been shown to contribute to invasion 
by many pathogens. For example, Yersinia spp. use the Inv or YadA invasin proteins to 
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invade epithelial cells via integrin receptors by activating several kinases, including the 
MAPKs (74, 249). Furthermore, JNK inhibition prevented Neisseria meningitidis 
internalization through integrin receptors (264). Some type-III secretion effectors (Sops 
and Sips) from Salmonella enterica serovar Typhimurium act as nucleotide exchange 
factors to manipulate actin-associated proteins, such as Cdc42 and Rac, in their “trigger” 
pathway. Blocking Cdc42 activation prevents the activation of downstream MAPK 
signaling in this pathway (39, 105, 114).  
 GC invasion occurs when GC penetrate into the epithelial cells via a dynamic 
“zipper” phagocytosis/internalization orchestrated by both bacterial and host cell factors 
(186). GC invade epithelial cells as a potential way to gain protection from extracellular 
immune defenses and persist in the host tissues. The fact that GC gain entry into host 
cells to attempt to establish a niche in host tissues demonstrates the importance of 
invasion in GC pathogenesis. Multiple gonococcal surface factors can interact with the 
cervical epithelial cell surface to facilitate GC invasion (162, 176). Pili, in conjunction 
with one or more gonococcal invasins (Opa, LOS, or Por, iC3 surface deposition), can 
coordinate host cell signaling modifications to drive host actin cytoskeleton 
polymerization beneath the site of adherence to form microvilli elongations that 
internalize GC (72, 84, 94, 98, 107, 243, 274, 295). 
 Opa proteins mediate intimate contact between the gonococcal surface and the 
surface of epithelial, endothelial, and phagocytic cells and facilitate host cell invasion 
(162, 176). An individual GC can express any combination of 0-11 different Opa proteins 
(18, 19, 25). Expression of each Opa is regulated by the pentameric CTCTT repeated 
sequence in the leader peptide portion of each protein sequence and AV occurs when opa 
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loci undergo homologous recombination with each other (273). Each Opa forms a β-
barrel in the GC outer membrane that contain eight membrane spanning regions and three 
distinct extracellular variable domains that determine receptor specificity (18, 28).  
 Two different classes of Opa proteins, OpaCEA and OpaHSPG, can bind 
carcinoembryonic antigen cellular adhesion molecules (CEACAM) and heparan sulfate 
proteoglycans (HSPG), respectively, to trigger uptake into different cell types (40, 112, 
162, 290, 293). Opa-HSPG interactions activate a tyrosine phosphorylation pathway 
involving phosphocholine-phospholipase C (PC-PLC) and acidic sphingomyelinase 
(ASM).  During these processes, the secondary messengers diacylglycerol and ceramide 
are released to trigger many host cell responses, including the recruitment of F-actin and 
other tyrosine phosphorylated proteins to the site of colonization (61, 93, 94). GC can 
invade epithelial cells using either the syndecan-1 or syndecan-4 members of the HSPG 
family. Engaging these receptors can also recruit protein kinase C (PKC), 
phosphatidylinositol-4,5-bisphosphate (PIP2), syntenin, and CASK to mediate GC entry 
(81). The extracellular matrix proteins vitronectin and fibronectin can bridge interactions 
between OpaHSPG and epithelial cell integrin receptors to promote invasion by triggering a 
signaling pathway that involves PKC (61, 66, 67, 89, 289). 
 Opa-dependent invasion through CEACAM binding leads to activation of 
different cellular factors. GC infection of epithelial and endothelial cells triggers the 
upregulation of CEACAM1 expression by activating NF-κB, which allows for increased 
OpaCEA-mediated binding to these cells (204, 205). GC invasion via CEACAM1, 5, or 6 
in transfected epithelial cells occurs via a macropinocytosis-like Rac1/Cdc42-
independent mechanism that is not blocked by kinase inhibitors and may not involve 
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actin recruitment (20, 26, 179). However, disrupting the cholesterol-rich lipid rafts that 
contain these CEACAM receptors at the cell membrane blocks GC uptake, indicating that 
membrane organization is important for GC invasion (251). GC binding to CEACAM3 
transfected cells triggers Src kinase phosphorylation of the immunotyrosine activating 
motif (ITAM) on CEACAM3 (180). Downstream signaling to PI3K and Rac1/Cdc42 
provokes actin rearrangements and GC entry (20, 26). 
 GC can invade cervical epithelial cells that do not express CEACAM and only a 
single member of the Opa protein family can bind HSPG (275, 290, 292). GC can initiate 
alternate ligand-receptor interactions to promote invasion into epithelial cells by Opa-
independent mechanisms. Defined LOS structures contribute to increased adhesion and 
host cell invasion in an Opa
-
 background (106, 196, 266). LOS is a primary component of 
the GC outer membrane that displays AV and PV (177). The LOS core is composed of a 
lipid A core linked to two 3-deoxy-D-manno-2-octulosonic acid (KDO) molecules and 
heptose core sugars. Extending from the core unit are chains of O-polysaccharides that 
are shortened in comparison to the repeating O-antigen subunits found in the LPS of most 
Gram-negative bacteria. LOS biosynthesis occurs via the sequential addition of 
monosaccharide subunits to a grown LOS chain by LOS glycosyltransferase (lgt) genes. 
Some lgt genes (most notably lgtA, lgtD, and lgtC) undergo PV and expression is 
controlled by homopolymeric tracts of guanines within their coding regions (53, 92). 
These repeated nucleotide stretches promote slip-strand mispairing during replication to 
shift the reading frame of lgt RNA (92). Lgt PV allows a single GC to simultaneously 
produce multiple antigenically distinct LOS structures on its cell surface. These structures 
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can mimic host glycosphingolipids and blood group antigens to prevent an effective host 
antibody response against a single LOS structure (6, 33, 85, 99, 254, 287).   
 The nonsialylated lacto-N-neotetraose (LnNT) LOS glycoform and the galNAc-
LnNT LOS structure allow GC to bind and invade into epithelial cells in the presence or 
absence of Opa (140, 266, 287). The LnNT and galNAc-LnNT α-chain LOS structures 
are synthesized by the Lgt enzymes derived from the lgtABCDE gene cluster (92). 
Deletion of the lgtD gene (∆lgtD) prevents the addition of the terminal galNAc to the α-
chain, which truncates LOS expression at the LnNT glycoform. Deletion of the lgtA gene 
(∆lgtA) further truncates the α-chain to a lactosyl structure devoid of both LnNT and 
galNAc-LnNT. GC expressing the LnNT LOS glycoform can bind to the 
asialoglycoprotein receptor (ASGP-R) to mediate entry into primary human urethral 
epithelial cells (PHUEC) by a clathrin-dependent mechanism (106, 228, 229). GC 
expressing polylactosaminylated LOS structures can bind to galectin-3, a lectin binding 
receptor on cervical epithelial cells, that may lead to invasion (141). Furthermore, the 
lipid A portion of LOS serves the site of complement factor C3 deposition on the GC 
surface where it is subsequently converted to iC3b (71). iC3b-bound GC can utilize porin 
and pili to coordinate a joint interaction with CR3 on primary cervical epithelial cells to 
trigger invasion (71, 72). This invasion mechanism involves activation of myosin light 
chain kinase (MLCK), PIP2, and GC phospholipase D (PLD)-dependent activation of 
Akt, but not PI3K (70). 
 Porin (Por) can also mediate GC invasion in an Opa-independent manner through 
pathways distinct from the CR3 pathway. Porin is the most abundant GC outer membrane 
protein and is phase invariable (143, 145). GC can be characterized by their expression of 
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one of two different porin subtypes—PorB 1A or PorB 1B. GC that express PorB 1A are 
more invasive (160, 288). In low phosphate environments, PorB IA-mediated invasion 
requires clathrin-coated pit formation, actin rearrangement, and Rho GTPases and may 
involve direct translocation of Por into the epithelial cell membrane (160, 242, 288). 
 Other GC factors also contribute to invasion, but the molecular mechanisms for 
these invasion pathways have not been as well-characterized. The L12 ribosomal protein, 
OmpA-like protein, and some RpoH-regulated genes all confer invasive phenotypes on 
Opa
-
 GC into various epithelial and endometrial cell types (65, 260, 268).  
 GC utilize a variety of receptor-mediated invasion pathways to enter epithelial 
cells. Specific kinases, such as PKC and Src, appear to associate with these receptors to 
transmit signals to downstream components. However, the downstream kinases and 
transcription factors activated through GC-receptor binding and how they are linked to 
the actin cytoskeleton are less understood. Signaling through the Opa-HSPG invasion 
pathway leads to the release of diacylglycerol and ceramide from the membrane, which 
are linked to actin reorganization (61, 93, 94). Opa-CEACAM3 interactions in 
phagocytes activate Src-family kinases, p-21 activated kinase (PAK), and JNK and 
trigger the Rac-1 GTPase to mediate actin rearrangements for phagocytosis (110, 113). 
However, a similar Src/PAK/JNK/Rac-1 pathway has not been demonstrated in epithelial 
cells. GC also activate the transcription factors NF-κB and AP-1 (through JNK) to 
mediate pro-inflammatory cytokine production and increased intercellular adhesion 
molecule-1 (ICAM-1) expression (135, 210, 211). A direct connection between MAPK 




D. Intracellular Survival, Transcytosis, and Host Cell Exit 
 Intracellular pathogens can utilize multiple methods simultaneously to sustain 
their ICS. Bacteria can induce anti-inflammatory cytokines, such as IL-10, to counteract 
the pro-inflammatory immune response or trigger increased expression of anti-apoptotic 
factors to prevent clearance via cell death (22, 23, 121, 199). Many organisms possess 
siderophores, scavenger receptors, or iron-binding proteins to acquire essential nutrients 
from the host to prevent starvation (49, 238). Intracellular pathogens also possess diverse 
strategies for dealing with phagolysosomes. Shigella flexneri and Listeria monocytogenes 
are two species that escape from the vacuole into the host cytosol by utilizing pore-
forming toxins to breach the phagosome membrane (88). Another strategy is to prevent 
the bacteria-containing vacuole from fusing with lysosome. Salmonella spp. secrete 
effectors that interfere with vesicular trafficking to disrupt vacuole maturation (82, 116). 
Other pathogens, like Mycobacterium tuberculosis, institute vacuolar remodeling 
whereby they prevent acidification and acquisition of lysosomal markers to create a less 
harsh environment within the bacteria-containing compartment (44).  
 Host epithelial cells can call upon multiple intracellular defense mechanisms to 
prevent the intracellular survival (ICS) of invading pathogens. Cytokines produced by 
epithelial cells can alert phagocytes to travel to infection sites to engulf both bacteria and 
infected cells (234, 235). Infected cells can undergo apoptosis, thereby limiting the ability 
of the pathogen to spread to neighboring cells (220). Epithelial cells can sequester 
essential nutrients, such as iron, to starve internalized microorganisms to prevent their 
growth and proliferation (279). The intracellular PAMP recognition receptors, NOD 
proteins, can recognize bacterial peptidoglycan and trigger defense responses (87, 131). 
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Epithelial cells can also directly kill bacteria within the phagolysosome (297). The 
overall effectiveness of these host defenses against GC remains questionable. Infected 
individuals fail to generate a substantial adaptive immune response against GC, which is 
characterized by a lack of GC antigen presentation to develop immunological memory in 
order to prevent subsequent reinfections (115). GC can establish chronic asymptomatic 
infections, especially in women, by evading the innate immune response and persisting at 
a low-level in the reproductive tract (270, 302).  
 Following invasion, GC can survive inside epithelial cells long enough to 
transcytose to the basolateral cell membrane and enter a subepithelial compartment or 
return to the extracellular lumen by exiting through the apical side of the cell (51, 181, 
261). GC within epithelial cells can escape the innate defenses of the external milieu and 
the underlying phagocytes to facilitate their spread to secondary sites of infection or 
generate systematic, disseminated disease (63, 202). Weel, et al. demonstrated the 
existence of two subpopulations of GC inside epithelial cells—intact GC maintaining 
membrane integrity and morphologically disintegrated GC. Preventing phagolysosome 
fusion and acidification blocked the destruction of the susceptible subpopulation (297, 
298), indicating GC need to avoid degradation in the lysosome to promote ICS. GC can 
stimulate calcium-mediated signaling responses in epithelial cells that may facilitate ICS 
by modifying phagolysosomal properties. Pili and Por can trigger calcium ion influxes 
into the epithelial cell cytosol to instigate the exocytosis of lysosomal associated 
membrane protein-1 (LAMP-1) and reduce levels of other lysosome components 
[LAMP-2, lysosomal acid phosphatase, and CD63] prior to gonococcal invasion (11, 16, 
206, 298). The GC IgA protease can cleave LAMP-1 at the plasma membrane to help 
 
 18 
delay phagolysosome maturation and promote intracellular survival (10-12, 111, 173, 
224, 225). However, loss of LAMP-1 function may not be sufficient to achieve GC ICS. 
A recent study indicated that GC displayed increased ICS in host cells deficient in both 
LAMP-1 and LAMP-2, but not in cells lacking only one of the two components (21). 
Finally, investigations have revealed intact GC in the host cytosol not surrounded by a 
vacuolar compartment (203). 
 GC expressing OpaCEA that invade epithelial cells via CEACAM3, but not 
CEACAM1, show evidence of increased PI3K activation and greater recruitment of 
LAMP-2 (26). Thus, the increased ICS of GC that invade via CEACAM1 may be 
explained by their ability to inhibit phagolysosome maturation events in host cells. 
Invasion via CEACAM3 leads to phosphatidylinositol-3-phosphate (PI3P) accumulation 
on GC-containing phagosomes—a maturation step that allows the phagosome to acidify 
and acquire lysosomal markers. During invasion through CEACAM1, only a portion of 
the phagosomes accumulate PI3P, which may allow GC to survive in some vacuoles (26).
 GC also utilize other surface factors to avoid intracellular killing. GC must 
acquire iron for ICS and require the expression of TonB and TdfF for intracellular iron 
acquisition. Other GC iron binding proteins, including the transferrin binding proteins 
TbpA and TbpB, the lactoferrin binding protein LbpA, the siderophore FetA, and the 
hemoglobin receptor HpuAB, can all bind cellular iron sources, but are not yet known to 
play a role in GC iron utilization inside host cells (34, 164, 183, 284). GC can also use 
Opa proteins to bind to pyruvate kinase in order to utilize intracellular pyruvate for 
growth when nutrients are scarce within host cells (303). GC also possess enzymes, such 
catalase, peroxidase, and nitrogen reductases that may help them confront reactive 
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oxygen or nitrogen intermediates within the intracellular environment (7, 109, 122, 184). 
In addition, Por has been implicated in inhibiting host myeloperoxidase (MPO) activity to 
prevent hypochlorous acid formation and late cytoplasmic granule fusion following 
phagolysosome formation (175). 
 Instead of surviving within epithelial cells, some GC can progress to additional 
locations within the host. GC can transcytose through an epithelial cell monolayer 
towards the basolateral membrane without disrupting monolayer integrity (91, 186). L12 
expression permits fast GC monolayer crossing potentially via a paracellular route (269). 
Expression of pili and Opa-CEACAM interactions assist GC traversal through an 
epithelial cell barrier as does the expression of two genes, fitA and fitB, of unknown 
function (120, 186, 293). GC transcytose through epithelial cells along actin 
microfilaments and microtubules by utilizing the motor activity of myosin, kinesin, and 
dynein (294). GC can exit through the basolateral side of the epithelial cell into 
subepithelial tissues and the bloodstream where they encounter phagocytes and 
complement (261). To evade complement and become serum resistant, GC bind the 
complement inhibitory factor H with Por or C4-binding protein or sialylate their LOS 
(217, 233). GC can also re-emerge into the extracellular environment by escaping 
through the apical membrane where they are positioned to be transmitted to a new host or 
invade nearby cells (51, 203). 
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Specific Aims and Approaches 
  This study was designed to investigate how N. gonorrhoeae manipulate the 
cervical epithelium to establish infection and persist in the female reproductive tract. The 
central hypothesis of this work is that GC utilize their repertoire of virulence factors to 
trigger host responses that allow the bacteria to invade into and survive within human 
epithelial cells. Through this dissertation I have explored host cell signaling pathways 
activated by GC in the early stages of infection, GC factors that contribute to host cell 
invasion, methods to improve the quantification of GC invasion, and the post-invasion 
fates of GC inside cervical epithelial cells. 
 Research in the Stein laboratory is focused on determining how GC elicit different 
disease outcomes in the male and female host, including understanding what factors 
contribute to the asymptomatic nature of GC disease in women. Mucosal epithelial cells 
represent the initial host cell barrier of defense against infectious agents and the first cell 
type encountered by most GC. GC colonize these cells to establish infection and 
penetrate this barrier to spread to additional tissues. Though GC are known to invade into 
various epithelial cells via multiple mechanisms, we do not understand the importance of 
each pathway in natural human infections, including which invasion pathways lead to 
greater disease severity. Furthermore, few links have been made between entry pathways 
that lead to GC survival versus those pathways that result in intracellular killing. This 
study identifies both host and bacterial factors involved in the invasion process and 
quantifies their impact on host cell entry and the cytokine response. This work also 
investigates the different strategies employed by GC to survive after invasion. I propose 
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that the specific interactions between GC and epithelial cells contribute to the varying 
outcomes of gonococcal disease.  
 In this study, I developed a tissue culture cell model to examine GC adherence, 
invasion, and intracellular survival. I utilized a main cervical epithelial cell line, ME180 
cells, and a second endometrial cell line, Hec1B cells, both of which have been shown to 
be susceptible to GC infection (38, 98, 266, 275). Invasion and survival assays where 
cells were incubated with different GC variants expressing different surface profiles or at 
different MOI for various time periods represent the foundational approach for most 
experiments in this work. After infection, host cells, host cell lysates, or recovered 
bacteria were analyzed to reveal different aspects of GC pathogenesis. 
 
Aim 1:  Little is known concerning the GC-induced signaling pathways that lead to 
invasion after receptor binding. I identified receptor-associated kinases and downstream 
kinases activated by GC prior to invasion by challenging ME180 cells with different 
surface variants over time. I discussed the potential role of each kinase in invasion. I also 
examined the role of the GC-activated kinase JNK in bacterial induced IL-8 production. 
 
Aim 2:  The number of GC that actually invade epithelial cells and the percentage of cells 
that are susceptible to this invasion are unclear. I constructed a β-lactamase expressing 
GC to quantify the number of ME180 cells in a GC-infected population that are invaded 
and determine the relative contribution of pili expression, Opa expression, and GC 
viability to the invasion process. I also examined the ability of different agents to inhibit 
invasion or improve invasion quantification methods. 
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Aim 3:  The intracellular fate of GC inside epithelial cells (survival, killing, or 
proliferation) remains controversial. I developed a tannic acid-based survival assay to 
quantify GC intracellular survival levels and the number of GC expressing different 
surface profiles that escape/re-emerge from ME180 cells. I also analyzed a potential 
mechanism of GC escape. 
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Materials and Methods 
Bacterial Strains, Cell Lines, Plasmids, and Reagents.  Neisseria gonorrhoeae strain 
FA1090 was obtained from Dr. W.M. Shafer (Emory University, Atlanta, GA). FA1090 
was a cervical isolate from a patient with a disseminated gonococcal infection; it is 
streptomycin resistant (Sm
R
) and is sensitive to both ceftriaxone and ciprofloxacin (45, 
140). Neisseria gonorrhoeae strain MS11 mKC (referred to as MS11) was obtained from 
Dr. J.M. Griffiss (University of California at San Francisco, San Francisco, CA) and 
MS11∆opa is a derivative of MS11 mKC that is genetically incapable of expressing Opa 
proteins. Neisseria gonorrhoeae strain F62 was obtained from P.F. Sparling (University 
of North Carolina, Chapel Hill, NC). Strain F62∆lgtD is a derivative of F62 that 
expresses LnNT α-chain LOS as its predominant LOS structure due to a deletion in lgtD 
(266). F62∆lgtA is a derivative of F62 that expresses lactosyl α-chain LOS due to a 
deletion in lgtA (266). Commensal organisms Neisseria sicca 342 and Neisseria subflava 
44 were obtained from H. Feldman (SUNY at Albany, Albany Medical Center, Albany, 
NY). In all procedures, GC and commensal Neisseria strains were grown overnight (~18 
h) at 37
o
C, 5% CO2 on GCK agar (Becton Dickinson, Sparks, MD) plus 1% Kellogg’s 
supplement unless otherwise stated (300). Penicillin G (75 ng/ml) was added to GCK 

















 based on their light refraction 
phenotype under a dissecting microscope. For analyses with nonviable organisms, 
bacteria were killed by incubation with 2 mg/ml gentamicin sulfate 
(BioWhittaker/Cambrex Biosciences, Walkersville, MD) followed by overnight storage 
at 4
o





[mcrA (mrr-hsdRMS-mcrBC) was obtained from New England Biolabs (Beverly, MA) 
and maintained on Luria-Bertani (LB) agar (US Biologicals, Swampscott, MA). Plasmids 
pFT180 (271), pK18 (230), and pK18UP (246) have been described previously. ME180 
cells, a human cervical epidermal carcinoma cell line (HTB-33; American Type Culture 
Collection [ATCC], Manassas, VA), were maintained in RPMI 1640 (Gibco/Invitrogen, 
Grand Island, NY) supplemented with 5% fetal bovine serum (FBS) (HyClone, Logan, 
UT), 1% penicillin-streptomycin (Pen-Strep) solution (Gibco/Invitrogen), and 10 µM 
Hepes (Mediatech, Herndon, VA). Hec1B cells, an endometrial adenocarcinoma cell line 
derived from the female uterus (HTB-113; ATCC) were obtained from K.V. Swanson 
(University of Maryland, College Park, MD) and maintained in Minimal Essential 
Media-Alpha Media with GlucoMax® (Gibco/Invitrogen) supplemented with 10% FBS, 
1% Pen-Strep, and 10 µM Hepes. In all procedures, seeding and incubating tissue culture 
cells alone or tissue culture cells infected with bacteria occurred at 37
o
C, 5% CO2 unless 
otherwise stated. All chemicals used in this study were reagent grade or better and were 
obtained from Sigma Aldrich (St. Louis, MO) unless otherwise specified (for reagents 
utilized see Table 1).  
 
 Statistical Analysis.  All graphical data were prepared using GraphPad Prism version 
3.00 for Windows (GraphPad Software, Inc., San Diego, CA). For data derived from 
three independent experiments each performed in triplicate, the error bars represent the 
standard error of the mean (SEM). For all other experiments, the error bars represent the 
standard deviation (SD). In experiments where the statistical significance between two 
data sets were analyzed, a p-value was determined by performing a two-tailed unpaired 
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Table 1.  Reagents and Buffers Used in This Study 
Solution      Composition 
 
Bacterial Culturing and Transformation 
Kellogg’s supplement 6.8 mM glutamine, 2.1mM Fe(NO3)3, 0.04 mM thiamine    
   pyrophosphate, 2.22 M glucose  
GCK agar  GC
1
 media base containing 5 g/L agar and 1% Kellogg’s supplement 
GCP   1.5% proteose peptone 3, 0.1% soluble starch, 7.3 mM KH2PO4, 23   
   mM K2HPO4, 85.5 mM NaCl, pH 7.4 
GC broth  GCP, 1% Kellogg’s supplement, 0.042% NaHCO3 
GC transformation broth GCP, 1% Kellogg’s supplement, 10 mM MgCl2, 0.042% NaHCO3 
Cell Culturing 





  5% FBS
4
, 0.5% Kellogg’s supplement, and 10 mM Hepes in RPMI 
Hec1B cells IM  10% FBS, 0.5% Kellogg’s supplement, and 10 mM Hepes in MEM-Alpha  
   Media with GlucoMax®  
serum-starved IM  0.5% FBS, 0.5% Kellogg’s supplement, 10 µM Hepes in RPMI 
serum-free IM  0.5% Kellogg’s supplement, 10 µM Hepes in RPMI 
Trypsin   0.05% trypsin/0.53 mM EDTA 
PBS   14.6 mM KH2PO4, 17.1 mM NaCl, 81mM Na2HPO4, pH 7.4, (dilute 1:10) 
Saponin   10% saponin in PBS 
Lysate Collection 
NP-40 lysis solution 1% NP40, 20mM Tris-Cl, pH 7.5, 150mM NaCl, 1mM MgCl2, 1mM EGTA,  
   10µg/ml leupeptin and aprotinin protease inhibitors, 50 mM NaF, 1mM Na3VO4 
NP-40 buffer  1% NP40, 20mM Tris-Cl, pH 7.5, 150mM NaCl, 1mM MgCl2, 1mM EGTA 
LOS
5
 lysis buffer  2% SDS
6
, 4% β-mercaptoethanol, 10% glycerol, 1M Tris [pH 6.8],   






resolving gel solution 25% 0.99 M Tris [pH 8.8], 0.1% SDS, X% of 37.5:1  acrylamide/bis-acyrlamide 
   stock [40% acrylamide/bis-acrylamide, 2.67 C] depending on the gel percentage, 
   bring to volume with HPLC grade-water, degassed for 10 min, 0.1% APS
8
 and  
   0.001% TEMED added after degassing) 
stacking gel solution 25% 0.5 M Tris [pH 6.8], 12.5% acrylamide/bis-acrylamide stock, 0.1 % SDS,  
   61% HPLC-grade water, degassed for 10 min, 0.1% APS and 0.001% TEMED  
   added after degassing 
1X running buffer 25 mM Tris, 192 mM glycine, 1% SDS 
2X loading buffer 50% glycerol, 5% SDS, 0.25M Tris-Cl pH 6.8, 0.04% 2-mercaptoethanol,  
   25µg/ml bromophenol blue 
Gel Staining 
Coomassie Blue  Coomassie Brilliant Blue R-250 
Coomassie Blue destain 50% methanol, 40% HPLC-grade water, 10% glacial acetic acid 
Fixing solution  30% ethanol, 10% glacial acetic acid, 60% HPLC-grade water 
Silver Stain  0.8 g AgNO3 in 4 ml HPLC-grade water added dropwise to: 1.4 ml NH4OH, 0.1  
   g NaOH, 25 ml HPLC-grade water 
Developing solution 50 µg/ml citric acid, 0.019% formaldehyde 
Western/Immunoblotting 
1X transfer buffer 25mM Tris, 192mM glycine, 15% methanol, pH 8.2 
wash buffer  1X PBS/0.05% Tween-20 
blocking solution  Western wash buffer, 1% fish skin gelatin 




 solution 2 µg/ml Ab, 0.1 M Na2HPO4, pH 9.0 with HCl 
ELISA wash buffer 0.05% Tween-20, 1X PBS, pH 7.4 
Detection Ab solution 1 µg/ml Ab, 10% FBS in ELISA wash buffer 
SAP
10





 substrate solution one 5 mg PNPP tablet dissolve in 5 ml (0.24 mM MgCl2·6H2O, 9.6%   
   diethanolamine, pH 9.8) prepared just prior to use 
Antibody Purification and Labeling 
Starting Buffer  100 mM Tris, 100 mM NaCl, pH 7.5 
Elution Buffer  100 mM glycine, pH 2.5 
Neutralization Buffer 1 M Tris, pH 8.0 
Bicarbonate solution 1M NaHCO
3
, pH 8.3 
Spin column buffer 2 mM sodium azide in PBS 
Immunofluorescence 
blocking solution  10% FBS and 10 µM glycine in 1X PBS 
permeabilization solution 0.1% Triton X-100, 10% FBS, 10 mM glycine in 1X PBS 
Molecular Cloning and Agarose Gel Electrophoresis 
10X ligase buffer  0.5M Tris-HCl [pH 7.8], 0.1M MgCl2, 10mM ATP, 500 µg/ml BSA 
1X TBE buffer  89 mM Tris-HCl [pH 8.0], 89 mM boric acid, 2mM EDTA 
loading dye  5% glycerol, 0.05% Orange G 
Nitrocefin Hydrolysis Assay 
PE buffer  0.1 M phosphate buffer, 1 mM EDTA, pH 7.0 
 
1    GC = gonococci 
2    DMEM = Dulbecco’s minimal essential media 
3    IM = invasion media 
4    FBS = fetal bovine serum 
5    LOS = lipooligosaccharide 
6    SDS = sodium dodecyl sulfate 
7    PAGE = polyacrylamide gel electrophoresis 
8    APS = ammonium persulfate 
9    Ab = antibody 
10  SAP = streptavidin-alkaline phosphatase 
11  PNPP = p-nitrophenyl phosphate 
 
 28 
t-test with a 95% confidence interval using GraphPad Prism version 3.00 for Windows. 









 FA1090 Φ(bla-iga’) in Figure 15A, only experiments were 
greater than 10% of the ME180 cell population were invaded by GC were chosen for 
analysis. Data where the means were determined to be statistically different/significant 
were denoted by (*), (**), or (***) depending on the strength of the statistical data.  
 
LOS Sialylation.  GC strain F62∆lgtD was grown overnight and resuspended to a Klett 
of 40 in GCP solution containing 1% Kellogg’s supplement and 0.042% NaHCO3. 1 ml 
of GC was transferred into a 10 ml polypropylene tube and 50 µl of 1 mg/ml CMP-
NANA added. (A corresponding tube for each trial was grown without CMP-NANA as a 
negative control for sialylation.) The tubes were incubated for 4 h in a rotation shaker at 
37
o
C and then added directly to ME180 cells for signaling assays described below. LOS  
was extracted from one set of tubes to test for LOS sialylation via Tris-Tricine SDS-
PAGE analysis described below. 
 
Signaling Assays.  ME180 cells were seeded in serum-starved invasion media (IM) in 6-
well tissue culture plates (5 x 10
5
 cells/well) or 100 mm diameter (100 mm) tissue culture 
plates (1 x 10
7
 cells/well). ME180 cells were incubated for ~60 min in serum-free IM 
prior to incubation with GC, N. sicca 342, N. subflava 44, or inert bovine serum albumin 
(BSA)-coated microspheres/beads at a MOI of 10. Fluoresbrite® YG carboxylated 
microspheres (1 µm) were coated with BSA using the carbodiimide kit and sterilized with 
70% ethanol rinsing according to the manufacturer’s instructions (Polysciences, Inc., 
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Warrington, PA). Prior to their addition to ME180 cells, the beads were resuspended in 
RPMI similar to bacteria.  
 After incubation, the tissue culture plates were placed on an ice bath and washed 
three times with ice-cold PBS (pH 7.4). Lysates were collected by adding 100 µl (6-well) 
or 250 µl (100 mm plates) of NP-40 lysis solution to each well, scraping the cells from 
the plates with a cell scraper, and pipetting the lysate into microcentrifuge tubes. The 
lysates were placed on ice for 20-30 min, vortexed briefly every 7 min, centrifuged at 4
o
C 
for 30 min at 12000 rpm, and the supernatants transferred to a new microcentrifuge tube 




LOS Preparation from GC.  LOS was prepared using the procedure of Hitchcock and 
Brown (118). GC were grown overnight and resuspended in GCP to Klett 100. An aliquot 
(1 ml) was transferred to a microcentrifuge tube and centrifuged for 3 min at 12000 rpm. 
Supernatants were removed via aspiration and 50 µl lysis buffer and 10 µl proteinase K 
(2.5 mg/ml) added. Samples were boiled for at least 60 min at 60
o
C and diluted 1:25 in 
lysis buffer after boiling. Aliquots (10-15 µl) of each LOS sample were run on Tris-
Tricine/SDS polyacrylamide gels and silver stained to detect LOS bands as described 
previously (283). Images were acquired using the Gel Doc XR transilluminator (Biorad) 
and processed using Quantity One 1-D analytical software version 4.6.1 (Biorad). 
 
Protein Concentration Assay (Bradford Assay).  Lysates were diluted 1:5 in NP-40 
buffer and 10 µl of diluted lysate was added to a 96-well plate in triplicate. Different 
concentrations of BSA (0.5, 0.4, 0.25, 0.1, 0.05 µg/µl) were added to the 96-well plate in 
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duplicate as protein concentration standards. To each well, 200 µl of Biorad Protein 
Assay reagent (diluted 1:5) was added, samples were incubated 20-30 min at room 
temperature (RT), and analyzed on a Labsystems Multiskan Ascent (MTX Lab Systems, 
Inc., Vienna, VA) 96-well plate reader at λ = 595 nm. A standard protein concentration 
curve (OD595 nm [y-axis] vs. concentration (µg/ml) [x-axis]) was generated for the BSA 
samples using GraphPad Prism 3.0. By comparing the OD595 nm readings for each lysate 
to the BSA standard curve, the protein concentration of each lysate was determined and 
equilibrated in NP-40 buffer. 
 
SDS-PAGE and Western Blot.  SDS-PAGE gels of varied concentration (10%-15%, 4-
15% gradient, or 4-20% gradient) were purchased precast from Biorad or were manually 
cast as described previously (244). Lysates were diluted with 2X loading buffer in a 1:1 
ratio, boiled for 5 min, and centrifuged for 2 min at 12000 rpm. Unpolymerized 
acyrlamide was removed from the lanes, lysates were loaded, and the gels 
electrophoresed at 0.01Amp/gel at room temperature until the dye front reached the 
bottom of the gel. Gels were analyzed by: (1) Coomassie blue staining (2) silver staining 
(3) Western/immunoblotting. For Coomassie blue staining, the gels were stained 
overnight with mild shaking at RT according to the procedure of Maniatis (244). Gels 
were destained and images were acquired on a Gel Doc XR ultraviolet transilluminator 
(Biorad) and processed using Quantity One 1-D analytical software version 4.6.1 
(Biorad). For silver staining, the gels were fixed, incubated with a silver nitrate solution, 
washed, and the bands visualized in developing solution as described previously (244). 
For Western blotting experiments, samples were processed through a SDS-PAGE gel, the 
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gel equilibrated in transfer buffer, and the proteins transferred to a PVDF membrane 
(Osmonics). (The PVDF membrane was prepared by immersing the membrane in 
methanol, rinsing with HPLC-grade water and equilibrating in transfer buffer). Proteins 




 The PVDF membrane was incubated in blocking solution overnight at RT. The 
membrane was washed and incubated in primary antibody (Ab) solution (Ab in blocking 
solution) for 90 min at RT. (A list of primary Ab used in this study and their appropriate 
secondary Ab is found in Table 2). After washing, membranes were incubated in 
secondary Ab solution (secondary Ab-IgG-HRP conjugate in PBS/0.5% gelatin) for 60 
min at RT followed washes. Membranes were developed with luminal/peroxide Western 
Lightning
TM
 Chemiluminescence Reagent Plus (Perkin Elmer, Boston, MA) and exposed 
to blue autoradiography film (Marsh Bioproducts, Rochester, NY). To normalize for actin 
loading controls, membranes were incubated in stripping buffer for 45 min at 50
o
C, 
washed thoroughly with wash buffer and reprobed for actin protein detection following 
the procedure listed above.  
 
IL-8 Enzyme-Linked Immunosorbent Assays (ELISA).  ELISA experiments were 
performed to detect human interleukin-8 (IL-8) secretion from ME180 cells. ME180 cells 
were seeded in 24-well tissue culture plates (1 x 10
5
 cells/well) overnight in serum-
starved IM. ME180 cells were pre-incubated in serum-free IM and GC were prepared and 
added to ME180 cells as described in the signaling assays above. ME180 cells were 
incubated with GC or purified LOS (purified according to the Westphal and Jann hot-  
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Table 2.  Antibodies Used in This Study 
Primary Antibody   (Isotype) Secondary Antibody  
Mouse α-phosphotyrosine 4G10  (IgG2bκ)  Goat α-mouse IgG2b-HRP     
Rabbit α-phospho ERK 1/2  (IgG)  Goat α-rabbit IgG-HRP 
Rabbit α-phospho JNK   (IgG)  Goat α-rabbit IgG-HRP 
Rabbit α-phospho p38   (IgG)  Goat α-rabbit IgG-HRP 
Rabbit α-phospho EGFR [Tyr 1173] (IgG)  Goat α-rabbit IgG-HRP 
Rabbit α-β-actin    (IgG)  Goat α-rabbit IgG-HRP 
Rabbit α-phospho PKCα [Thr 638]  (IgG)  Goat α-rabbit IgG-HRP 
Rabbit α-human phospho Bad [Ser 136] (IgG)  Goat α-rabbit IgG-HRP 
Rabbit α-phospho Akt/PKB [Thr 308] (IgG)  Goat α-rabbit IgG-HRP 
Rabbit α-phospho Src [Tyr 418]  (IgG)  Goat α-rabbit IgG-HRP 
Mouse α-human IL-8   (IgG2bκ) 
Mouse α-human IL-8 [biotinylated]  (IgG2b) 
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phenol method) for 24 h in serum-free IM (299). Culture supernatants were collected, 
centrifuged at 12000 rpm for 5 min, and the supernatants transferred to new 
microcentrifuge tubes. Leupeptin and aprotinin protease inhibitors (fc 10 µg/ml) were 
added to each supernatant and supernatants were stored at -20
o
C (short-term storage) or   
-80
o
C (long-term storage). In JNK inhibition experiments, anthra[1,9-cd]pyrazol-6(2H)-
one (SP600125) (Biosource, Camarillo, CA), a JNK 1,2,3 inhibitor, was added to ME180 
cells at various concentrations 30 min prior to the addition of GC (15). 
 Sandwich ELISA were performed according to the protocols provided by BD 
Pharmigen (San Diego, CA) and all IL-8 Ab and recombinant standards were purchased 
from BD Pharmigen.  Briefly, to a non-sterile 96-well plate, 50 µl of mouse anti-human 
IL-8 IgG2bκ capture Ab solution was added to every well to be tested for the presence of 
IL-8. The plate was sealed with parafilm and stored overnight at 4
o
C. For all other 
incubations, the outgoing solution was decanted, the wells washed with ELISA wash 
buffer, and incubated in the incoming solution at RT.  Wells were blocked with 10% FBS 
in PBS for 30 min. 100 µl of the appropriate supernatant or IL-8 recombinant protein 
standard was added to each well for 4 h at RT or overnight at 4
o
C.  (Standards were 
prepared by resuspending the stock solution to 4000 pg/ml in RPMI and performing 1:2 
serial dilutions from 4000 pg/ml—7.8 pg/ml). IL-8 in the wells was detected by adding 
100 µl of biotinylated mouse anti-human IL-8 IgG2b Ab solution for 60 min. 100 µl of 
streptavidin-alkaline phosphatase (SAP) (Southern Biotech, Birmingham, AL) solution 
was added to each well for 30 min. 100 µl p-nitrophenyl phosphate (PNPP) substrate 
(Southern Biotech) solution was added to each well. The plate was immediately covered 
with aluminum foil and checked periodically for detection of yellow color production in a 
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linear range in the wells containing standards. At the appropriate time (~ after 15-30 
min), the plate was analyzed at λ = 405 nm using a Labsystems Multiskan Ascent 96-well 
plate reader (MTX Lab Systems, Inc.). Similar to the Bradford Assay above, a standard 
curve (OD405 nm vs. protein concentration) was developed for the IL-8 standards using 
GraphPad Prism 3.0 and the protein concentration of each supernatant was derived from 
their OD405 nm by comparison to the standard curve. 
 
Goat anti-GC IgG Polyclonal Antibody Purification.  All steps in this procedure were 
performed at 4
o
C unless otherwise stated. Agarose anti-goat IgG beads were washed with 
20 ml of starting buffer and centrifuged at 1000 rpm for 10 min three times. The beads 
were resuspended in 60-80 ml of starting buffer and slowly packed into an 8 mm 
diameter column. The beads were allowed to settle and the buffer was eluted. Crude goat 
serum containing anti-GC polyclonal Ab (Alpha Diagnostics, Inc., San Antonio, TX) was 
centrifuged at 10000 rpm for 10 min and the supernatant was diluted 1:2 in starting 
buffer. The Ab solution was added to the column and the liquid was eluted until all the 
Ab solution was added to the column. (The elutant was saved since some Ab did not bind 
due to column saturation.) Starting buffer was added to the column and elutant was 
collected in 2 ml increments. Each elutant was shaken to test for the generation of 
bubbles (an indication that non-specific proteins are still bound to the column) and no 
more starting buffer was added to the column once no more bubbles were observed. 
Elution buffer was added to the column and 2 ml fractions of elutant were collected in 
polypropylene tubes containing 200 µl of neutralization buffer. The absorbance of each 
fraction was measured spectrophotometrically at λ = 280 nm and all fractions with an 
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OD280nm above 0.2 were pooled together for protein concentration. The column was 
cleaned with 10 ml of elution buffer and 20 ml of starting buffer and stored in starting 
buffer containing azide at 4
o
C. 2 ml of purified Ab was added to a Centricon® reservoir 
capped with a collection vial. Samples were centrifuged at 3000 rpm for 30 min in an SS-
34 rotor and the filtrate was discarded. These steps were repeated until all purified Ab 
was bound to the filter matrix. The Centricon® tube was inverted and the new bottom of 
the tube was capped with a retention vial and centrifuge at 2500 rpm for 5 min. The 
recovered liquid was resuspended in 50% glycerol solution and the concentration of the 
recovered protein was measured using the Bradford assay. 
 
Conjugation of Chromophores to Purified Antibody.  Purified goat anti-GC Ab was 
conjugated to Oregon green 488 using the FluoReporter® Oregon Green 488 Protein 
Labeling Kit (Molecular Probes/Invitrogen). Briefly, 200 µl of Ab and 20 µl of 
bicarbonate solution were transferred to a reaction tube. In a separate tube, 500 µg of 
reactive Oregon green 488 dye (warmed to RT) was resuspended in 50 µl DMSO. Dye 
solution was stirred into the Ab solution for 60 min at RT protected from light based on 
the following equation:  
 
 µl of dye solution = [(Ab concentration)(0.2)/MW](509)(100)(MR) 
 
where MR = 15 or 20 if the purified Ab concentration is 1-3 mg/ml and MR = 10 or 15 if 
the purified Ab concentration is 4-10 mg/ml) and MW = the molecular weight of the Ab. 
Near the end of the labeling incubation, the column buffer was drained from a spin 
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column (containing a 30000 MW exclusion resin) and the spin column was placed in a 2 
ml collection tube. The column was centrifuged at 1100 x g for 3 min and the collected 
liquid was discarded. The labeling reaction was centrifuged at 12000 rpm for 5 min and 
the supernatant was added dropwise to the spin column to allow the labeled Ab to absorb 
onto the resin. The spin column was placed in a collection tube and centrifuged as 





Immunofluorescence Microscopy Analysis.  In general, ME180 cells were seeded on 
circular silicate glass coverslips (13 mm diameter x 0.13 mm—0.17 mm thick (Gold Seal, 
Eric Scientific Company, Portsmouth, NH)) in 24-well plates overnight. GC were added 
to wells and incubated for various lengths of time. Cells were washed with IM and once 
with PBS. Cells were fixed for 20 min with 4% paraformaldehyde (Electron Microscopy 
Sciences, Ft. Washington, PA) and treated with blocking solution for 5 min prior to 
staining. GC and host cells were stained on ice covered from light (unless otherwise 
stated).  
 To determine the cellular distribution patterns of GC on ME180 cells, 
extracellular adherent GC were stained with the Oregon green 488 conjugated goat anti-
GC Ab (100 µg/ml) on ice for 60 min. Cells were washed with PBS and treated with a 
permeabilization solution for 5 min at RT. F-actin was stained with Alexa Fluor 546-
labeled phalloidin (4 U/ml) (Molecular Probes/Invitrogen) in the permeabilization 
solution on ice for 60 min. In F-actin inhibitor studies, ME180 cells were pretreated for 
90 min with various concentrations of cytochalasin D prior to staining. In all procedures 
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following staining, cells were washed with PBS, fixed with 2% paraformaldehyde, and 
mounted on glass slides (Fisher Scientific, Pittsburgh, PA) with Gel/Mount (Biomeda, 
Foster City, CA). Cells were analyzed using laser scanning confocal microscopy (LSCM) 
(Zeiss LSM 510, Carl Zeiss North America, Thornwood, NY) utilizing the 488 nm and 
543 nm excitation lasers. 
 
Gentamicin and Tannic Acid Protection Assays.  ME180 or Hec1B cervical epithelial 
cells were seeded in 6-well tissue culture plates (5 X 10
5
 cells/well) or in 24-well plates 
(1 X 10
5 
cells/well) and incubated overnight. Prior to infection, GC strains FA1090, 
MS11 mKC, F62, F62∆lgtD, and F62∆lgtA were grown on GCK for 16-18 h; 
FA1090(pFT180) and FA1090 Φ(bla-iga’) were grown on GCK PenG for 16 h-18 or 20-
22 h, respectively; and E. coil strain DH5α was grown 16 h on LB agar. Bacteria were 
resuspended in GCP to a cell density of 1 x 10
9
/ml, added to host cells at the appropriate 
MOI, and incubated in ME180 cell-IM or Hec1B cell-IM for the designated times. Cells 
were washed four times with IM (or twice with IM and twice with PBS in wells to be 
treated with tannic acid [TA]). To quantify the total number of adherent and invasive GC 
(i.e., cell associated), IM was added to triplicate wells for 2 h. Wells were washed, treated 
with 1% saponin for 15 min, lysates were collected, and aliquots plated on GCK agar. To 
quantify the number of invasive GC, gentamicin (200 µg/ml or 500 µg/ml in specified 
experiments) or TA (0.1%, 0.2%, 0.5 %, or 0.2% 90 min + 1% 30 min in specified 
experiments) was added 2 h prior to the preparation of ME180 cell lysates. Supernatants 
were collected to quantify extracellular GC that remain resistant to gentamicin or TA 
treatment. The number of CFU arising on GCK agar was determined after 36-48 h 
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incubation. In experiments utilizing potential invasion inhibitors, ME180 cells were 
pretreated with TA (0.2% for 90 min, then 1% for 30 min) for 2 h, gentamicin (200 
µg/ml) for 2 h, or cytochalasin D (3 µM) for 45 min prior to incubation with GC. 
Cytochalasin D was maintained in wells during the incubation of ME180 cells with GC. 
 
Polymerase Chain Reaction.  All PCR reactions were performed using the Expand 
Long Template PCR Kit (Roche Applied Science, Penzberg, Germany). A series of 
reactions were prepared in two stock solution tubes. The first tube contained the 
appropriate forward and reverse primers (200 ng/reaction each) (Integrated DNA 
Technologies, Coralville, IA), template DNA (usually 1 µl), each of the four nucleotide 
triphosphates (ATP, TTP, CTP, and GTP) (175 µM each), and HPLC grade water. The 
second tube contained the appropriate DNA polymerase buffer (875µM) and Taq Long 
Template DNA Polymerase (1.25 U/reaction). An aliquot (22.25 µl) from the first stock 
tube was added to 8-strip thin-walled PCR tubes (Fisher Scientific, Pittsburgh, PA) and 
mixed with an aliquot (2.75 µl) from the second stock tube immediately prior to insertion 
into the thermocycler (MJ Research, Inc., Waltham, MA). PCR conditions were: 95
o
C for 
2 min, 10 amplification cycles (denaturation at 95
o
C for 30 sec, annealing at the 
appropriate temperature for 30 sec, and primer extension at 68
o
C for the appropriate 
time), then 30 additional amplification cycles with a higher annealing temperature 
(usually + 5
o
C) and 20 additional sec added to the primer extension of each cycle, and 
storage at 4
o




Agarose Gel Electrophoresis.  Agarose gels (1%) were prepared in TBE buffer with 10 
µl ethidium bromide (10 mg/ml). Agarose gel electrophoresis was performed at constant 
voltage (100 V) until the loading dye front reached the bottom of the gel.  Gels were 
visualized using a Gel Doc XR ultraviolet transilluminator (Biorad) and gel images were 
processed using Quantity One 1-D analytical software version 4.6.1 (Biorad). 
 
General Cloning Procedures.  Digestion and ligation of bacterial DNA was performed 
using restriction and ligation enzymes, buffers, and protocols provided by New England 
Biolabs (Beverly, MA). In general, digestion reactions totaled 20 µl, consisted of 
template DNA, HPLC grade water, 2 µl of 10X digestion buffer, and 1 µl of restriction 
enzyme (10-20 U/reaction), and proceeded at 37
o
C for 2 h or overnight. Ligation 
reactions totaled 20 µl, consisted of the appropriate molar ratios of template DNA(s), 
HPLC grade water, 2 µl of 10X ligase buffer, and <1 µl of T4 DNA ligase (~100-200 




Transformation of E. coli DH5α.  E. coli DH5α were made competent for heat-shock 
transformation using the Inoue method (244). An aliquot of competent E. coli DH5α was 
placed on ice for 10 min and mixed with transforming DNA. After a 2 min heat shock, 
cells were incubated for 30-45 min in a rotating shaker at 37
o
C. Transformants were 







GC Transformations.  GC were swabbed from GCK agar and resuspended to faint 
turbidity in sterile GC transformation broth in a polypropylene tube. 1 ml of resuspended 
GC was transferred to a borosilicate glass tube (Fisher Scientific, Pittsburgh, PA) and 
mixed with transforming DNA or no DNA (negative control).  The transformation mix 
was incubated in a rotating shaker for 3-4 h at 37
o
C, plated on selective antibiotic-
containing GCK agar, and incubated for 48 h. 
 The spot transformation was performed using the procedure of Gunn and 
coworkers (103). Briefly, one isolated P
+
 GC colony was resuspended in 100 µl GCP, 10 
mM MgCl2 solution. The GC solution was serial diluted 1:3 (25µl into 50 µl GCP), 10 
mM MgCl2 and 1 µl of high concentration (>1 µg/µl) DNA of interest was added to each 
dilution tube. An aliquot (5 µl of each dilution) was spotted onto GCK agar plates, spots 
were allowed to dry, and incubated overnight.  Isolated colonies were patch plated onto 
GCK PenG (10 ng/ml) and GCK plates to select for GC transformants possessing the bla-
igaβ gene fusion construct. 
 
Establishing the Reporter Strain, FA1090 Φ(bla-iga’).  The Bla-IgAβ fusion protein 
was constructed using a gene replacement strategy (see Fig. 11A and Fig. 11B) and was 
expressed in FA1090 to yield strain FA1090 Φ(bla-iga’). FA1090 chromosomal DNA 
was purified (Wizard Genome DNA kit, Promega, Madison, WI) and the IgA protease 
gene, iga, was amplified by the PCR from FA1090 chromosomal DNA using primers 
igaβ F2 and igaβ R2. The iga PCR product was digested with EcoRI and XbaI and 
directionally cloned into pK18 forming plasmid pSEB77. The first 3294 bp of the iga 
coding region and an additional 149 bp upstream of the iga start codon were deleted 
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utilizing deletion PCR with primers igaβ del F and igaβ del R. The deletion PCR product 
was digested with the BamHI and religated onto itself, forming pSEB77∆ (~5200 kb). 
The bla gene was amplified via the PCR from pBR322 using primers bla F and bla R, 
digested with BamHI and XmaI, and directionally cloned into pSEB77∆, forming 
pSEB79. (The bla PCR extended from 250 bp upstream of the bla start codon through the 
entire coding region, but excluded the bla stop codon.) pSEB79 contains the Φ(bla-iga’) 
gene fusion construct. The Φ(bla-iga’) construct was amplified from pSEB79 via the 
PCR with igaβ F3 and igaβ R3. The resulting PCR product was digested with XbaI and 
cloned into pK18UP, which possesses the gonococcal uptake sequence (GUS), to form 
pSEB82. GC strain FA1090 was transformed with pSEB82 utilizing the gonococcal DNA 
spot transformation procedure. Transformants were selected on GCK agar containing 10  
ng/ml PenG and confirmed to possess PenG resistance on 75 ng/ml GCK PenG media.  
(All primers used in this study are described in Table 3.) 
 
Nitrocefin Hydrolysis Assay.  Bla activity was determined using a modified version of a 
spectrophotometric assay established by O’Callaghan et al. (214) (see Fig. 12A). Briefly, 
GC were grown overnight at 37
o
C in GC broth, resuspended to a Klett of 100, and 
collected by centrifugation for 1 min at 12000 rpm. Culture supernatants were saved. 
Pellets were resuspended in PE buffer. A 500 µg/ml (1 mM) stock solution of nitrocefin 
substrate (Calbiochem, LaJolla, CA) was prepared according to the manufacturer’s 
instructions and stored as aliquots at -20
o
C. Appropriate dilutions of bacteria culture 
supernatants (overnight broth cultures diluted to Klett 50, centrifuged for 1 min at 12000 
rpm, supernatants transferred to a new tube, and diluted in PE buffer for  
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Table 3.   List of Primers Used in This Study 




Bla F    TCCCCCCGGGCCGCATTAAAGCTTATCGATG
b
 
Bla R    CGGGATCCCCAATGCTTAATCAGTGAGG
c
  
igaβ F2    GCTCTAGACCCGAGATACTGACCAAATG
d
   
igaβ R2    CGGAATTCCAAAGGCATTGAGCTGTAGC
e
   
igaβ del F   CGGGATCCCCCGGGCTGTTATTCAAGCGAAGATGGGAAGC
f
   
igaβ del R   CGGGATCCGTACAGCAAAACAATGTGGAAATTGC
g
   
igaβ F3    CCAATGCATCTAGACCCGAGATACTGACCAAATG
h
   
igaβ R3    CCAATGCATCTAGAGGCATTGAGCTGTAGCTTTG
i
  
Omega F   GACCTGCAGTTGCAAACCCTCACTGATCC
j
 
Omega R   CAGTCTGCAGGAGTTAAGCCGCGCCGCGAA
k
 
GCKatA F1   TCCCCCCGGGGTGCCTCGTCAGAATAGGAC
l
  
GCKatA R1   CCCAAGCTTAATGCCAATACTGATGCGAGG
m
 
GCKatA del F1   AAAACTGCAGCGGAAAGCGTATTCGTAACCGG
n
 




                                                                                                                                                                
 
a  The underlined sequence represents the restriction enzyme site   
b  Amplifies bla starting 250 bp upstream of bla start codon, XmaI site    
c  Amplifies bla starting at the 3’ end of bla excluding the stop codon, BamHI site   
d  Amplifies iga starting 1095 bp upstream of iga start codon, XbaI site   
e  Amplifies iga starting 94 bp downstream of iga stop codon, EcoRI site   
f  Amplifies sequence starting 149 bp upstream of the iga promoter and continues upstream of iga, BamHI site   
g  Amplifies the β-domain of iga and downstream sequence, BamHI site 
h  Amplifies the Φ(bla-iga’) construct from pK18 Φ(bla-iga’) starting upstream, XbaI site 
i   Amplifies the Φ(bla-iga’) construct from pK18 Φ(bla-iga’) starting downstream, XbaI site 
j   Amplifies the ΩSpec cassette from pHP45 starting upstream, PstI site 
k  Amplifies the ΩSpec cassette from pHP45 starting downstream, PstI site 
l   Amplifies katA starting 1090 bp upstream of katA start codon, XmaI site 
m Amplifies katA starting 1280 bp downstream of katA stop codon, HindIII site 
n  Amplifies sequence starting 62 bp upstream of katA start codon and continues upstream of katA, PstI site 
o  Amplifies sequence starting 259 bp upstream of katA stop codon and continues downstream of katA, PstI site 
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spectrophotometric reading) or buffer blanks (diluted to a concentration where OD 
readings fell into a linear range of nitrocefin hydrolysis) were incubated with nitrocefin 
(fc 50 µg/ml) at RT for 30 min and centrifuged for 1 min at 12000 rpm. Supernatants 
were collected and transferred to disposable plastic cuvets and the OD at λ = 520 nm 
measured. Control samples included PE buffer alone, nitrocefin alone in PE buffer, each 
GC strain alone in PE buffer, and GC broth in PE buffer. The Bla activity of the FA1090 
Φ(bla-iga’) pellet was established as 100 arbitrary units (AU) for a selected individual 
trial (within the triplicate trials). 100 AU of activity is defined as the amount of nitrocefin 
hydrolyzed in 30 min by 1 x 10
9
 FA1090 Φ(bla-iga’) in a 1 ml reaction. The enzymatic 
activity in other pellet samples and culture supernatants were normalized to this reading. 
In experiments with nonviable GC, prior to analysis, GC were killed with gentamicin and 
4
o
C overnight storage as described previously (218). 
 
Cellular Distribution of CCF2-AM.  ME180 cells were seeded in 24-well plates on 
coverslips overnight as described above, washed with RPMI 1640 containing 10 µM 
Hepes, and loaded with 1 µM CCF2-AM (Invitrogen/PanVera, Carlsbad, CA) for 90 min 
at room temperature. Hoechst 33342 (100 ng/ml) (Molecular Probes/Invitrogen) was 
added for the final 60 min. Cells were washed once with PBS and mounted on glass 
slides with Gel/Mount. Cells were analyzed using a Zeiss Axioplan 2 fluorescence 
microscope (Carl Zeiss North America, Thornwood, NY). 
 
Fluorescence-based β-lactamase Reporter Assay.  ME180 cells were seeded in 24-well 
plates on coverslips (for fluorescence microscopy) or in 6-well plates without coverslips 
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(for flow cytometry) overnight. FA1090 Φ(bla-iga’) was grown on GCK PenG 
overnight, added to the wells at the indicated MOI, and incubated for 6 h (unless 
otherwise stated). GC culture supernatants were prepared as above and filtered through 
0.2 µm Acrodisc Syringe Filter (Pall/Gelman Laboratory, East Hills, NY)] before 
incubation with host cells. After washing, cells were incubated with 1 µM CCF2-AM for 
90 min (for fluorescence microscopy) or 0.25 µM CCF2-AM for 45-60 min (for flow 
cytometry) at RT covered from light. For microscopic visualization, cells were washed 
with PBS and coverslips were mounted on glass slides with Gel/Mount. Cells were 
analyzed using a Zeiss AxioImagerZ1 microscope (Carl Zeiss North America) with 
excitation at 405 nm and image quality was optimized using AxioVision 4.6 software 
(Carl Zeiss North America). For flow cytometry analysis, cells were washed with PBS, 
incubated in trypsin (Mediatech, Herndon, VA) for 15 min at 37
o
C, and pelleted. Cells 
were resuspended in 5 ml polystyrene round bottom tubes (12 x 75 mm) (BD 
Biosciences, Bedford, MA) and centrifuged at 1250 rpm for 5 min at 4
o
C. Trypsin was 
decanted and ME180 cells were gently resuspended in PBS and placed on ice covered 
from light until analysis. Samples were gravity filtered through 30 µm Filcons (Consul 
T.S., Torino, Italy) immediately prior to analysis. Cells were resuspended in PBS and 
analyzed using the 405 nm (photomultiplier tube FL6) and 488 nm (photomultiplier tube 
FL1) excitation lasers on a CyAn ADP flow cytometer (Dako Cytomation, Fort Collins, 
CO). (Experimental trials for flow cytometry analysis where procedural changes occur, 
including alterations in the invasion MOI, invasion time course, CCF2-AM 
concentrations, or CCF2-AM loading time, are indicated in the appropriate figure legends 
and/or Results subsection.) For experiments utilizing inhibitors, ME180 cells were 
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pretreated with cytochalasin D (100 µM) for 60 min or latrunculin B (5 µM) for 45 min 
prior to incubation with GC and the inhibitors were maintained in the media throughout 
the incubations. Data were analyzed using the Summit 4.1 software (Dako Cytomation). 
 
Establishing the Catalase Deficient Strain, FA1090∆katA.  The GC catalase gene 
(katA) was deleted and replaced with a spectinomycin resistance (Spec
R
) cassette (ΩSpec) 
using a gene replacement strategy (see Fig. 26A and Fig. 26B) and was expressed in 
FA1090 to yield strain FA1090∆katA. FA1090 chromosomal DNA was purified (Wizard 
Genome DNA kit, Promega) and the katA gene was amplified by the PCR from FA1090 
chromosomal DNA using primers GCKatA F1 and GCKatA R1. The katA PCR product 
(~3880 bp) was digested with XmaI and HindIII and directionally cloned into pK18 
(~2700 bp) forming plasmid pSEB3 (~6550 bp). The first 1254 bp of the katA coding 
region and an additional 62 bp upstream of the katA start codon were deleted utilizing 
deletion PCR with primers GCKatA del F1 and GCKatA del R1 (A GUS is located 77 bp 
downstream of the katA stop codon in the flanking region amplified by GCKatA del R1). 
The deletion PCR product was digested with the PstI and religated onto itself, forming 
pSEB3∆ (~5230 bp). The ΩSpec cassette (~1450 bp) was amplified via the PCR from 
pHP45 (~2340 bp) using primers Omega F and Omega R, digested with PstI, and cloned 
into pSEB3∆, forming pSEB5 (~6680 bp). GC strain FA1090 was transformed with 
pSEB5. Transformants were selected on GCK agar containing 50 µg/ml kanamycin and 
50 µg/ml Spec. The lack of catalase activity was confirmed in transformants by adding 
hydrogen peroxide (10%) dropwise to patch streaks to test for the production of O2 
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bubbles. FA1090 was tested with hydrogen peroxide as a positive control. (All primers 
used in this study are described in Table 3.)  
 
Generating Spontaneous Rifampicin and Naladixic Acid Resistant Mutants of GC.  
GC strains FA1090 and FA1090∆katA were grown overnight and resuspended to a Klett 
of 100 in GCP solution. Bacteria (250 µl) were plated on GCK agar containing rifampicin 
(Rif) (50 µg/ml) or naladixic acid (Nal) (50 µg/ml) and incubated for 48-72 h. Colonies 







GC Intracellular Survival and Escape Assays.  ME180 cells or Hec1B cells were 
seeded in 6-well or 24-well tissue culture plates and incubated with GC as described in 
the gentamicin protection assay above unless otherwise stated. In all survival and escape 
assays, supernatants and cell lysates were collected at each time point as described in the 
gentamicin protection assay unless otherwise stated.  
 To quantify GC adherence, invasion, and intracellular survival under continuous 
bactericidal agent treatment, cells were treated with gentamicin (200 µg/ml or 500 
µg/ml) or TA (0.1% or 0.5%) for 2 h post-infection. Wells were washed and treated with 
the same concentration of gentamicin or TA for 2 and 4 h chase periods. Alternatively, to 
quantify GC invasion, intracellular survival, and escape with intermittent bactericidal 
agent treatment, survival assays were performed as described above except wells were 
treated with gentamicin (200 µg/ml) or TA (0.1% or 0.2% 90 min+ 1% 30 min) for 2 h 
post-infection and then treated with IM during the 2 and 4 h chase periods. After the 
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chase period, some wells were treated with 0.1% TA for 1 h. To measure GC survival, 
lysates were collected at each time point and to quantify escape, supernatants were 
collected at each time point. In experiments where cytoskeletal inhibitors were used, 
cytochalasin D (3 µM), latrunculin B (1 µM), or nocodazole (35 µM) were added to the 
gentamicin for the final 15 min of the 2 h post-infection treatment and added during the 





 FA1090 Φ(bla-iga’) for 6 h and treated with gentamicin (200 
µg/ml) for various lengths of time. Following gentamicin treatment, cells were loaded 
with 0.25 µM CCF2-AM for 45-60 min and analyzed by flow cytometry as described 
above. 
 For competitive intracellular survival assays between FA1090 and FA1090∆katA, 
ME180 cells were seeded in 6-well tissue culture plates (4 x 10
5
 cells/well). To each well, 
half of the added GC were FA1090 and the other half were FA1090∆katA as follows: (1) 
Rif
R
 FA1090 vs. Nal
R
 FA1090∆katA or (2) Nal
R
 FA1090 vs. Rif
R
 FA1090∆katA. ME180 
cells were incubated with 8 x 10
6
 GC/well (4 x 10
6
 FA1090 and 4 x 10
6
 FA1090∆katA) 
(for assays with a starting MOI 10) or 8 x 10
8
 GC/well (4 x 10
8
 FA1090 and 4 x 10
8
 
FA1090∆katA) (for assays with a starting MOI 1000) for 6 h and chased with 200 µg/ml 
gentamicin (MOI 10 assays) or 500 µg/ml gentamicin (MOI 1000 assays) to test for GC 
adherence, invasion, and survival in the presence of continuous bactericidal agent 
treatment as described above. In all TA treated wells, the initial wash after treatment was 
performed with PBS followed by additional washes with IM. All data was compiled 




Gentamicin or TA GC Kill Curve Assays.  GC were grown overnight and resuspended 
in GCP (1 x 10
9
/ml). For the gentamicin kill curve assay, GC were diluted (7.5 x 10
7
 
GC/well) in IM with or without gentamicin in 6-well tissue culture plates. Samples were 
collected every 20 min over a 2 h period and diluted for viable cell count on GCK. For 
the TA kill curve assay, GC were diluted (1 x 10
 8
 GC/well) in PBS plus 1% Kellogg’s 
supplement with or without TA in 6-well tissue culture plates. Samples were collected at 
0, 30, 60, 120, and 210 min and diluted for viable cell count on GCK.  The number of 
CFU arising on GCK agar was determined after 36-48 h incubation. 
 
Viability Staining.  For viability staining procedures, ME180 cells were incubated with 
GC in 24-well tissue culture plates as described in the gentamicin protection assay above. 
Afterwards, ME180 cells were treated with IM, gentamicin (500 µg/ml) in IM, or TA 
(0.1%) in PBS for 60 min. Cells were washed with PBS, stained for 60 min with SYTO 
13 (1-2 µM) (Invitrogen/Molecular Probes) and propidium iodide (250 ng/ml) 
(Invitrogen/Molecular Probes), and post-fixed and mounted as described in the 
immunofluorescence microscopy analysis above. In trials without ME180 cells, 5 x 
10
8
/well GC were incubated in IM or TA and resuspended in SYTO 13/propidium iodide 
solution. After staining, GC were washed three times with PBS and resuspended in PBS 
at a concentration of 1.7 x10
7
 GC/µl in 30 µl. The entire suspension was streaked onto 
glass slides, air dried at RT protected from light for 45 min, and heat-fixed to the slide 




TA Disc Diffusion Assay.  FA1090 were resuspended to a cell density of 1 x 10
9
 GC/ml, 
diluted (1 x 10
8
 GC/ml), and 100 µl of diluted culture was swabbed onto GCK. Blank 
paper discs (6 mm diameter, Becton Dickinson) were immersed in TA or PBS, removed 
until no longer dripping with solution, and placed on the FA1090-swabbed GCK plate. 
Disc-containing GCK plates were incubated for 24 h. Following incubation, the diameter 
of the each zone of FA1090 growth inhibition generated around each disc was measured 
from two separate positions on the zone of inhibition. 
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CHAPTER 1—HOST CELL SIGNALING INDUCED BY NEISSERIA 
GONORRHOEAE PRIOR TO INVASION 
Introduction 
 During host-pathogen interactions, bacteria, such as GC, can bind to cell surface 
receptors by mimicking receptor ligands. Receptors undergo conformational changes that 
can lead to receptor autophosphorylation or the recruitment of scaffolding/adapter 
proteins that possess binding sites for signaling molecules, such as kinases. Kinases 
mediate phosphorelay transfers from receptors to various internal signaling molecules 
and amplify signals during these phospho-transfers. A signal initiated at a single receptor 
can be amplified by kinase activity to trigger an entire signaling cascade [for review see 
(128)]. Since GC can bind to a variety of host receptors using different GC surface 
molecules, the order of receptor binding and the number of different receptors bound may 
influence which host cell signaling pathways are affected, the degree of 
activation/deactivation of each pathway, and the eventual outcome of infection. GC 
infections in women are characterized by an initial asymptomatic state and bacterial 
invasion into subepithelial tissues (270); thus, GC must interact with and signal to 
cervical epithelial cells in a manner that allows invasion without eliciting inflammatory 
immune responses.  
The MAPK signaling pathways are central regulators of numerous host cell 
processes, including cell survival, proliferation, differentiation, apoptosis, and stress 
responses [for review see (41, 240)]. MAPK activation is linked to actin reorganization 
and elongation of actin microfilaments around GC subsequently encloses the bacteria 
within the host cell (98, 126). Each MAPK module consists of a MAPK kinase kinase, a 
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MAPK kinase, and the actual MAPK (ERK, JNK, or p38). All three MAPKs 
phosphorylate a variety of cytoskeletal proteins, including paxillin by ERK, p38, and 
JNK; caldesmon by p38; and profilin and p150-spir by JNK (90, 125, 127, 136, 159, 
215). MAPK can also trigger downstream kinases, which activate actin-related proteins. 
ERK can phosphorylate ribosomal S6 kinase 1 (RSK1) or PAK to regulate filamin A, an 
actin cross linking protein involved in actin rearrangements (286, 305). ERK can also 
transfer phosphates to MLCK to activate the actin motor protein myosin and increase 
membrane protrusions (155, 212, 282). Signaling by p38 to MAPKAP 2/3 phosphorylates 
p16 of the Arp 2/3 actin regulation complex and heat-shock protein 27 to instigate actin 
polymerization (102, 263). These indirect activation strategies permit signals to be 
amplified further by these downstream kinases prior to transfer to the actin cytoskeleton. 
MAPK could also translocate into the nucleus to activate transcription factors to turn on 
actin-associated genes and cytokine genes to mediate proinflammatory immune responses 
(240).  
 Combinations of p38, JNK, and/or ERK signaling have been determined to 
contribute to invasion by many pathogens, including N. meningitidis (75, 77, 124, 157, 
249, 264, 278). A connection between MAPK activation and GC invasion into epithelial 
cells has not been established, but JNK does contribute to GC internalization into 
phagocytes (110, 113). OpaCEA-expressing GC trigger ASM in monocytes, which leads to 
increased Src activation, downstream upregulated of JNK phosphorylation, and GC 
internalization (110, 113). GC pilus retraction was shown to enhance the activation of all 
three MAPK in T84 epithelial cells and GC were shown to activate JNK in Chang 
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conjunctiva and HeLa cells to increase activator protein 1 (AP-1) activation and cytokine 
production (123, 210).  
 Signaling through the epidermal growth factor receptor (EGFR, or ErbB1) 
represents a well-known pathway to activate ERK. ErbB1 is activated by binding to 
ligands directly or through transactivation. During transactivation, ligand binding to G-
protein coupled receptors triggers proteases to release growth factors from the cell that 
can then bind to other receptors, such as ErbB1 (221). Once activated, ErbB1 dimerizes 
and autophosphorylates using its inherent tyrosine kinase activity. Various signaling 
molecules, including Grb2, SOS, and Ras are recruited to phosphorylate ErbB1. Ras then 
signals to a MAPK kinase kinase to initiate a MAPK signaling module (221). Signaling 
continues through ErbB1 until specific tyrosines on ErbB1 become phosphorylated and 
recruited phosphatases, such as SHP-1, dephosphorylate the receptor and attenuate the 
pathway (149). Once GC attach to epithelial cells, they recruit ErbB1 as part of cortical 
plaque formations (185), suggesting that ErbB1 manipulation is important in GC 
pathogenesis. 
 Signaling pathways other than MAPK are also modulated by pathogens, eliciting 
host cell responses. Bad is a pro-apoptotic factor from the Bcl-2 protein family that binds 
to Bcl-2 and Bcl-XL to promote apoptosis (54). Whether GC trigger apoptosis in 
epithelial cells remains controversial. In a study where GC upregulated anti-apoptotic 
factors, Bad activation levels were unchanged (23). In studies where GC PorB induced 
epithelial cell apoptosis, Bad was not investigated. Bad can be phosphorylated by JNK or 
Akt to promote cell survival by preventing its binding to Bcl-2 and Bcl-XL (54, 174). Akt 
is involved in cell cycle regulation, cell survival, and proliferation (259). Previous reports 
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indicate that GC target Akt activation to enhance entry as part of specific invasion 
pathways. GC PLD can bind directly to Akt to increase CR3-mediated invasion in 
primary cervical cells and blocking PI3K/Akt signaling and recruitment to GC 
microcolonies inhibits epithelial cell invasion (70, 167). 
 PKC is another signaling molecule linked to bacterial invasion. A signal through 
PKC can be directed to numerous pathways depending on the cell conditions and the 
stimulating ligand (208). PKC activation requires an increase in intracellular calcium 
levels triggered by secondary messengers such as diacylglycerol or inositol-triphosphate 
(236, 237). Inhibition of PKC blocks internalization of GC and heparin-coated beads 
through HSPG receptors in HeLa and Hec1B epithelial cells, but not in ME180 cells or 
Chang conjunctiva cells (59, 61, 81). The interaction of GC pili and Por with A431 
epithelial cells also induces elevated cytoplasmic calcium levels suggesting PKC may be 
activated in these cells (13, 146).  
 Src represents another family of at least eight kinases involved in a diverse 
network of cellular functions [for review see (280)]. Several studies indicate GC target 
Src during host cell invasion via CEACAM receptors. Inhibition of Src kinases inhibits 
Opa-dependent GC internalization via CEACAM 3 in HeLa cells or the CEACAM 
1/ASM signaling pathway in neutrophils (110, 180). Infection with piliated GC also 
induces phosphorylation of the pilus receptor, CD46 by a specific Src kinase—c-Yes 
(166). Most of these studies point to a greater role for Src in GC interaction with 
phagocytes, but the role of Src signaling in epithelial cell invasion is unknown.   
 In this study, I identified signaling pathways manipulated by GC that may 
facilitate GC invasion and immune evasion in the ME180 epithelial cell line. Since most 
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epithelial cells internalize GC 4-6 h after inoculation (98, 261, 266), I focused on GC-
host cell signaling transpiring during the first 3 h of infection. I reasoned that signaling 
events during these early time points would be responsible for the conformational 
changes in host cell proteins and alterations in host cell gene expression that lead to GC 
invasion. I followed activation of signaling pathways by performing immunoblots and 
probing for the phosphorylated forms of each protein of interest. The proinflammatory 
response of epithelial cells during incubations with GC was measured by detecting IL-8 
cytokine production through ELISA. I determined that GC induce MAPK activation in 
ME180 cells, but do not manipulate Bad, Akt, PKC, or Src-dependent signaling 
pathways. I identified an unusual prolonged ERK activation profile. ERK was triggered 
by GC early in infection and extended into time periods where GC are thought to initiate 
invasion. I also demonstrated that LOS antigenic variation influences JNK activation 
levels, which in turn, influences host cell proinflammatory cytokine production. My data 
indicate that GC expressing LnNT LOS may be better equipped for immune evasion. 
Overall, this study uncovers the fact that GC stimulate MAPK pathways at time points 




Tyrosine phosphorylation changes in ME180 cells induced by interactions with GC. 
 To determine the host cell signaling molecules GC trigger to mediate invasion, I 
incubated ME180 cells with strain F62 and monitored changes in protein tyrosine 
phosphorylation over time in comparison to untreated cells. I identified a ~200 kDa 
protein that displayed consistent decreased phosphorylation and ~40 kDa protein that 
showed increased phosphotyrosine levels (Fig. 2A). I performed a similar experiment 
over a longer time course using strain F62∆lgtD, which does not express the terminal 
GalNAc on its α-chain LOS, and observed five additional proteins from different trials 
that exhibited altered tyrosine phosphorylation (Fig. 2B). Each of the identified proteins 
showed different phosphorylation patterns: some exhibited detectable phosphorylation by 
as early as 5 min and lost their signal by 30 min (see Fig. 2B, proteins d and e), while 
other proteins were not activated until 30 min and/or sustain their signal until at least 90 
min (see Fig. 2A and Fig. 2B, protein a). These data indicate GC trigger host cell 
signaling pathway alterations during the early stages of infection leading up to invasion 
and suggest that changes in LOS structure affect these pathways. 
 
Activation of the ERK pathway in cervical epithelial cells.  A critical step in the GC 
invasion process is the rearrangement of the host actin cytoskeleton. Since the MAPKs 
have molecular weights near 40 kDa (the approximate size of some of the tyrosine 
phosphorylated proteins identified in Figure 2) and the MAPKs are associated with 
proteins involved in actin microfilament and microtubule rearrangement (41), I focused 




Figure 2—The effect of GC interaction with cervical epithelial cells on protein 
phosphorylation.  Signaling assays were performed by incubating ME180 cells with (A) 
no GC (-) or F62 or (B) no GC (-) or F62∆lgtD. In panel A, images show two host cell 
proteins (~200 kDa and ~40 kDa, respectively) with altered phosphorylation levels; actin 
= loading control. In panel B, proteins a-e represent five proteins with altered 
phosphorylation levels; (1) ~ 70 kDa (2) ~60 kDa (3) ~ 50 kDa (4) ~40-45 kDa. Protein 
phosphotyrosine was detected by probing lysates with an anti-phosphotyrosine 4G10 




 and time periods = min; data in each panel are 
representative of at least three independent experiments. 
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 To investigate the signaling pathways that control actin dynamics, I incubated 
ME180 cells with different GC variants and probed host cell lysates for phosphorylated 
proteins of interest by immunoblot analysis. GC strains stimulated prolonged activation 
of ERK. ME180 cells incubated in the absence of GC displayed little or no ERK 
phosphorylation over the course of the experiments (Fig. 3A, Fig. 3D, and Fig. 3F), 
indicating that increases in ERK phosphorylation were due to the added bacteria. When 
commensal Neisseria strains N. sicca 342 and N. subflava 44 were added to ME180 cells, 
rapid ERK activation was observed during the first 30 min, but this pattern differed from 
the extended ERK phosphorylation maintained for the entire 3 h time course in host cells 
incubated with GC strain F62∆lgtA (Fig. 3B). Since ERK phosphorylation was initiated 
(although in different patterns) by both commensal strains and GC, I determined if the 
ERK activation was the result of host cell contact with extracellular stimuli, in general. I 
coated carboxylated microspheres with bovine serum albumin (BSA) and introduced 
them to ME180 cells. The BSA coated beads were not able to activate ERK over 5 h (Fig. 
3C), indicating neisserial factors were triggering ERK and continuous ERK activation 
was a unique characteristic of the pathogenic GC. 
 I investigated the potential GC surface factors responsible for the prolonged 
phosphorylation of ERK. ME180 cells treated with LnNT LOS-expressing F62∆lgtD 
displayed extensive ERK activation over 3 h regardless of Opa expression (Fig. 3D) and 
only a slight reduction between 90 min and 3 h in cells infected with nonpiliated 
derivatives (Fig. 3E). Host cells infected with the lactosyl LOS-expressing F62∆lgtA 
showed a similar ERK activation profile to F62∆lgtD-infected cells (Fig. 3F-H). 




Figure 3—GC trigger extended ERK activation in epithelial cells. Signaling assays 









 F62∆lgtA (∆lgtA) or the commensal Neisseria strains N. sicca 342 (342) or 
N. subflava 44 (44), (C) the commensal strains N. sicca 342 or N. subflava 44 or bovine 
serum albumin-coated microspheres (BEADS), (D and E) F62∆lgtD (F and G) F62∆lgtD 
or F62∆lgtA or (H) F62∆lgtA; data in panels A, D, F, and G representative of at least 
three independent experiments; panels B and H representative of two independent 
experiments; panels C and E = single experiment. In each panel, untreated ME180 cells 
incubated in media alone (labeled [no GC] or [-]) served as negative controls for ERK 
activation and in selected panels, actin = loading control. ERK phosphorylation was 
detected by probing lysates with an anti-phospho-ERK 1/2 polyclonal antibody; time 
periods = min. The image quality of each blot shown was optimized for presentation and 
equivalent adjustments were made for each lane within a given image. 
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in epithelial cells for greater than 3 h. Pili expression appears to exhibit an enhanced 
contribution to ERK activation, but overall alterations in pili, Opa, and LOS expression 
did not result in strong ERK signal fluctuations. Thus, ERK activation may be provoked 
by an unidentified GC surface structure or may be activated by several factors in a 
redundant manner. Regardless, these data suggest a critical role for ERK in GC infection 
and its activation time course indicates this signaling may be an early step in generating 
invasion-susceptible host cells. 
 
GC-epithelial cell interactions lead to gradual p38 activation. To determine whether 
ERK is a specific GC target or if GC activate other MAPK during infection, I incubated 
ME180 cells with the GC variants utilized to study ERK activation described in Figure 3 
and tested host cell lysates for phosphorylation of the stress response kinase, p38. As in 
Figure 3, ME180 cells incubated in the absence of GC or treated with BSA-coated beads 
displayed little or no p38 phosphorylation (Fig. 4A, Fig. 4D, Fig. 4F, and Fig. 4I = 
untreated cells; Fig. 4C = beads), indicating that any p38 phosphorylation would be the 
results of added bacteria. N. sicca 342 and N. subflava 44 both activated p38, but their 
activation pattern varied between experimental trials (Fig. 4B and Fig. 4C). Among the 
F62 strains examined, all variants exhibited similar patterns of p38 activation. 
Phosphorylation levels were low over the first 30 min and increased to peak activation at 
the later 90 min and 3 h time points (Fig. 4D-J).  The only observed deviation from this 








 F62∆lgtA. In this 
phenotypic background, F62∆lgtA p38 activation peaked by 30 min at a higher degree 




Figure 4—GC elicit prolonged, but delayed, activation of p38. Signaling assays were 









 F62∆lgtA (∆lgtA) or the commensal Neisseria strain N. sicca 342 (342), (C) N. 
sicca 342, N. subflava 44 (44), or bovine serum albumin-coated microspheres (BEADS), 
(D and E) F62∆lgtD, (F-H) F62∆lgtD or F62∆lgtA, or (I and J) F62∆lgtA; data in panels 
A and D representative of at least three independent experiments; panels B, F, G, and I 
representative of two independent experiments; panels C, E, and H = single experiment. 
In each panel, untreated ME180 cells incubated in media alone (labeled [no GC] or [-]) 
served as negative controls for p38 activation and in selected panels, actin = loading 
control. p38 phosphorylation was detected by probing lysates with an anti-phospho-p38 
polyclonal antibody; time periods = min. The image quality of each blot shown was 




and pili expression did not alter the p38 phosphorylation pattern. Overall, these data 
indicate that p38 activation is downstream in the time course of host cell activation by 
GC relative to ERK activation. Phosphorylation of p38 is not influenced by LOS, Opa, or 
pili antigenic and phase variation suggesting p38 activation is not triggered by these 
invasion-promoting factors, but instead is a general stress response generated by GC. 
 
Influence of GC LOS antigenic variation and Opa expression on JNK signaling.  I 
examined JNK signaling in response to GC during the initial 3 h of infection by 
incubating ME180 cells with the GC variants utilized to study ERK and p38 activation 
described in Figures 3 and 4, respectively, and testing host cell lysates for JNK 
phosphorylation. As seen with other MAPK, ME180 cells incubated in the absence of GC 
or treated with BSA-coated beads displayed little or no JNK phosphorylation (Fig. 5A, 
Fig. 5B, and Fig. 5H). The commensals N. sicca 342 and N. subflava 44 showed a rapid 
JNK activation profile similar to the commensal-induced ERK signaling (see Fig. 3B). 
For these strains, the highest phosphorylation levels were observed in the first 30 min, but 
JNK activation peaked at later time points for GC (Fig. 5C). I also observed that the 
phospho-JNK antibody recognized multiple JNK isoforms.  
 To define the GC surface structures responsible for host cell JNK signaling, I 
incubated ME180 cells with different GC surface variants. In ME180 cells treated with 
F62∆lgtD, JNK activation peaked at 90 min and was reduced in host cells incubated with 
an Opa
+
 variant (Fig. 5D). These data suggest Opa expression decreases epithelial cell 
JNK activation. LOS truncation also influenced the host cell JNK activation profile. JNK 





Figure 5—GC activation of JNK.  Signaling assays were performed by incubating 








 F62∆lgtA (∆lgtA) or 




 F62∆lgtA (∆lgtA) or 
the commensal Neisseria strains N. sicca 342 (342) or N. subflava 44 (44), (D) F62∆lgtD, 
(E-G) F62∆lgtD or F62∆lgtA, or (H and I) F62∆lgtA; data in panels A and E 
representative of at least three independent experiments; panels D, F, G, and I 
representative of two independent experiments (I = different exposures from the same 
experiment); panels B, C, and H = single experiment. In each panel, untreated ME180 
cells incubated in media alone (labeled [no GC] or [-]) served as negative controls for 
JNK activation and in selected panels, actin = loading control. JNK phosphorylation was 
detected by probing lysates with an anti-phospho-JNK 1/2/3 polyclonal antibody; time 
periods = min. The image quality of each blot shown was optimized for presentation and 
equivalent adjustments were made for each lane within a given image. 
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cells incubated with Opa
+
 F62∆lgtA compared to Opa
+ 
F62∆lgtD-infected cells (90-180 




 F62∆lgtD derivatives, host cell phospho-
JNK levels are similar to levels created by the corresponding F62∆lgtA variants (Fig. 5F 




 F62∆lgtD reduce JNK signaling relative to 
other variants. Opa expression by piliated F62∆lgtA did not reduce host cell JNK 
phosphorylation as seen with the LnNT LOS strains above (Fig. 5H). P
-
 F62∆lgtA-
infected cells displayed a lower activation level of the major phospho-JNK isoform at 30 
min (Fig. 5I, panel 1), but exhibited a higher degree of activation of the two minor 
isoforms (characterized by slower migration on SDS-PAGE) at 3 h (Fig. 5I, panel 2). 
Taken together, these data demonstrate that GC expressing truncated LOS elicit more 
rapid and intense JNK activation from host cells compared to LnNT LOS-expressing GC 
in an Opa
+
 background. GC expressing Opa and LnNT LOS can inhibit and delay JNK 
signaling in infected host cells, which suggests that preventing a strong JNK activation 
signal in host cells is advantageous to GC infection.   
 
Role of LOS in inducing IL-8 expression from cervical epithelial cells.  One role of 
MAPK activation is to activate transcription factors to increase expression of 
proinflammatory cytokine genes. Since epithelial cells secrete proinflammatory 
cytokines, such as IL-8 and IL-6 in response to GC (78, 80, 108), I determined if 
increased activation of the JNK pathway influenced ME180 cells to produce more IL-8. I 
incubated ME180 cells with F62∆lgtD and F62∆lgtA for 24 h, collected culture 




F62∆lgtA triggered greater IL-8 




F62∆lgtD (p-value = 0.0001), but 
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treating cells with purified LOS from either strain was not sufficient to elicit IL-8 
secretion (Fig. 6A). The difference in IL-8 production appeared to correlate with the 




 F62∆lgtD or 
F62∆lgtA in Figure 5E. To determine if the increased JNK activation elicited by 
F62∆lgtA contributes to greater IL-8 secretion by epithelial cells, I treated ME180 cells 
with an inhibitor of JNK kinase activity, SP600125, to block further downstream JNK 
signaling events prior to incubation with F62∆lgtD or F62∆lgtA. In the presence of 
SP600125, IL-8 production from F62∆lgtA-infected ME180 cells was reduced, but 
remained higher than IL-8 levels in F62∆lgtD-infected cells, which were not affected by 
the inhibitor (Fig. 6B). Taken together, these data demonstrate that LnNT LOS 
expression by GC inhibits IL-8 production from epithelial cells (Fig. 6). IL-8 expression 
in epithelial cells is triggered by GC-induced signaling through the JNK pathway and at 
least one other unidentified pathway. GC expressing truncated LOS appear to activate the 
JNK pathway as an additional stimulus for IL-8 production. LnNT LOS-expressing GC 
do not signal through the JNK pathway and only activate the unidentified pathway(s) to 
elicit IL-8 production. Thus, IL-8 production is reduced during infections with LnNT-
expressing GC, which may help this variant inhibit recruitment of immune cells, such as 
neutrophils and macrophages, to infection sites.  
 
Contact with bacterial stimuli reduces ErbB1 autophosphorylation at tyrosine 1173.  
A previous report showed that the cell surface receptor ErbB1 (185 kDa) was recruited to 
sites of GC adherence on host epithelial cells (185). Autophosphorylation of ErbB1 at the 
regulatory site tyrosine 1173 (Y
1173





Figure 6—IL-8 production by epithelial cells infected with GC expressing different 
LOS structures.  ELISA were performed by incubating ME180 cells with: (A) 
F62∆lgtD, F62∆lgtA, or their corresponding purified LOS, or (B) F62∆lgtD or F62∆lgtA 
in the absence or presence of the JNK inhibitor, SP600125 (30 min pretreatment and 
maintained throughout incubation); data in panel A are representative of two independent 
experiments each performed in triplicate (±SD) and panel B = average (±SD) of triplicate 
trials (-inhibitor) or duplicate trials (+inhibitor) from a single experiment. In panel A, a 
statistical comparison between IL-8 production from F62∆lgtD-infected cells and 
F62∆lgtA-infected cells (bacteria) yielded a p-value = 0.0001. In panel B, a similar 
comparison between F62∆lgtA-infected cells (-inhibitor) and F62∆lgtA-infected cells (+ 5 
µM inhibitor) yielded a p-value = 0.0118 and the comparison between F62∆lgtA-infected 
cells (-inhibitor) and F62∆lgtA-infected cells (+ 0.5 µM inhibitor) yielded a p-value = 
0.0014. Cells incubated without GC (no GC) or media incubated without cells or GC 







which deactivates ErbB1 and prevents signaling to ERK. These factors combined with 
my finding that GC promote extended ERK activation in epithelial cells (see Figure 3) 
made this ErbB1 residue an excellent candidate for GC to target for dephosphorylation 
during infection. 
 To identify the ~200 kDa host cell protein from Figure 2A that exhibited 
decreased tyrosine phosphorylation upon incubation with F62, I incubated ME180 cells 
in the presence or absence of different GC variants as described in Figure 3 and examined 
ErbB1 phosphorylation. Untreated cells displayed high autophosphorylation at the Y
1173 
regulatory site over the course of the experiments (Fig. 7A and Fig. 7F), indicating that 
ErbB1 was not activated prior to GC infection. The addition of GC decreased ErbB1 
Y
1173
 phosphorylation suggesting GC induced activation of this pathway (Fig. 7A). 
However, none of the GC surface molecules examined influenced ErbB1 phosphorylation 
patterns. Lack of pili or Opa expression did not prevent GC-induced Y
1173
 
dephosphorylation (Fig. 7B-E), but Y
1173
 autophosphorylation levels tended to recover 
better at later time points (90 min, 3 h, or 5 h) in ME180 cells incubated with P
-
 variants 
(Fig. 7C and Fig. 7E). LOS variation also did not alter ErbB1 dephosphorylation patterns 
(Fig. 7F-H). Since ErbB1 is not known as a direct receptor for GC, I hypothesized that 
the physical contact of GC with epithelial cells may be responsible for the observed 
decrease in Y
1173
 phosphorylation. ME180 cells incubated with N. sicca 342 and N. 
subflava 44 showed similar ErbB1 dephosphorylation levels to GC over the first 90 min 
of infection, but recovered to normal phosphorylation levels similar to P
-
 GC by 3 h (Fig. 
7I and Fig. 7J). Less dramatic Y
1173
 dephosphorylation was also observed in ME180 cells 






Figure 7—Extracellular stimuli decrease phosphorylation of ErbB1 at tyrosine 










 F62∆lgtA (∆lgtA) or the commensal Neisseria strains N. sicca 342 
(342) or N. subflava 44 (44), or (J) the commensal strains from panel I or bovine serum 
albumin-coated microspheres (BEADS); data in panels D and G representative of at least 
three independent experiments; panels A, H, and I representative of two independent 
experiments; panels B, C, E, F, and J = single experiment. In each panel, untreated 
ME180 cells incubated in media alone (labeled [no GC] or [-]) served as negative 
controls for ErbB1 activation and in selected panels, actin = loading control. ErbB1 
phosphorylation was detected by probing lysates with an anti-phospho-ErbB1 polyclonal 
antibody; time periods = min. The image quality of each blot shown was optimized for 
presentation and equivalent adjustments were made for each lane within a given image.  
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dephosphorylation in epithelial cells is triggered by physical contact with extracellular 
stimuli rather than a specific interaction with GC. Even so, GC may utilize this signaling 
caveat to sustain prolonged ERK activation by continuous signaling through ErbB1 and 
thereby prevent ErbB1 autophosphorylation at Y
1173
.   
 
Identification of signaling molecules in ME180 cells whose phosphorylation levels 
are not altered by GC.  Other proteins that exhibited changes in tyrosine 
phosphorylation in Figure 2 migrated in the 50-80 kDa range or below 30 kDa (data not 
shown) on SDS-PAGE. Therefore, I examined signaling molecules in this size range 
linked to regulation of the host cytoskeleton in order to identify other factors involved in 




 F62∆lgtD displaying sialylated 
or nonsialylated LnNT LOS. LOS sialylation should block GC-induced signaling 
propagated by the LnNT moiety. 
 Lysates recovered from GC treated cells showed no differences in Akt, Bad, and 
PKC phosphorylation patterns compared to untreated cells regardless of LOS sialylation 
and showed no difference in Src phosphorylation regardless of Opa expression. Akt (~60 
kDa) was not activated in untreated cells and no proteins in the Akt size range were 
activated by GC (Fig. 8A). The pro-apoptotic Bad protein (~23 kDa) was phosphorylated 
in both untreated and GC-treated cells (Fig. 8B), indicating GC did not induce apoptosis. 
Two proteins that may represent PKCα (~80 kDa) were also phosphorylated in untreated 
cells, but incubations with GC did not alter their activation state (Fig. 8C). Src 
phosphorylation was also constitutive in untreated cells and unaltered by GC infection 




Figure 8—GC do not trigger universal changes in host cell signaling: central kinases 
not activated during GC infection. GC strain F62∆lgtD was sialylated (S) by treatment 
with CMP-NANA or left untreated (NS). Signaling assays were performed by incubating 





nonsialylated F62∆lgtD; time periods = min. Activation of each protein was determined 
by immunoblot analysis by probing with an (A) anti-phospho-Akt (T
308
); data 
representative of two independent experiments, (B) anti-phospho-Bad (S
136
); data 
representative of two independent experiments, (C) anti-phospho-PKC (T
638
); data 
representative of three independent experiments, or (D) anti-phospho-Src (Y
418
); data 
representative of three independent experiments. In each panel, untreated ME180 cells 
incubated in media alone (labeled [no GC] or [-]) served as negative controls for protein 
phosphorylation and in selected panels, actin = loading control. In panels A, B, and D, 
positive (+) and negative (-) control lysates were analyzed as phosphorylation standards 
for each protein. In panel C, analysis of a F62∆lgtD bacterial lysate (BL) treated with 
SDS, but not incubated with ME180 cells, ensured that the analyzed proteins were 
derived for the host cells (not from GC). The image quality of each blot shown was 




epithelial cells during infection. Instead, GC alter specific signaling targets, such as 
MAPKs, which may allow GC to mediate the inflammatory response and stimulate host 
cell entry. 
 
Opa expression alters MAPK phosphorylation.  To better understand the role of Opa 
in GC pathogenesis, I investigated the ability of GC that cannot express Opa to signal 
through the MAPK pathways. I incubated ME180 cells with variants of GC strain MS11 
including: MS11 with an Opa
+
 phenotype at the onset of the incubation; MS11 whose 
initial phenotype was Opa
-
, but possess the genes to turn on Opa expression; and strain 
MS11∆opa that cannot express Opa due to opa gene knockouts. ME180 cells incubated 
with phenotypic Opa
-
 or the genetic Opa
- 
(∆opa) MS11 exhibited a general increase in 
p38 phosphorylation and similar p38 activation profiles (Fig. 9A). JNK activation in cells 
incubated with phenotypic Opa
-
 MS11 occurred at the 90 min and 3 h time points and 
was delayed compared to Opa
+
 MS11 where JNK phosphorylation was observed at 30 
min and 90 min. MS11∆opa-infected ME180 cells showed a slight increase in JNK 
activation at 90 min in comparison to signaling by the phenotypic Opa
-
 variant (Fig. 9C). 
As for the ERK activation profile of these host cells, each MS11 variant triggered the 
characteristic prolonged ERK activation observed in host cells incubated with other GC 
strains (see Figure 3). However, MS11∆opa-infected cells displayed a peak in ERK 
phosphorylation at 90 min that did not occur in the parent MS11 strain (Fig. 9B). During 
the infection with the phenotypic Opa
-
 strain, a mixed population of GC containing Opa
+
 
variants can arise due to Opa phase variation. Thus, the Opa
+
 variants in both the Opa
+
 
starting inoculum and the phenotypic Opa
-




Figure 9—Effect of Opa expression on MAPK phosphorylation in ME180 cells. 











∆Opa MS11; time periods = min. Activation of each MAPK was determined by 
immunoblot analysis by probing with an (A) anti-phospho-p38 antibody, (B) anti-
phospho ERK 1/2 antibody, or (C) anti-phospho JNK antibody; data in all panels = a 
single experiment and the same lysates were tested in each panel, but panel (C) was 
performed as a separate experiment. In each panel, untreated ME180 cells incubated in 
media alone (-) served as negative controls for MAPK activation and actin = loading 
control. The image quality of each blot shown was optimized for presentation and 
equivalent adjustments were made for each lane within a given image. 
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reduced ERK activation between the 30 min and 90 min time points. These data 
demonstrate that knocking out Opa expression affects GC-induced host cell signaling and 




 GC are well adapted to the female host and often infections are characterized by 
GC invasion into host tissues without eliciting symptoms. How GC achieve the balance 
of activating host cells for invasion without stimulating detrimental immune responses 
remains the subject of ongoing investigation. Nonphagocytic cells, such as cervical 
epithelial cells, are not designed to engulf bacteria, so GC must manipulate host cells to 
instigate invasion-promoting cellular processes. GC provoke these abnormal cellular 
events by binding to receptors and triggering alterations in host cell signaling pathways. 
One major reason GC hijack signaling pathways is to gain control over the actin 
cytoskeleton (117, 179, 187). In a normal state, host cells polymerize and rearrange actin 
for movement and to maintain cell integrity. GC-induced signaling amplifies and changes 
these actin-mediated processes to promote actin recruitment to sites of adherent bacteria 
and actin reorganization around invading GC. In this study, I identified signaling 
pathways in cervical epithelial cells that GC activate leading up to invasion. I discovered 
that, prior to invasion, GC activate each of the three MAPK (Fig. 10). Previous reports 
have demonstrated that MAPK signaling is linked to regulating actin reorganization and 
cytokine production—two major cell processes GC must regulate to ensure a successful 
infection (41, 126, 240).     
  MAPK activation within GC-infected epithelial cells may drive invasion-
promoting actin dynamics. My data in Figures 3-5 show that each MAPK exhibited 
phosphorylation at 3 h when GC have established intimate adhesion to host cells. At this 
time, GC are positioned to elicit morphological changes in the host cell actin cytoskeleton 
to make them susceptible to invasion. GC could signal through MAPKs to manipulate 
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Figure 10—Working model for MAPK signaling by GC in cervical epithelial cells. 
GC expressing the different combinations of pili (triangle), Opa (circle), or LOS [LnNT 
(rectangle+D) or lactosyl (square+A)] each triggered a delayed activation of p38 and 
prolonged activation of ERK. Pili may play a greater role in ERK activation and ErbB1 
transactivation appears to play a role in GC-induced ERK signaling. Activated p38 and 
ERK may signal to downstream actin-associated proteins or transcription factors to 
promote GC invasion and alter host cell gene expression. GC expressing LnNT LOS and 
Opa reduce JNK activation in host cells, but GC expressing other combinations of Opa 
and LOS exhibit stronger JNK activation. A portion of the IL-8 induced by GC is derived 
from the JNK signaling pathway. Decreased GC-induced JNK activation could diminish 
downstream signaling to transcription factors, such as AP-1, which may lower the IL-8 
levels produced by epithelial cells. 
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actin-associated proteins. Activating actin-associated proteins could facilitate GC 
invasion by promoting actin polymerization and rearrangement at the plasma membrane. 
Therefore, even though I did not establish a direct link between MAPK signaling and GC 
invasion in this study, I propose that GC-induced MAPK activation contributes to host 
cell invasion based on the timing of signal activation, the links these pathways have to 
downstream cytoskeletal proteins, and their established role in the invasion pathways of 
other pathogens. 
 One of the most interesting findings in this study was the different time courses of 
MAPK activation by GC in cervical epithelial cells. Activation of p38 was delayed 
compared to ERK and JNK, and I also observation that GC induced prolonged ERK 
phosphorylation. Signaling through a specific MAPK could dictate a cellular response at 
a certain time point or signaling through a combination of MAPK could cooperate to 
manipulate the cell. For example, in the time course studied, activation of JNK and ERK 
is initiated earlier than p38, but only p38 and ERK sustain peak-level activation at the end 
of the time course. Extended ERK activation (i.e. sustained strong phosphorylation for 
greater than 2-3 h) is a rare occurrence. Most pathogens that trigger ERK signaling in 
various epithelial cells, including the commensals N. sicca and N. subflava tested in this 
study, only induce transient fluctuations in ERK phosphorylation (i.e. increased 
phosphorylation for usually less than 1 h) (30, 151, 198, 247, 296).  
 My results in Figure 3 demonstrated that no single surface structure analyzed was 
solely responsible for the GC-induced prolonged ERK activation. P
+
 GC appeared to 
maintain a somewhat stronger ERK signal at the 3 h time point in Figure 3E and 3H, but 
P
-
 bacteria still exhibited a significant signal above the controls. These data suggest pilus-
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mediated signaling may enhance prolonged ERK activation in infected cells. Howie, et 
al. presented the only previous report that revealed GC can induce sustained ERK 
activation. This group showed that mechanical forces on the host cell membrane 
generated by pilus retraction enhanced signaling by all three MAPK (123). Therefore, 
pilus retraction may be important in my proposed MAPK-directed regulation of actin that 
leads to GC invasion. The pilus receptor, CD46, has been shown to signal to ERK in 
PMA-treated T-cells (245).  
 Opa may also influence host cell ERK signaling and help prolong ERK mediated 
responses. In Figure 9B, I showed that GC incapable of expressing Opa (MS11∆opa) 
elicited greater ERK activation in ME180 cells at a pre-invasion time point compared to 
host cells infected with the phenotypic MS11 Opa
+
 and MS11 Opa
-
 strains. During 
incubations with the phenotypic Opa
-
 variants, Opa phase variation can occur to create a 




 GC that interact with host cells. Therefore, ME180 
cells were most likely exposed to Opa
+
 GC in these two scenarios, which may have 
contributed to their altered ERK signaling profile that differed from MS11∆opa-infected 
cells. Overall, Opa expression may contribute to epithelial cell ERK activation during 
GC-host cell interactions.   
 GC also appear to signal to ERK through the well characterized ErbB1 pathway. I 
demonstrated that GC contact with host cells dephosphorylated ErbB1 at the Y
1173
 
downregulation site throughout the 3 h time course. By blocking Y
1173
 phosphorylation 
over time, ErbB1 signaling can continue to downstream substrates, including ERK (149). 
The ErbB1 Y
1173
 dephosphorylation time course in Figure 7 correlated well with the time 
course for GC-induced ERK activation in Figure 3 indicating GC may signal to ERK 
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through ErbB1. Since ErbB1 is not known as a GC receptor, GC may trigger ERK 
activation through ErbB1 via transactivation after binding to one its primary receptors 
(Fig. 10). Whether pili-CD46 interactions or pilus retraction leads to ErbB1 
transactivation has not been established. Clearly, there are several possible mechanisms 
for GC to maintain extended ERK activation, which could lead to greater GC control 
over actin dynamics to mediate invasion. Contributing to these results, a colleague in the 
lab has demonstrated that inhibiting ERK signaling blocks GC invasion into epithelial 
cells confirming a role for ERK activation in GC internalization (K.V. Swanson, 
unpublished observations). 
 Regulating JNK activation in host cells may contribute to the ability of GC to 
evade the innate immune response. Above, I also discussed the potential links between 
GC elicited JNK phosphorylation and regulating the actin cytoskeleton. However, my 
results in Figure 5 and 6 suggest that GC induction of JNK signaling may play a more 
prominent role in mediating proinflammatory cytokine production. In Figure 5E, I 
showed that the more virulent strain, Opa
+
 F62∆lgtD generated a lower JNK signal in 
infected ME180 cells relative to Opa
+ 
F62∆lgtA. Furthermore, in Figure 6, the weaker 
JNK signal in Opa
+ 
F62∆lgtD-infected cells corresponded to a decreased IL-8 response 
and, based on JNK inhibitor studies, the increased IL-8 production in Opa
+ 
F62∆lgtA-
infected cells was a result of greater JNK activation. Suppressing IL-8 production may 
help Opa
+ 
F62∆lgtD better avoid provoking host immune responses, such as the 
recruitment of immune cells, which could help explain why GC expressing longer chain 
LOS structures are more infectious (142, 252, 266). Evidence exists that LOS 
modifications can influence cytokine production by GC since removal of an acyl chain 
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from the lipid A portion of LOS decreased IL-6 and IL-8 secretion by epithelial cells 
(108). Previous studies also indicate that GC expressing LnNT LOS (i.e. F62∆lgtD) can 
bind to the asialoglycoprotein receptor (ASGP-R) and exhibit increased invasion of 
epithelial cells compared to GC expressing truncated LOS (i.e. F62∆lgtA) (106, 266). The 
ASGP-R does possess a cytoplasmic domain that has been shown to signal to ERK after 
binding the IGF-1 growth (64, 161). However, no link between ASGP-R binding and 
JNK signaling has been demonstrated. So, whether LnNT LOS can serve as an inhibitor 
ligand for ASGP-R signaling to JNK or the truncated lactosyl LOS structure can activate 
greater JNK levels through an unidentified mechanism is unknown. Nevertheless, LnNT 
LOS expression appears to decrease the proinflammatory immune response in GC-
infected epithelial cells by limiting JNK activation and this inhibition may contribute to 
the increased virulence of LnNT expressing GC (Fig. 10).    
 GC trigger unique MAPK activation profiles that differ from commensal 
Neisseria. The MAPK activation time course and the finding that changes in GC surface 
structures alter MAPK signaling provide clues that these pathways contribute to GC 
invasion and virulence. GC-induced MAPK signaling can also lead to the induction of 
cytokine expression and the development of immune responses against GC. How GC 
balance activating specific pathways to achieve their pathogenic goals without also 
stimulating defenses mechanisms that clear infection is undefined, but this study reveals 




CHAPTER 2—INVASION OF NEISSERIA GONORRHOEAE INTO HUMAN 
CERVICAL EPITHELIAL CELLS  
Introduction 
 GC invasion requires both bacterial and host cell factors (186).  Pili (P), in 
conjunction with one or more gonococcal invasins (Opa, LOS, and/or Por) or iC3b 
surface deposition, can induce changes in host cell signaling to drive host actin 
cytoskeleton polymerization beneath the site of GC adherence to trigger microvilli 
elongations that promote GC invasion (72, 84, 94, 98, 107, 182, 243, 274, 295). Pili 
retract to bring GC closer to host cells to permit more intimate adhesions through the 
binding of Opa and LOS to host cell surface receptors (123, 189, 229, 231).  Opa proteins 
are thought to promote adherence and invasion by binding to CEACAM on host cells (40, 
112, 162, 293). However, GC can invade cervical epithelial cells that do not express 
CEACAM (275), indicating that alternate ligand-receptor interactions can lead to 
invasion. A member of the Opa protein family can bind host cell HSPG to mediate 
invasion and alternative GC surface molecules can also serve as invasins (290, 292). 
LnNT LOS contributes to host cell invasion in an Opa
-
 background (266). In low 
phosphate environments, PorB IA mediates invasion in an Opa-independent manner that 
requires clathrin-coated pit formation, actin rearrangement, and Rho GTPases (160). Por, 
along with pili and iC3b deposition on the lipid A portion of LOS, can coordinate an 
interaction with CR3 on primary cervical epithelial cells to trigger invasion (71, 72).  
 One reason why Opa is believed to play a prominent role in GC invasion was 
from studies that investigated invasion into host cells transfected with CEACAM or 
HSPG as the sole GC receptor. Cells used in these studies did not permit GC invasion, 
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but following transfection with these Opa-specific receptors, Opa-expressing GC were 
internalized (2, 20, 26, 40, 95, 222). However, since these cells lack receptors for other 
proposed invasins, such as Por, LOS, and L12, the contributions of these factors in 
invasion were not analyzed. Clearly, GC possess alternate mechanisms to invade host 
cells that lack Opa receptors and can invade into host tissue in microenvironments where 
Opa expression is repressed. The redundancy of GC surface factors that promote invasion 
demonstrates the importance of this process in GC pathogenesis. 
 The hallmark of GC invasion into human epithelial cells is the recruitment and 
rearrangement of host cell F-actin at the site of colonization. F-actin polymerization 
occurs in host cells by adding globular (G)-actin monomers to the +end of a growing 
actin microfilament when G-actin exceeds a critical concentration in the cell (76). GC 
trigger actin polymerization in host cells to cause F-actin rich microvilli to elongate 
around GC and internalize them (84). Disrupting actin polymerization with inhibitors, 
such as cytochalasin D, reduced GC invasion into Chang epithelial cells (94). 
Cytochalasin D, a fungal toxin, and latrunculin B, a sponge toxin, inhibit actin 
polymerization (46, 248, 267). Phalloidin, another fungal toxin, prevents actin 
depolymerization by stabilizing F-actin filaments (46). Use of these agents has been 
useful in investigating the cellular processes that require actin, such as GC invasion. 
 GC invasion into host epithelial cells has been quantified through adaptations of 
an antibiotic protection assay first developed by Shaw and Falkow (261). GC are deemed 
invasive/intracellular based on their resistance to a membrane-impermeable antibiotic 
added to the host cells following infection (132, 261). Invasion data generated from the 
antibiotic protection assay possesses inherent limitations:  it does not measure the number 
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of host cells invaded; it cannot measure the frequency by which bacteria invade and exit 
host cells; it cannot determine if nonviable bacteria are capable of entering into host cells; 
and the distinction between intracellular and extracellular bacteria is hindered by the 
protection of extracellular bacteria sequestered inside of a microcolony from antibiotics. 
Scanning electron micrographs comparing viable and chloramphenicol-treated FA1090 
revealed that nonviable GC failed to induce microvilli elongation in Hec1B cervical 
epithelial cells, and visual internalization of nonviable GC by these cells was not seen 
(98). The cortical actin microfilament rearrangements normally observed during invasion 
by viable GC were not seen during the interaction of chloramphenicol and heat-killed GC 
with A431, Chang conjunctiva, Hec1B, or T84 epithelial cells (187). Heat-killed MS11mk 
GC do not downregulate the expression of the antimicrobial peptide LL-37 when they 
interact with ME180 cervical cells (17). While these studies suggest that bacterial 
viability is required for GC invasion into epithelial cells, methodological limitations 
prevent the direct quantification of invasion by nonviable GC. 
 I developed a reporter assay based on Bla expression to study GC-host cell 
interactions. Since Gram-negative bacteria localize Bla to the periplasm (163), I created a 
fusion protein that would express Bla on the outer membrane of GC. I took advantage of 
the fact that IgA protease is an enzyme consisting of an autotransporter domain (β-
domain) and a passenger domain (protease domain) (225). (Autotransporter-mediated 
surface display, or autodisplay, is a protein expression strategy where heterologous 
passenger domains are express on the outer surface of bacteria when fused with an 
autotransporter protein (178)). In this study, I established a GC reporter strain, FA1090 
Φ(bla-iga’), which expresses a Bla-IgA protease β-domain (IgAβ) fusion protein using 
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an autodisplay strategy. Using FA1090 Φ(bla-iga’) and the fluorescence-based, Bla 
reporter assay, I quantified the number of ME180 cervical epithelial cells invaded by GC 
variants expressing different surface molecules and compared the invasion levels of 
viable and nonviable GC. I found that despite their ability to adhere to almost all ME180 
cells in an infected population, viable GC expressing pili invaded only a subpopulation of 
cells. Furthermore, FA1090 Φ(bla-iga’) that do not express Opa invaded a larger 
subpopulation of ME180 cells compared to Opa
+
 GC. Nonviable GC adhered to, but did 
not invade into ME180 cells, regardless of their pili and Opa expression states. Nonviable 
GC adhered to, but did not invade into ME180 cells, regardless of their pili and Opa 
expression states, and failed to recruit F-actin to sites of adherent bacteria. Overall, I 
show that epithelial cell invasion is a dynamic process that requires viable GC that 
express pili, but not Opa, and I demonstrate the advantages of the Bla reporter system in 




FA1090 autodisplays β-lactamase as strain FA1090 Φ(bla-iga’).  Autodisplay of a 
normally periplasmic protein onto the extracellular side of the bacterial outer membrane 
through fusion with an autotransporter domains is well documented (154, 163, 178). The 
GC IgA protease gene (iga) is composed of a Sec-dependent leader sequence, a protease 
domain, and a β-barrel autotransporter motif (β-domain). The β-lactamase-IgA protease 
β-domain (Bla-IgAβ) fusion protein expressed in GC strain FA1090 Φ(bla-iga’) was 
constructed using the cloning strategy outlined in Fig. 11A. The genetic constructs 
generated during the construction of FA1090 Φ(bla-iga’) are shown in Fig. 11B. In strain 
FA1090 Φ(bla-iga’), I replaced the protease domain of IgA protease with Bla and 
utilized the β-domain of IgA protease to localize Bla on the extracellular face of the GC 
outer membrane (Fig. 11C). 
 The expression of Bla can be quantified by measuring its enzymatic activity. Bla 
hydrolyzes nitrocefin to yield a red product detectable by spectrophotometry (Fig. 12A). 
To demonstrate that Bla is cell-associated in FA1090 Φ(bla-iga’), I compared FA1090 
Φ(bla-iga’) nitrocefin hydrolysis activity to FA1090 and to FA1090(pFT180), which 
expresses soluble Bla from a multiple-copy number plasmid, pFT180. In general, 
FA1090(pFT180) displayed a higher level of Bla activity than FA1090 Φ(bla-iga’) (Fig. 
12B). FA1090 showed no Bla activity. Most (~80%) of the enzymatic activity from 
FA1090 Φ(bla-iga’) was localized in the bacterial pellet (100 arbitrary units [AU] 
compared to <30 AU of Bla activity in the culture supernatant), whereas in 
FA1090(pFT180), most (~90%) of the Bla activity was detected in the culture 




Figure 11—Construction of a GC strain that autodisplays the Bla-IgAβ fusion 
protein. (A) A schematic diagram showing the gene replacement strategy to construct 
Bla-IgAβ and establish FA1090 Φ(bla-iga’) (see Materials and Methods). (B) Agarose 
gel showing the DNA fragments generated during construction of FA1090 Φ(bla-iga’) to 
confirm the presence and proper orientation of each DNA of interest. Restriction 
enzymes used for digestions are as follows: E = EcoRI, Xb = XbaI, B = BamHI, and Xm 
= XmaI.  DNA samples not treated with restriction enzymes represented PCR products 
[i.e. iga, bla, and Φ(bla-iga’) in FA1090] or uncut plasmids. (C) The predicted steps in 
the autodisplay of the Bla-Igaβ fusion protein in FA1090 Φ(bla-iga’). Passenger domains 
(red), such as Bla, fused to Igaβ (black), are translated in the bacterial cytoplasm (CP) 
and transported through the inner membrane (IM) into the periplasm (PP) in their 
unfolded state using the general Sec pathway (brown). In the PP, the fusion protein folds 
and the IgAβ domain inserts into the outer membrane (OM) forming a β-barrel motif. Bla 
is autotransported through the IgAβ domain to face the extracellular milieu. Image 





Figure 12—Quantification of Bla expression in GC strains. (A) The nitrocefin 
hydrolysis assay to measure Bla activity was modified from O’Callaghan, et al. (214). In 
the presence of Bla, the amide bond in the β-lactam ring of nitrocefin is cleaved (red 
bolt). The yellow substrate is converted into a reddish product detectable at λ = 520 nm 
over time. A sample with low, mid, or high Bla activity appear yellow, orange, or red, 
respectively, after incubation with nitrocefin. The molecular structure of nitrocefin was 
copied from www.nugi-zentrum.de/Bilder/Nitrocefin.gif. (B) Bla activity in FA1090 
Φ(bla-iga’) is cell associated. Nitrocefin hydrolysis assays were performed on FA1090 
Φ(bla-iga’) or FA1090(pFT180) pellets or culture supernatants. Bla activity for the 
FA1090 Φ(bla-iga’) pellet in a selected trial was defined as 100 AU and used as the 
standard to normalize the Bla activity of all other samples. Data are representative of 
three independent experiments performed in triplicate (± SD). 
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data indicate that Bla is anchored to the membrane in FA1090 Φ(bla-iga’) and secreted 
by FA1090(pFT180). 
 To determine if Bla autodisplay by FA1090 alters its ability to adhere to and/or 
invade into cervical epithelial cells, I performed a gentamicin protection assay. 
Gentamicin is a cell-impermeable aminoglycoside antibiotic that inhibits protein 
synthesis in prokaryotes, such as GC, but not eukaryotic cells (56). During a 6 h 
infection, a similar number of FA1090 and FA1090 Φ(bla-iga’) adhered (Fig. 13A, black 
bars) to and invaded (Fig. 13A, white bars) ME180 cells. Furthermore, laser scanning 
confocal microscopy (LSCM) analysis revealed that FA1090 Φ(bla-iga’) and FA1090 
associated with ME180 cells in similar distribution patterns (Fig. 13B). FA1090 and 
FA1090 Φ(bla-iga’) are observed surrounding most ME180 cells (60-70%) to cover the 
cell surface, rather than appearing as a microcolony (20-30%) bound to a small surface 
area or dispersing randomly on the cell surface (<10%) (Fig. 13C). Bla expression by 
FA1090 does not alter the type of LOS structures expressed by GC, indicating Bla 
expression does not alter the GC surface that directly interacts with host cells (Fig. 13D). 
These data indicate that Bla expression by FA1090 does not interfere with GC-host cell 
interactions or GC surface molecule expression.  
 
Quantification of cervical epithelial cells invaded by GC.  I utilized the Bla-expressing 
reporter strain FA1090 Φ(bla-iga’) to quantify the number of cervical epithelial cells that 
were invaded by GC during a 6 h infection. Upon entering ME180 cells loaded with 
CCF2-AM, Bla
+
 GC will cleave a portion of the green fluorescent dye to yield a blue, 





Figure 13—Analysis of FA1090 Φ(bla-iga’) and FA1090 interactions with ME180 
cells and LOS expression.  In panels A and B, ME180 cells were incubated with GC at 
an MOI of 10. (A) Gentamicin protection assays; data representative of three independent 
experiments performed in triplicate (± SD). Gentamicin = 200 µg/ml. (B and C) 
Immunofluorescence microscopy analysis: (B) Bar, 10 µm and (C) GC were scored on 
their cellular distribution patterns on approximately 300 randomly selected ME180 cells 
as layers of dispersed GC surrounding the cell (surround), microcolon(ies) on the cell 
(microcolony), or randomly distributed individual GC or small clusters (random). LSCM 
images are shown to provide a visual representation of each distribution category. Data = 
average (± SD) percentage of ME180 cells that display each distribution pattern from 
three independent experiments. (D) FA1090 Φ(bla-iga’) and FA1090 express identical 
LOS species. Crude LOS preparations from FA1090 and FA1090 Φ(bla-iga’) were 




 GC were 
used in all experiments. 
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uncleaved and will not yield the blue fluorescent product (Fig. 14A). To examine the 
intracellular distribution of CCF2-AM, I analyzed uninfected CCF2-AM loaded ME180 
cells under a fluorescent microscope. The data show that CCF2-AM was present in both 
cytosolic and nuclear compartments of ME180 cells and there were no detectable 
intracellular compartments where CCF2-AM was excluded (Fig. 14B). 
 To identify individual invaded host cells, I incubated ME180 cells with FA1090 
Φ(bla-iga’) for 6 h at an MOI of 10, washed away non-adherent bacteria, and then loaded 
cells with CCF2-AM. Fluorescence microscopy showed that only ME180 cells inoculated 
with FA1090 Φ(bla-iga’) exhibited detectable blue fluorescence (Fig. 14C). I determined 
the percentage of ME180 cells that displayed blue fluorescence using flow cytometry to 
quantify the FA1090 Φ(bla-iga’)-invaded cells in the population. Less than 40% of 
ME180 cells show a fluorescence level of cleaved CCF2-AM higher than negative 
controls, indicating that only a subset of ME180 cells were invaded by FA1090 Φ(bla-
iga’) (Fig. 14D, Fig. 21A, and Fig. 23A), (~36% invaded cells in the trial shown). 
Uninfected ME180 cells and cells inoculated with FA1090 that did not express the 
reporter construct were analyzed as negative controls (Fig. 14D, Fig. 21A, and Fig. 23A). 
 The conditions utilized to quantify invaded ME180 cells in Figure 14C and Figure 
14D represent the optimal conditions for the β-lactamase reporter assay as determined 
experimentally. I found that a minimum of 0.25 µM CCF2-AM and 45-60 min dye 
loading time were needed for optimal detection of GC-invaded ME180 cells (Fig. 14E, 
Fig. 14F, Fig. 22A, Fig. 22B, Fig. 23E, and Fig. 23F). I noted that invasion appeared to 
be more efficient when lower starting MOI were used to initiate the assay (Fig. 14G, Fig. 
22C, and Fig. 23G). I also observed that the number of invaded ME180 cells increased  
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Figure 14—Analyses of FA1090 Φ(bla-iga’) invasion into ME180 cells utilizing the 
fluorescence-based Bla reporter assay. (A) The Bla reporter system. The Bla reporter 
assay can detect invaded host cells loaded with CCF2-AM based on their fluorescent 
properties. CCF2-AM is a cell permeable molecule that remains colorless until it crosses 
a host cell membrane and is converted into CCF2 by cytosolic esterases. CCF2 is a 
charged Bla substrate that emits green fluorescence when excited at λ = 405 nm. When 
Bla is present in the host cell, CCF2 is cleaved to release a coumarin product that emits 
blue fluorescence when excited at λ = 405 nm.  Image modified from (312). (B) CCF2-
AM cellular distribution assay in ME180 cells; CCF2-AM (1 µM, green) and Hoechst 
33342 (100 ng/ml, blue). (C-I) Fluorescence-based Bla reporter assays were performed 
by incubating ME180 cells with FA1090 or FA1090 Φ(bla-iga’). After invasion, cells 
were loaded: (C) with or without 1 µM CCF2-AM for 90 min; bars, 20 µm. Image quality 
was optimized using the AxioVision 4.6 software release from Carl Zeiss North America, 
(D) 0.25 µM CCF2-AM for 45-60 min, (E) different concentrations of CCF2-AM for 45-
60 min, (F) 0.25 µM CCF2-AM for different lengths of time, (G) 0.25 µM CCF2-AM 
after being incubated with GC at different MOI during the invasion, (H) 0.25 µM CCF2-
AM after being incubated with GC for different invasion time periods, (I) 0.25 µM 
CCF2-AM after being incubated with filtered supernatants (with varied levels of Bla 
activity) derived from overnight broth cultures of wild-type FA1090 (<1 AU), FA1090 
Φ(bla-iga’) (<3 AU), or FA1090(pFT180) (~700 AU). ME180 cells were incubated with 
FA1090 Φ(bla-iga’) at an MOI 10 (10 AU) as a positive control for CCF2-AM cleavage 
in part H. In (D-I), Bla reporter assays were analyzed by flow cytometry and FA1090 or a 
FA1090 culture supernatant served as gating controls. All flow cytometry dot plots 
shown are representative data of two to five independent experiments. All GC used in 










from 0-6 hr reaching their maximal level by 4-6 h. Few invaded ME180 cells were 
recovered at the early 2 h time point (< 1% invaded), and the number of invaded cells did 
not increase with continued incubation after 6 h. Invasion with control Bla
-
 GC yielded < 
1% invaded cells (Fig. 14H, Fig. 22D, and Fig. 23H). To demonstrate that CCF2-AM 
cleavage was the result of FA1090 Φ(bla-iga’) uptake and not soluble secreted Bla 
pinocytosed by ME180 cells from the culture supernatant, I incubated ME180 cells with 
culture supernatants of FA1090(pFT180) for 6 h. The FA1090(pFT180) supernatants 
contained approximately 700 times more arbitrary units of Bla activity than was present 
in incubations of ME180 cells with intact FA1090 Φ(bla-iga’) at an MOI 10 (Fig. 12B). 
The cleavage of CCF2-AM loaded into ME180 cells occurred in less than 1.5% of the 
population after incubation with FA1090(pFT180) supernatants, which is much lower 
than the ~31% of ME180 cells that exhibited internalized FA1090 Φ(bla-iga’) at an MOI 
10 in the same experiment (Fig. 14I, Fig. 21B, and Fig. 23B). Taken together, these data 
show that I have identified the optimal conditions to detect and quantify GC-invaded host 
cells using the Bla reporter system. The results also show the assay is highly specific for 
invasion events since no CCF2-AM cleavage is detected in host cells in the absence of 
Bla or in the presence of extracellular Bla. The Bla reporter assay shows that only a 
subpopulation of ME180 cells with cell-associated GC are invaded during infection. The 
Bla cell reporter assay provides a strong method to quantify the number of host cells 
invaded by GC.   
 
Expression of pili, but not Opa, is required for GC invasion into cervical epithelial 
cells.  I examined the contributions of pili and Opa, two major GC surface structures, to 
 
 92 

















 FA1090 Φ(bla-iga’). I 














 GC (14.69%). GC lacking pili displayed almost no invasion (<0.75%) into 










 GC yielded 
<1% invaded cells (Fig. 15A, Fig. 21C, and Fig. 23C). These data indicate that GC 





serves to validate the capability of the Bla reporter assay to distinguish between invaded 
and noninvaded strains of GC. Furthermore, GC that express pili, but not Opa, were more 
efficient at invading ME180 cells than GC expressing both pili and Opa. 
I compared the invasion data generated by the Bla reporter assay with the 






















exhibited reduced adherence and invasion compared to the other variants (Fig. 15B). 








 strains were 
recovered (Fig. 15B). These data were consistent with data from the Bla reporter assay in 
Figure 15A indicating that P
+
 GC invade into ME180 cells. In contrast, incubation of 








 GC did not yield detectable numbers of invaded 
host cells in the Bla reporter assay, yet gentamicin resistant GC were recovered for each 
of these stains in the gentamicin protection assay (Fig. 15B). These data suggest that, 
compared to the Bla reporter assay, the gentamicin protection assay may overestimate the 
number of P
-





Figure 15—GC invasion requires the expression of pili, but not Opa. Bla reporter 
assays (panel A), gentamicin protection assays (panel B), and immunofluorescence 
microscopy analysis (panels C and D) were performed by incubating ME180 cells with 
FA1090 or FA1090 Φ(bla-iga’) expressing different combinations of Opa and pili at an 




FA1090 served as a gating control; data are representative of three independent 









FA1090 Φ(bla-iga’)]. (B) Gentamicin = 200 µg/ml; data = average (± SD) of two 
independent experiments each performed in triplicate; data normalized to CFU/well at t = 
0. (C and D) Bar, 15 µm; FA1090 Φ(bla-iga’) expressing different combinations of pili 
and Opa were scored on their cellular distribution patterns on approximately 200 
randomly selected ME180 cells as described in Fig. 13C; data = average (± SD) 




 To understand the discrepancy in the data generated from these two different 
assays, I used LSCM analysis to examine the distribution pattern of different variants of 
FA1090 Φ(bla-iga’) that associate with ME180 cells during infection. After being 
incubated with P
+
 FA1090 Φ(bla-iga’), the majority of ME180 cells were surrounded by 









 FA1090 Φ(bla-iga’) did not form microcolonies or surround ME180 cells, but were 
randomly dispersed as individual diplococci or small clusters (Fig. 15C and Fig. 15D).  
These data suggest that the expression of pili allows GC to adhere better and spread out 
along the cell surface of ME180 cells, which could allow more GC to be internalized 




 GC may create 
“false positives” for invasion in the gentamicin protection assay due to the protection of 
GC sequestered within microcolonies from gentamicin despite their extracellular 
location. Thus, Opa appears to facilitate microcolony formation on host cells more than it 
promotes invasion. 
 
Failure to recruit F-actin prevents nonviable GC from invading cervical epithelial 
cells.  The Bla reporter assay allowed me to determine if GC viability was required for 




 FA1090 Φ(bla-iga’) though 
gentamicin treatment and storage at 4
o
C overnight. Killing GC with gentamicin leaves 
GC intact and does not denature surface molecules that interact with host cells (218). 
Data from the nitrocefin hydrolysis assay showed that gentamicin-killed FA1090 Φ(bla-
iga’) maintained a Bla activity level similar to live FA1090 Φ(bla-iga’) (Fig. 16A). I 
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Figure 16—GC viability is required for F-actin recruitment and invasion into 
ME180 cells. ME180 cells were incubated with viable or gentamicin-killed (nonviable) 
FA1090 Φ(bla-iga’). (A) A nitrocefin hydrolysis assay; data representative of three 
independent experiments performed in triplicate (± SD). (B) Bla reporter assay; cells 
loaded with 0.25 µM CCF2-AM for 45-60 min after incubation with nonviable FA1090 
Φ(bla-iga’) at different MOI; data representative of five independent experiments. Cells 
incubated with viable FA1090 Φ(bla-iga’) at an MOI 10 served as a positive control for 
invasion/CCF2-AM cleavage. (C and D) Immunofluorescence microscopy analyses. (C) 
Images of cells after incubation with nonviable FA1090 Φ(bla-iga’) at different MOI. 
(D) Quantification of the GC cellular distribution patterns on approximately 200 
randomly selected ME180 cells scored as described in Fig. 13C; data = average (± SD) 
percentage of ME180 cells that display each distribution pattern from three independent 
experiments. (E) Higher magnification images of ME180 cells incubated with viable 
FA1090 Φ(bla-iga’) at an MOI 10 or nonviable FA1090 Φ(bla-iga’) at an MOI 100. (F) 
Highly magnified regions of ME180 cells associated with individual viable FA1090 
Φ(bla-iga’) or nonviable FA1090 Φ(bla-iga’). (G) Quantification of the actin recruitment 
by viable and nonviable FA1090 Φ(bla-iga’) on approximately 100 randomly selected 
ME180 cells from the LSCM images in panel E. Actin recruitment was scored as specific 
actin recruitment to sites of adherent GC (+GC, + actin), accumulation of actin in regions 
where no GC were bound (-GC, +actin), and no actin recruitment at sites of adherent GC 











tested to see if the physical interaction of GC surface molecules with the host cell is 
sufficient to induce GC uptake by ME180 cells when GC are nonviable. Internalization of 
gentamicin-killed GC was monitored by the Bla reporter assay. At all MOI tested, no 
significant percentage of ME180 cells fluoresced blue, indicating that cervical epithelial 
cells were not invaded by nonviable FA1090 Φ(bla-iga’) (Fig. 16B, Fig. 21D, and Fig. 
23D). These data show that, in addition to expressing the required surface molecules to 
trigger internalization, GC must also be viable to invade host cells. 
 To determine why nonviable GC that possess the same repertoire of virulence 
factors as their viable counterparts failed to invade into cervical epithelial cells (see Fig. 





iga’) with ME180 cells at various MOI by LSCM. If I assume a generation time for 
FA1090 Φ(bla-iga’) during incubation with ME180 cells to be ~45 min a starting 
inoculum of live GC at an MOI 10 would yield ~1000 GC/cell after 6 h incubation. Since 
no GC replication will occur for gentamicin-killed FA1090 Φ(bla-iga’) during the assay, 
I assumed that the starting MOI and MOI after the 6 h incubation will be similar. I 
quantified the FA1090 Φ(bla-iga’) distribution patterns on 200
+
 randomly chosen ME180 
cells over three independent experiments in each case using LSCM. When inoculated 
with viable bacteria, GC surrounded the majority of ME180 cells in a uniform 
distribution (Fig. 16C and Fig. 16D). ME180 cells incubated with gentamicin-killed GC 
at lower MOI had either no associated GC (MOI 1), were in contact with randomly 
dispersed mono- and diplococci (MOI 1 or 10), or were associated with GC patterns that 
resembled small microcolonies (MOI 10 or 100). At the higher MOI of nonviable 
bacteria (MOI 100 and 1000), some microcolony-like clusters of gentamicin-killed GC 
 
 98 
start to form association patterns on ME180 cells that appeared similar to viable GC 
inoculated at a starting MOI of 10 (Fig. 16C and 16D). These data indicate that nonviable 
GC can adhere to ME180 cells. To understand why adherent nonviable GC fail to invade 
into ME180 cells, I examined the intracellular distribution of filamentous (F)-actin 
relative to adhered GC. I found that the intracellular distribution of F-actin in the majority 
of ME180 cells (> 90%) interacting with nonviable GC appeared evenly distributed 
beneath the plasma membrane. In contrast, the majority of ME180 cells (> 90%) 
interacting with live GC revealed F-actin accumulations beneath sites of GC adherence 
(Fig. 16E and 16G). At small locations on ME180 cells where individual GC were 
attached, the recruitment of F-actin was only observed under the adherence sites of 
individual live GC, but such recruitment was not observed with single nonviable GC 
(Fig. 16F). These data indicate that nonviable GC, possessing the same surface molecules 
as invasive viable GC, do not efficiently recruit F-actin and do not invade host cells. 
 
Analysis of host cell F-actin dynamics and GC invasion in the presence of potential 
inhibitors.  I wanted to further determine if the inhibition of host cell actin dynamics 
altered the invasion of FA1090 into ME180 cells. I pretreated ME180 cells with various 
concentrations of cytochalasin D, a fungal toxin that binds to the + end of growing actin 
microfilaments to prevent further F-actin polymerization (248), and stained these cells 
with phalloidin to observe F-actin distribution. ME180 cells treated with 3 µM, 15 µM, 
and 30 µM cytochalasin D all showed punctate F-actin staining, indicating disruption of 
F-actin assembly (Fig. 17A). However, gentamicin protection assays demonstrated that 
FA1090 invaded into ME180 cells treated with cytochalasin D at similar levels to 
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Figure 17—Analysis of GC invasion in the presence of invasion inhibitors. ME180 
cells were incubated with: (A) no GC, (B) FA1090, (C-D) FA1090 or FA1090 Φ(bla-
iga’), or (E) FA1090. (A-D) Disrupting host cell actin polymerization increases non-
specific bacterial invasion into ME180 cells. (A) Immunofluorescence microscopy 
analyses of cells treated with different concentrations of cytochalasin D (0, 3, 15, and 30 
µM); bar, 5 µm.  (B) Gentamicin protection assay; cells pretreated with or without 
cytochalasin D (3 µM, 45 min and throughout invasion); gentamicin = 200 µg/ml; data = 
average (± SD) of two trials from a single experiment. (C and D) Bla reporter assays, 
cells loaded with 0.25 µM CCF2-AM following invasion; cells pretreated with or 
without: (C) cytochalasin D (100 µM, 60 min and throughout invasion) or (D) latrunculin 
B (5 µM, 45 min and throughout invasion). FA1090 served as a CCF2-AM loading 
control and the data panels C and D are each single experiments. (E) Inhibition of actin 
dynamics in TA treated cells blocks GC invasion. Gentamicin protection assays; cells 
pretreated and post-treated with gentamicin (200 µg/ml, 2 h) or TA (0.2% for 90 min + 
1% for 30 min); data = average (± SD) of a single experiment performed in triplicate. GC 










untreated cells, suggesting actin polymerization is not required for invasion (Fig. 17B). In 
contrast, the Bla reporter assay revealed that, compared to untreated ME180 cells, a 









 FA1090 Φ(bla-iga’) (~18% vs. <1%), which do not 
invade into untreated ME180 cells (Fig. 17C). To confirm these results, I treated ME180 
cells with latrunculin B, a different actin polymerization inhibitor, and observed that a 





iga’) compared to untreated cells in the Bla reporter assay (Fig. 17D). Together these data 
suggest that disrupting actin polymerization causes host cells to weaken their barrier 
function for invasion, which allows even noninvasive GC to enter into host cells in an 
actin-independent manner at a relatively high frequency. 
 To further investigate the role of F-actin in invasion, I treated ME180 cells with 
the cell impermeable fixative TA prior to invasion. TA inhibits endocytosis and 
exocytosis by restricting membrane fluidity and blocking vesicle-membrane fusion 
without interfering with intracellular processes (207, 226) (see pgs. 123-124). The 
gentamicin protection assay showed that the invasion of FA1090 into ME180 cells was 
blocked in TA treated cells (Fig. 17E). These data suggest that host cell F-actin cannot 
rearrange to internalize GC in TA treated cells since intracellular F-actin recruitment 
should occur as normal. Overall, these data confirm that GC invasion into host cells is a 
specific process. Viable GC must recruit F-actin and induce the proper F-actin 
rearrangements in host cells to direct their own internalization. When actin dynamics are 
disrupted, GC entry becomes inhibited or non-specific. 
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Various GC strains, but not E. coli, interact with a broad range of cervical epithelial 
cells.  To better understand the host cell range and specificity of GC invasion into 
epithelial cells, I employed the gentamicin protection assay. I incubated cervical 
epithelial cell lines with GC or E. coli DH5α for 6 h, washed away nonadherent bacteria, 
and quantified adherence and invasion of host cells after 2 additional h with or without 
gentamicin treatment. GC strain FA1090 adhered to and invaded ME180 cells, but E. coli 
DH5α displayed limited adherence and no detectable invasion into these cells (Fig. 18A). 
MS11 mKC, a clinical GC isolate recovered from a male challenge study at the onset of 
dysuria (253), adhered to and invaded ME180 cells at similar levels compared to FA1090 
(Fig. 18B). Furthermore, FA1090 adherence and invasion were analogous in ME180 cells 
and Hec1B endometrial-like cells (Fig. 18C). These data suggest invasion into ME180 
cervical epithelial cells is GC-specific, but not specific to strain FA1090. These data 
suggest a broad range of GC strains can invade into a variety of host cells. 
 
TA eliminates background resistant GC to provide “cleaner” quantification of GC 
invasion.  One consistent issue encountered with the gentamicin protection assay was the 
recovery of viable GC in the extracellular supernatants of wells treated with gentamicin. 
They represent extracellular GC that survived gentamicin treatment by means other than 
internalization into host cells. The number of recovered GC seemed to vary between 
experiments and the Opa, pili, and LOS expression states of GC appeared to contribute to 
the varying degree of gentamicin resistance (data not shown). These resistant GC indicate 
the level of background GC that were quantified in a particular invasion lysate as “false 




Figure 18—Invasion into cervical epithelial cells is GC-specific. Gentamicin 
protection assays were performed by incubating host cells with: (A) FA1090, (B) 
FA1090 or MS11 mKC, or (C)  FA1090 or DH5α. Data in panel A = average (± SD) of a 
single experiment performed in triplicate; panel B =  average (± SD) of four trials 
performed as four independent experiments for the adherence data and the invasion data 
is an average (± SD) of six (FA1090) or seven (MS11 mKC) trials performed over four 
independent experiments; panel C = average (± SD) of two trials performed as two 
independent experiments for the adherence data and the invasion data is an average (± 
SD) of four trials performed over three independent experiments. ME180 cells were 




 in panels A and B; 




; gentamicin = 200 µg/ml. 
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limited to experiments where FA1090 interact with host cells. I incubated a culture of 
FA1090 with different concentrations of gentamicin for 2 h in the absence of ME180 
cells and plated GC for viable plate count every 20 min. Incubations in the presence of 
200 µg/ml gentamicin killed an entire culture (over 4 x 10
7
 GC/well) in 60-80 min. Even 
the lowest concentration of gentamicin tested (100 µg/ml) killed the entire population of 
GC by 2 h (Fig. 19A). These data indicate that the background gentamicin resistant GC is 
due to the interaction of GC with host cells. 
 In order to address the background gentamicin resistance issue, I replaced 
gentamicin with TA in the gentamicin protection assay. TA is a plant-derived, cell-
impermeable fixative with anti-GC activity (207, 226). I tested the survival of FA1090 in 
the presence of different concentrations of TA similar to the gentamicin survival tests in 
Figure 19A. Only the highest concentration of TA tested (0.5%) killed an entire culture 
(over 1 x 10
8
 GC/well) in fewer than 2 h (Fig. 19B). To confirm these results, I stained 
FA1090 to detect viable and nonviable GC after incubation in the absence or presence of 
TA. In this staining method, viable GC with intact membranes only incorporate the cell 
permeable SYTO dye to fluoresce green and nonviable GC with compromised 
membranes incorporate SYTO dye and the normally cell-impermeable propidium iodide 
to fluoresce yellow. FA1090 treated with IM and then stained for viability fluoresced 
green indicating that they remained viable, but FA1090 treated with TA concentrations as 
low as 0.1% for 1 h stained yellow and were nonviable (Fig. 19C). In addition, I 
performed a disc diffusion assay with FA1090 in the presence of filter paper discs 
containing different concentration of TA. Both the high (0.5%) and moderate (0.05%) 




Figure 19—Analysis of the ability of TA and gentamicin to kill background GC in 
the presence of host cells. (A-B) FA1090 kill curve assays in the presence of (A) 
gentamicin or (B) tannic acid; each data point is a single trial. Data were normalized to 
the concentration of FA1090 at t = 0 min. (C) Viability staining of FA1090 treated with 
or without TA (0.1%, 60 min); samples analyzed by LSCM, bar = 10 µm. (D) TA disc 
diffusion assay for FA1090; data = average (± SD) of six measurements taken from three 
separate discs. Discs immersed in PBS served as negative controls for FA1090 growth 
inhibition. (E) Gentamicin protection assay performed by incubating ME180 cells with 
FA1090 and quantifying the number of background (not intracellular) GC resistant to 
gentamicin (500 µg/ml) or TA (0.5%). (F) Viability staining of FA1090 associated with 
ME180 cells and treated with or without TA (0.1%). Samples were analyzed using 
LSCM, bar = 5 µm. (G) Gentamicin protection assay to quantify invasive GC from the 
experiment in panel E; Data in panels E and G = averages (± SD) of at least eight trials 











concentration tested (0.005%) yielded no zone of inhibition (Fig. 19D). These data 
demonstrate that concentrations of TA between 0.5%-0.05% are bactericidal to FA1090. 
 I performed parallel gentamicin protection assays with gentamicin or TA as the 
antimicrobial agent and collected supernatants and saponin-treated lysates from each well 
to compare background resistance GC and invasive GC levels. The assays performed 
with TA revealed no background GC in the supernatants compared to the gentamicin 
treated assays (Fig. 19E). Viability staining assays of ME180 cells incubated with 
FA1090 and treated with TA revealed that most GC stained yellow indicating TA 
treatment killed the majority of GC adherent to host cells (Fig. 19F). (Few GC stained 
yellow in wells treated with gentamicin suggesting gentamicin did not kill FA1090 
interacting with ME180 cells. However, gentamicin renders GC nonviable by inhibiting 
protein synthesis and does not compromise membrane integrity as needed for 
incorporation of propidium iodide during viability staining.) Despite the enhanced anti-
GC activity of TA compared to gentamicin, similar numbers of invasive GC were 
recovered from lysates of TA treated cells compared to lysates from gentamicin treated 
cells (Fig. 19G). Overall, these data show that TA better eliminates background 
extracellular GC in the gentamicin protection assay to yield a more accurate 
representation of the total number of GC that invade into a population of host cells. 
 
Analysis of CCF2-AM loading at different time points in the Bla reporter assay.  In 
the Bla reporter assay protocol, CCF2-AM is added after ME180 cells are incubated with 
GC. I performed a Bla reporter assay where CCF2-AM was loaded into ME180 cells at 
the beginning of the incubation with FA1090 Φ(bla-iga’) and maintained in the growth 
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media throughout the experiment. Treatment of ME180 cells with CCF2-AM throughout 
incubation with FA1090 Φ(bla-iga’) does not yield an increase in the subpopulation of 
cells invaded by GC. A similar percentage of ME180 cells showed an increase in blue 
fluorescence when incubated with FA1090 Φ(bla-iga’) regardless of whether CCF2-AM 
was loaded into cells at the beginning or after the 6 h incubations (Fig. 20). These data 
suggest that CCF2-AM is degraded by host cells during prolonged incubation. FA1090 
Φ(bla-iga’) that invade into host cells, but are killed by or escape from host cells prior to 
flow cytometry analysis could cleave CCF2-AM. However, since CCF2-AM appeared to 
degrade over time, these “early invasion” events may not be detected in the Bla assay. An 
alternative explanation is that only the subpopulation of invaded host cells recovered at 
the conclusion of the Bla reporter assay are the only cells susceptible to invasion 
throughout the assay.  The majority of host cells may be insensitive to GC invasion 
regardless of whether GC are viable and express an invasion-promoting surface profile.  
 
The relative mean fluorescence of CCF2-AM loaded ME180 cells parallels the 
percentage of invaded cells.  I graphed the relative mean fluorescence due to uncleaved 
and cleaved CCF2-AM from all trials represented in Figure 14D-I, Figure 15A, and 
Figure 16B (Fig. 21 and Fig. 22). In all trials where a significant percentage of ME180 
cells displayed an increase in relative blue fluorescence due to CCF2-AM cleavage, there 
was parallel trend of increased relative mean fluorescence over controls with no CCF2-
AM cleavage (not statistically significant). Among trials where CCF2-AM cleavage was 
observed, populations with a higher percentage of invaded ME180 cells also showed a 





Figure 20—Analysis of CCF2-AM: pre-invasion loading vs. post-invasion loading. 
Bla reporter assays showing the subpopulation of ME180 cells invaded by FA1090 
Φ(bla-iga’) does not change when CCF2-AM is loaded into cells at the beginning of the 
assay; data = a single experiment. In the CCF2-AM pre-loading assay, cells were loaded 
with 0.25 µM CCF2-AM at the time of GC addition, incubated for 6 h, and then also 
loaded with 0.25 µM CCF2-AM post-invasion as in a standard Bla reporter assay. Assays 
were analyzed via flow cytometry; cells incubated with FA1090 served as a gating 









Figure 21—Quantification of the relative mean fluorescence. Bla reporter assay data 
from (A) Fig. 14D, (B) Fig. 14I, (C) Fig. 15A, and (D) Fig. 16B and graphical 
representations of the relative mean fluorescence of each sample; data representative of 
two to five independent experiments and the mean fluorescence plots are averages (± SD) 
from those experiments. Green fluorescence = mean fluorescence due to uncleaved 





Figure 22—Quantification of the relative mean fluorescence. Bla reporter assay data 
from (A) Fig. 14E, (B) Fig. 14F, (C) Fig. 14G, and (D) Fig. 14H and graphical 
representations of the relative mean fluorescence of each sample; data representative of 
two to four independent experiments and the mean fluorescence plots are averages (± 
SD) from those experiments. Green fluorescence = mean fluorescence due to uncleaved 




Figure 23—Quantification of the relative mean fluorescence ratios.  Graphical 
representations of the relative mean fluorescence ratios for the data in Fig. 21 and Fig. 22. 
The ratio of the relative mean blue fluorescence (cleaved CCF2-AM) to the mean green 
fluorescence (uncleaved CCF2-AM) was calculated for each trial; data represents the 
average (±SD) of the individual ratios from each trial. 
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occurred in Figure 14G and Figure 22C where FA1090 Φ(bla-iga’) invaded a slightly 
smaller subpopulation of ME180 cells at a starting MOI 10 (~28%), yet had a slightly 
higher relative mean blue fluorescence, compared to trials with a starting MOI 1 (~31% 
of cells invaded) (not statistically significant). This observation suggests that fewer 
ME180 cells are invaded at an MOI 10, but these invaded cells contain more FA1090 
Φ(bla-iga’), which cleave more CCF2-AM to yield a higher relative mean fluorescence 
(Fig. 22C). In all other trials, the data suggest that when a higher subpopulation of 
ME180 cells are invaded, a greater number of FA1090 Φ(bla- iga’) are internalized 
within those cells compared to the number of GC internalized by a smaller subpopulation 
of invaded cells. 
 
FA1090 maintain their pili and Opa expression states following gentamicin-killing.  
To confirm that the gentamicin treatment and 4
o
C storage processes utilized to render GC 




 phenotype of the 





 variant to interact with ME180 cells at MOI 100 using LSCM and 

















 strain was able to adhere to greater than 95% of the ME180 cells 
in the population. On the majority of host cells, this variant formed small microcolony-





 FA1090 Φ(bla-iga’) variant adhered to greater than 90% of the ME180 
cells, but on the majority of cells, GC were randomly dispersed (53%). For ME180 cells 








 variants, the cells either displayed 
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randomly dispersed GC (62% and 47%, respectively) or no adherent GC (27% and 42%, 





FA1090 Φ(bla-iga’) strain utilized in Figure 16A and Figure 16B does not lose pili or 
Opa surface expression when killed by gentamicin since these GC still interact with host 




 strain in Figure 




Figure 24—Analysis of the interaction of nonviable GC expression different 
combinations of pili and Opa. (A and B) Immunofluorescence microscopy analysis of 
ME180 cells incubated with gentamicin-killed FA1090 Φ(bla-iga’) expressing different 
combinations of pili and Opa. (A) bar = 5 µm; MOI of 100 and (B) scoring of the cellular 





 Considerable effort has been devoted to understanding how GC invade into 
human mucosal tissues. Invasion provides GC with a mechanism to avoid the 
extracellular, innate immune defenses, including neutrophils and macrophages, as well as 
antimicrobial peptides, defensins, and mucin (60, 190, 232). Invasion through epithelial 
barriers into underlying tissues can result in PID. Serum resistant GC can migrate through 
the subepithelium to secondary sites to cause DGI (182). 
 Invasion is a multi-stage process where GC can utilize multiple adhesins and 
invasins to initiate cross-talk with host cells by activating signaling pathways and altering 
gene expression. Bacteria that present an acceptable combination of surface adhesins and 
invasins to surface receptors on the host cells can initiate colonization and invasion. I 
show in Figure 18A that E. coli DH5α did not trigger invasion into cervical epithelial 
cells indicating they do not possess the specific surface molecules required for invasion 
into this cell type. When an appropriate combination of ligand-receptor interactions are 
engaged between GC and cervical epithelial cells, host cell factors are recruited to induce 
cell signaling patterns that lead to GC invasion (185). Pilus retraction allows pathogenic 
Neisseria to achieve a more intimate adhesion to host cells (231). The level of GC-host 
cell cross-talk progresses as more GC surface molecules, such as Opa, LOS, Por, and/or 
iC3b, bind to the host cell (72, 192). Ultimately, GC orchestrate F-actin-rich 
rearrangements in host cells at sites of adherence to internalize GC (73, 94, 187). If these 
receptor-ligand interactions were sufficient to trigger the GC-host cell responses 
necessary for invasion, gentamicin-killed GC that possess the same ligands as viable GC 
should invade into host cells. However, using a novel Bla reporter assay, I showed in 
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Figure 16B that nonviable GC do not enter into human cervical epithelial cells. This 
finding indicates that the molecular cross-talk between GC and host cells that leads to 
invasion requires GC viability in addition to the appropriate surface ligand-receptor 
interactions.   
There are many stages of the invasion process where GC viability may be 
required to establish GC-host cell cross-talk to promote GC internalization. During each 
stage of pathogenesis, GC undergo changes in gene expression to adapt to new 
microenvironments in the host (195). Nonviable GC would be metabolically and 
physically inactive and, thus, fail to modulate their response to the host. The lack of 
cross-talk by nonviable GC after contact with host cells could be one explanation for their 
lack of invasion. Several microarray studies have revealed extensive alterations in gene 
expression by viable pathogenic Neisseria in the presence of host cells (83, 96, 97). 
Several neisserial genes that possess the contact regulatory element of Neisseria (CREN) 
in their promoter regions are activated during contact with host cells (57, 58, 200). Only 
viable GC are capable of proper gene regulation; therefore, nonviable GC may not invade 
host cells due to a lack of invasion-promoting gene regulations. 
Data from the Bla reporter assay in Figure 15A show that viable FA1090 Φ(bla-
iga’) must express pili to invade ME180 cells. Gentamicin-killed P
+
 FA1090 Φ(bla-iga’) 
can adhere to, but not invade into ME180 cells, suggesting adhesion defects do not 
account for the inability of nonviable GC to invade into ME180 cells. These results 
indicate that loss of pilus functions (other than mediating attachment) by nonviable GC 
could also explain why they do not invade host cells. After adhering to host cells, GC 
retract pili powered by the ATPase motor protein, PilT (189). PilT-mediated pilus 
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retraction triggers the PI3K/Akt signaling pathway in epithelial cells and blocking this 
retraction-induced signaling inhibits invasion (167). Gentamicin-killed GC are 
metabolically inactive and cannot generate adenosine triphosphate (ATP) to drive pilus 
retraction. Without pilus retraction, nonviable GC would not trigger retraction-induced 
signaling in host cells or form more intimate adhesions with host cells to establish 
subsequent cross-talk essential for GC entry. 
  I and others (187) have shown that the interaction of nonviable GC with host cells 
does not culminate in F-actin recruitment and rearrangement at sites of adherent GC (see 
Fig. 16E-G), which prevents nonviable GC from completing the invasion process. I show 
in Figure 17C and Figure 17D that host cells treated with F-actin inhibitors resulted in the 
opposite outcome by triggering an increase in the non-specific entry of GC into host 
cells. These results suggest that nonviable GC fail to stimulate F-actin recruitment and 
reorganization, rather than disrupt the polymerization of recruited F-actin, and further 
indicate that F-actin-dependent GC invasion is a bacteria-directed process that requires 
GC viability. In this study, I showed that viable P
+
 GC, but not nonviable P
+
 GC, can 
induce cortical actin rearrangements and invade host cells. These data support the notion 
that pilus retraction is important in the induction of F-actin rearrangements and invasion.   
Most methodologies employed to investigate GC invasion into host cells fail to 
quantify GC-host interactions at the single cell level. The gentamicin resistance assay 
represents the standard method to quantify bacterial invasion into host cells by estimating 
the total number of viable, intracellular GC recovered from the entire population of 
infected cells (261). This assay has helped reveal many important aspects of GC invasion, 
yet it is restricted in measuring the cellular details of the invasion process. The 
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gentamicin protection assay does not provide direct information about the infected host 
cells, including the number of host cells in a population invaded by GC or how many GC 
are present in each infected cell. Since the assay only makes quantitative measurements 
on the total number of GC recovered before and after gentamicin treatment, formulating 
an assumption on the number of invasive GC per host cell overextends the data. To better 
quantify invasion into host cells, Pils, et al. developed a method where they fluorescently 
pre-labeled GC prior to invasion and detected GC fluorescence inside host cells using 
flow cytometry (222). Host cells are infected and quenched with trypan blue prior to flow 
cytometry analysis to remove background fluorescence from adherent GC. Invasion is 
quantified by measuring the fluorescent intensity of labeled GC inside host cells. 
However, this approach is limited to investigating invasion during short time course 
invasions (1-2 h) because the fluorescent signal in pre-labeled bacteria dissipates as GC 
replicate over time. After only a few rounds of replication, the fluorescent label becomes 
undetectable in the population (data not shown). Data from the Bla reporter assay in 
Figure 14H and previous investigations show that GC invasion into most host cell types 
requires 4-6 h. The Pils, et al. approach cannot quantify GC invasion at these extended 
time points.  
I utilized the Bla reporter assay in combination with flow cytometry throughout 
this study to quantify the number of host cells in the population invaded by GC during 
any time course. Our data reveal that even though nearly 100% of ME180 cells displayed 
viable adherent P
+
 FA1090 Φ(bla-iga’) by 4-6 h, the percentage of invaded cells in the 
population never exceeded 40% without the aid of cytoskeletal disrupting agents. In 
addition, within the invaded subpopulation of cells, the flow cytometry analyses revealed 
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a wide range of relative blue fluorescence. Together, these data indicate that GC only 
trigger invasion into a subset of cervical epithelial cells and some invaded cells may 
contain more internalized Bla-expressing GC compared to other invaded cells. These 
findings also imply that GC-host cell interactions on the majority of cells do not produce 
the proper sequence of cross-talk responses to yield invasion.   
The gentamicin protection assay also has the propensity to recover extracellular, 
non-invaded GC sequestered within microcolonies that represent “false-positives” for 
invasion. During gentamicin treatment, a fraction of adherent extracellular GC localized 
within the cores of microcolonies may be protected from gentamicin by layer(s) of 
surrounding GC and misinterpreted as invaded, intracellular GC. Different GC variants 
can cluster together into microcolonies to varying degrees depending on their surface 
composition, which leads to varying degrees of GC invasion overestimations. For 
example, Opa
+
 GC aggregate more than Opa
-
 GC due to Opa-LOS interactions between 
neighboring GC (24), which may create an overestimation of the number of invaded Opa
+
 
GC in this assay. Due to this variable clumping phenotype by GC, the gentamicin 
protection assay may not accurately compare the invasion of different variants with 
different GC-GC interaction abilities.  
The Bla reporter assay does not rely on antibiotic resistance, and GC microcolony 
formation has no significant effect on its readout for invasion. Therefore, this assay 
permits a more accurate comparison of invasion between GC variants with different 
surface properties. Data in Figure 15B suggest that the gentamicin resistance assay may 
have mischaracterized the role of Opa in the invasion process. The Bla reporter assay in 




 FA1090 Φ(bla-iga’) invade a higher percentage of 
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 FA1090 Φ(bla-iga’), which suggests Opa interferes 
with the invasion process and indicates the existence of Opa-independent invasion 
pathways. These data agree with our previous findings that Opa expression is not 
required for GC invasion into ME180 cells (266). I propose Opa acts predominately as a 
host cell adhesin and a “clumping” factor that promotes GC microcolony formation on 
host cells. Our findings argue that GC possess a redundancy of surface invasins that 
contribute to the overall invasion potential of the organism. When Opa expression is 
phase “off” (Opa
-
) other surface factors, such as Por, LOS, and/or L12 can compensate in 
GC invasion. 
 The Bla reporter system provides a powerful tool to measure bacterial invasion 
into host cells and host cell responses to invasion at the single cell level. The assay can be 
used to isolate invaded host cells from noninvaded cells and examine their gene 
expression patterns and signaling pathways. The gene expression in bacteria recovered 
from invaded host cells in the assay can be compared to bacteria not exposed to host cells 
to identify novel genes essential for invasion. The Bla reporter assay also provides a new 
way to assess the virulence potential of clinical isolates, uncharacterized strains, or 
mutant libraries within a single population of host cells or over a range of cell types. To 
our knowledge, this represents the first study where the Bla reporter assay has been used 
to investigate the invasion of bacteria, rather than the secretion of effector proteins, into 
host cells and the first time the invasion potential of nonviable bacteria has been directly 
quantified. This assay should be expandable to quantify invasion into any cell type, by 
any bacteria, and on any time scale providing a new approach to resolve the cellular and 
molecular details of host cell invasion. 
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CHAPTER 3—NEISSERIA GONORRHOEAE INTRACELLULAR SURVIVAL AND 
ESCAPE FROM CERVICAL EPITHELIAL CELLS 
Introduction 
 The ability of GC to be continually transmitted and adapt to new host 
environments allows the organism to establish long-term persistence in the human 
population. GC are internalized by host cells during infections and, thus, contend with 
intracellular environments. Their survival and persistence during infection of epithelial 
cells helps determine whether GC will establish disease and is likely to contribute to the 
severity of the disease outcome (191, 192, 272). GC appear to be well adapted for 
immune evasion and ICS in the female reproductive tract, since female hosts remain 
asymptomatic during the initial stages of infection and develop features of PID after 
prolonged survival of GC (69, 270).  As described in Chapter 2, GC invade into cervical 
epithelial cells via multiple pathways. However, the fate of intracellular GC after 
invasion, including the GC-host cell interactions that regulate ICS, the intracellular 
compartments where GC reside, and how GC maintain their survival and control 
inflammation in order to continue efficient host to host transmission, is not clear.  
 The notion that GC can survive and/or replicate inside human epithelial cells 
remains controversial due to limitations and variations in ICS quantification methods. 
Most GC ICS studies involve the gentamicin protection assay followed by a chase period 
to quantify the surviving population of intracellular organisms. How host cells are 
incubated during these chase periods varies and can involve continuously exposing cells 
to gentamicin throughout the chase, treating cells with gentamicin both before and after 
the chase, or administering a single gentamicin treatment prior to the chase period. 
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Researchers have utilized these various strategies to attempt to devise the most accurate 
method to measure GC ICS. Overall, it is generally accepted that GC can persist within 
host tissue since GC survive for long durations in the female reproductive tract and 
migrate to secondary sites.  
 Epithelial cells possess killing mechanisms directed at limiting the ICS of 
invading pathogens, but GC have developed strategies to overcome these defenses. GC 
can induce the expression of pro-inflammatory cytokines, such as TNFα, IL-6, and IL-8, 
from host cells to trigger phagocytes to migrate to the site of infection and to phagocytize 
both extracellular GC and GC-infected host cells (78, 211, 234, 235). Epithelial cells also 
possess lysosomal compartments similar to phagocytes for pathogen degradation. Images 
of intracellular GC show both disintegrated and morphologically intact GC both inside 
vacuoles or free in the cytoplasm of epithelial cells (5, 98, 107, 203, 281, 293, 297, 298, 
303). GC can disrupt LAMP function to prevent phagolysosome maturation in epithelial 
cells and GC exhibit enhanced ICS in cells derived from LAMP knockout mice (10-12, 
16, 21, 111, 173, 206, 224, 225, 298).  These data indicate that epithelial cells can clear 
internalized bacteria within phagolysosome-like compartments, but also show GC 
possess mechanisms to avoid phagolysosomal killing. Epithelial cells can kill 
intracellular bacteria using oxygen and nitrogen radicals (14, 219). Some epithelial cells 
produce nitric oxide (NO) radicals that combat intracellular pathogens (129, 170). GC 
possess enzymes to deal with bactericidal agents inside host cells. GC could utilize at 
least three nitrogen reductases including, nitrite reductase (AniA), nitroreductase (NfsB), 
and nitric oxide reductase (NorB), for anaerobic respiration or to inactivate reactive 
nitrogen intermediates (RNI) if cytoplasmic granules fuse with GC-containing vacuoles 
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(122, 156). GC also produce high levels of peroxidase (CcpA) and catalase (KatA), 
enzymes suggested to protect GC against reactive oxygen intermediates (ROI) and 
hydrogen peroxide (7, 285, 308).  
 GC must acquire iron from host cells for ICS (104, 284). Hagen and Cornelissen 
demonstrated that FA1090 survival in ME180 cells declined initially for 8 h post-
invasion, but then GC replicated over the final 16 h of the chase period in iron 
supplemented media. However, in iron-depleted media, GC survival continued to decline 
throughout the chase (104). Epithelial cells can sequester iron to starve internalized 
bacteria to prevent their growth and proliferation (279). 
 GC that survive inside epithelial cells can further progress to other cellular niches. 
GC can transcytose through host cells and exit through the basolateral surface into 
subepithelial tissues without disrupting cell tight junctions (186, 293). GC could also 
persist by escaping back into the extracellular environment. The re-emergence of 
pathogens from host cells after invasion has been demonstrated for Trypanosoma cruzi 
and group A Streptococci and was speculated to occur for GC (4, 36, 179, 203). Criss and 
Seifert showed that FA1090 exited from T84 cells into both apical and basolateral 
compartments (51), which suggests GC do cycle out of epithelial cells after invasion.    
 During the experiments presented in this chapter, I utilized TA to investigate GC 
intracellular survival and escape. TA is a complex polyphenolic polymer primarily 
composed of gallic acid and glucose that is produced in the cell wall and vacuoles of 
many plant species (101, 201). TA acts as a cell-impermeable mordant/fixative when 
added to cell membranes by cross-linking the amino or carboxyl groups of extracellular 
proteins (201). Thus, TA treatment prevents endocytosis and exocytosis from host cells 
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without interfering with intracellular functions by fixing secretory and endocytic vesicles 
as they fuse with cell membrane (201, 226). Through these cellular effects, TA can 
inhibit the re-emergence of bacteria from host cells. Treating mouse embryonic 
fibroblasts with tannic acid prevented the escape of internalized Streptococcus pyogenes 
without compromising bacterial intracellular survival (207). TA can also trigger the 
redistribution of tight junction proteins in polarized cells to disrupt polarization (216). 
Furthermore, the pytochemicals found in Terminalia macroptera leaves, including TA 
derivatives and precursors, are bactericidal to GC (262).  
 In this chapter, I demonstrate that subsets of intracellular GC can persist in the 
host by surviving inside cervical epithelial cells or by cycling in and out of host cells via 
an escape pathway. I developed a TA survival assay to demonstrate that GC trapped 
inside host cells maintain a relative intracellular stasis when bactericidal agents are not 
left in the extracellular media for long time periods. Therefore, I utilized TA to 
disconnect GC ICS from escape so that these two processes could be analyzed apart from 
each other. I generated a catalase deficient mutant and acquired a nitrogen reductase 
(nfsB) mutant and determined that neither enzyme contributed to GC ICS in cervical 
epithelial cells. My data also indicate that a subpopulation of internalized GC escape 
intracellular killing by utilizing host cell exocytosis machinery to exit host cells. I 
propose GC cycle in and out of host cells as a mechanism to avoid both extracellular 
immune defenses and intracellular killing as a means of persisting at a low-level in the 




GC do not survive inside cervical epithelial cells after invasion when subjected to 
continuous exposure to bactericidal agents.  Using a modified gentamicin protection 
assay as a method to recover viable intracellular GC, I determined if GC internalized by 
the invasion susceptible subpopulation of cervical epithelial cells can survive inside these 
host cells. ME180 cells were infected with GC expressing different cell surface 
molecules to allow for invasion. Cells were treated with gentamicin or TA to kill 
extracellular GC. These killing agents were also maintained in the extracellular media 
during an ICS chase period to prevent the proliferation of any GC in the extracellular 
environment and to force GC to persist inside host cells as the only option for survival. 
The data show that GC ICS decreased in ME180 cells during 4 h chase periods after 
invasion (Fig. 25A). FA1090 exhibited a similar negative slope for ICS in Hec1B 
cervical endometrial cells when compared to ME180 cells over the same 4 h time span 
(Fig. 25B). FA1090 showed an even more rapid decline in ICS when incubated in the 
constant presence of TA (Fig. 25C). Furthermore, altering Opa or LOS phenotypes did 
not alter GC ICS. Opa-expressing FA1090 did not exhibit increased survival over an Opa
-
 
strain (Fig. 25C).  In strain F62, LnNT LOS-expressing variants did not display any 





backgrounds (Fig. 25D). Taken together, these data suggest that GC die over time inside 
cervical epithelial cells, regardless of their LOS and Opa phenotypes. 
 
Expression of the enzymes catalase (KatA) and the nitrogen reductase NfsB do not 





Figure 25—Analysis of GC intracellular survival when subjected to prolonged 
exposure to bactericidal agents.  GC intracellular survival assays were performed in the 
presence of prolonged gentamicin or TA treatment. Host cells were incubated with: (A) 
FA1090 or MS11 mKC; data = average (± SD) of six (FA1090) or seven (MS11 mKC) 






(B) FA1090; data = average 





FA1090; data = average (± SD) of five (gentamicin trials) or seven (TA trials) trials from 
three independent experiments. (D) F62∆lgtD or F62∆lgtA; initial invasion (t = 0) were 
normalized to 8 x 10
3
 CFU/well and data = average (± SD) of three trials from a single 
experiment. ME180 cells were utilized in all trials (and Hec1B in panel B). GC were 
added to cells at an MOI of 1000 in panels A-C and at a MOI of 10 in panel D. 
Gentamicin = 500 µg/ml in panels A-C and 200 µg/ml in panel D. TA = 0.5% in panel C. 
 
 127 
in the intracellular environment of host cells, including superoxide radicals, peroxide 
derivatives, and nitrogen radicals (130). To better understand how host cells kill GC, I 
analyzed mutants lacking genes that may be required for ICS. GC express high levels of 
catalase—an enzyme that contributes to bacterial survival by combating oxidative 
stresses within host cells, such as hydrogen peroxide and peroxide radicals (7, 309, 310). 
I deleted the catalase gene (katA) from FA1090 to yield the catalase deficient mutant 
FA1090∆katA (see Fig. 26). FA1090∆katA did not react with hydrogen peroxide to form 
water and O2 gas bubbles confirming that catalase enzymatic activity was eliminated in 
this strain (Fig. 26C). I tested whether FA1090∆katA displayed altered adherence, 
invasion or ICS. FA1090∆katA was less efficient at adhering to ME180 cells compared to 
FA1090, but the strains displayed similar invasion frequencies among the adherent GC 
(Fig. 27A). FA1090∆katA exhibited a similar negative slope for ICS compared to 
FA1090 suggesting that the parent and mutant have similar ICS properties (Fig. 27B). 
 In order to better understand the interactions of FA1090∆katA with cervical 
epithelial cells, I performed competitive survival assays between FA1090 and 
FA1090∆katA. I isolated spontaneous rifampicin (Rif
R
) and naladixic acid (Nal
R
) 
resistant FA1090 and FA1090∆katA mutants and tested the adherence, invasion, and ICS 
of these mutants using the gentamicin protection and survival assays. I incubated ME180 




 FA1090 and catalase mutant strain in the same well 
(i.e. FA1090 Rif
R
 vs. FA1090∆katA Nal
R
 or FA1090 Nal
R
 vs. FA1090∆katA Rif
R
). As 
observed in the noncompetitive assays, FA1090∆katA adhered to ME180 cells at lower 
levels compared to FA1090 in the same well, but showed a similar percentage of invaded 





Figure 26—Construction of FA1090∆katA, a GC strain deficient for the catalase 
enzyme. (A) Gene replacement strategy to establish the katA deletion strain (see 
Materials and Methods). (B) Agarose gel showing the DNA fragments generated during 
construction of FA1090∆katA to confirm the presence and proper orientation of each 
DNA of interest. Restriction enzymes used for digestions are as follows: X = XmaI, H = 
HindIII, and P = PstI. DNA samples not treated with restriction enzymes represented 
PCR products [i.e. katA and ΩSpec in FA1090] or uncut plasmids. (C) FA1090 and 
FA1090∆katA were patched onto GCK agar overnight and treated (+) or not treated (-) 




Figure 27—Deletion of the catalase gene does not alter GC intracellular survival. 
Gentamicin protection assays (panels A and C) or intracellular survival assays (panels B 
and D) performed in the presence of prolonged gentamicin treatment. ME180 cells were 
incubated with (A and B) FA1090 or FA1090∆katA in noncompetitive assays and (C and 
D) FA1090 Rif
R
 + FA1090∆katA Nal
R
 or FA1090 Nal
R
 + FA1090∆katA Rif
R 
in 
competitive assays. Data in panel A = average (± SD where possible) of one, two, or 
three trials from two independent experiments; panel B = average of two trials from two 





) were added at a MOI of 10 (gentamicin = 200 µg/ml) in panels 
A and B and at a MOI of 1000 (gentamicin = 500 µg/ml) in panels C and D; Rif
+
 = 
rifampicin resistant and Nal
+
 = naladixic acid resistant. 
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FA1090 (Fig. 27D). These data demonstrate that catalase expression does not play a role 
in protecting the gonococcus from dying inside cervical epithelial cells. 
 NfsB is an oxygen insensitive nitrogen reductase shown to be important in 
bacterial resistance to nitroaromatic compounds (301). A colleague in the laboratory 
created a mutation in nfsB in an FA1090 background (FA1090 M1, Esteban Carrizosa, 
unpublished data). FA1090 M1 adhered to and invaded ME180 cells at similar levels 
compared to FA1090 (Fig. 28A). FA1090 M1 was also killed at a similar rate to FA1090 
inside ME180 cells (Fig. 28B). These data indicate that nfsB does not play a role in GC 
ICS and suggests GC do not encounter nitroaromatic compounds inside cervical 
epithelial cells. Overall, these data show that neither catalase expression nor NfsB 
expression altered the rate of GC intracellular killing.  
 
Analysis of GC intracellular survival and potential escape during intermittent 
bactericidal agent exposure.  To determine if the observed decrease in FA1090 ICS 
within cervical epithelial cells was due to intracellular killing by host cells or penetration 
of the bactericidal agent into the cells, I incubated ME180 cells with FA1090 for 6 h and, 
after washing away nonadherent GC, treated the cells with TA for 1 h. In the samples 
incubated in TA-containing media for the duration of the chase period (continuous 
treatment), FA1090 ICS decreased over time (Fig. 29A). In the samples incubated in 
growth media during the chase period except for the final h (intermittent treatment) when 
samples were treated again with TA, FA1090 ICS decreased during the first 2 h, but then 
recovered over the remainder of the chase period (Fig. 29A). These data indicate that 





Figure 28—Inactivation of the nitrogen reductase gene, nfsB, does not alter GC 
intracellular survival. Gentamicin protection assays (panel A) or intracellular survival 
assays (panel B) performed in the presence of prolonged gentamicin treatment. ME180 
cells were incubated with FA1090 or FA1090 M1 in noncompetitive assays (A) ME180 
cells were incubated with FA1090 (black bars) or FA1090 M1; data = average (± SD) of 









Figure 29—Analysis of GC intracellular survival and potential escape. GC 









 FA1090 in panels B and C. (A) Comparison of GC intracellular 
survival when subjected to prolonged or intermittent exposure to 0.1% TA; data are 
representative (± SD) of two independent experiments each performed in triplicate. (B) 
GC may escape from inside host cells when not trapped by TA. Comparison of GC 
intracellular survival after an initial gentamicin (200 µg/ml) or TA (0.2% [90 min] + 1% 
[30 min]) treatment and no additional bactericidal agent treatment; data = average (± 
SEM) of three independent experiments each performed in triplicate, p-value = 0.0004 
for gentamicin-treated samples. (C) GC intracellular survival maintains a steady state 
when GC are forced to remain intracellular by TA (0.2% [90 min] + 1% [30 min]) 
treatment; data = average (± SD) of three trials from a single experiment. GC were added 
at a MOI of 100 in panel A and at a MOI of 10 in panels B and C. 
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However, when the selective pressure of bactericidal agents is removed from invaded 
host cells, GC survive inside host cells. These data suggest that TA can penetrate into 
host cells to contribute to GC intracellular death when the agent is maintained in the 
extracellular media.  
 As observed in Figure 17E, pretreatment of host cells with TA prior to incubation 
with GC blocks invasion. Therefore, treatment of host cells with TA post-invasion should 
trap invaded GC inside cervical epithelial cells and prevent additional GC from entering 
into the cells. I incubated ME180 cells with FA1090 for 6 h and treated the cells with 
either gentamicin or TA for 2 h. Extracellular adherent GC were efficiently killed by both 
treatments as little or no viable GC were recovered from cell culture supernatants 
following treatment (data not shown). In accordance with the intermittent survival assay, 
I removed the bactericidal agents after an initial 2 h treatment, incubated the cells in 
growth media until various time points, and quantified the levels of intracellular GC from 
cell lysates. In the TA treated samples, the number of intracellular GC remained 
relatively constant post-invasion (~10
4
 GC/well) (Fig. 29B and Fig. 29C) indicating that 
GC were indeed surviving inside cervical epithelial cells even over an extended time 
course. Surprisingly, in the gentamicin treated samples, I observed a significant decrease 
in the number of intracellular GC over time despite GC being incubated in favorable 
growth media (Fig. 29B, p-value = 0.0004). These data suggest GC are escaping from 
host cells after invasion when not trapped within these cells by TA. Overall, these data 
demonstrate GC survive within cervical epithelial cells in a relative stationary state where 




GC escape from cervical epithelial cells to persist after invasion.  To test if 
intracellular GC could escape back the extracellular milieu, I incubated ME180 cells with 
GC to allow for invasion, treated cells with gentamicin to kill extracellular GC, and 
added growth media during the 2 h and 4 h chase periods. Culture supernatants were 
collected at each time point to quantify the number of GC contained in the culture media. 
During the initial 2 h chase period, the number of FA1090 in the supernatants increased 
by about 10-fold above the background levels of bacteria present in the supernatant after 
gentamicin treatment (Fig. 30A). These data suggest that a portion of the invasive 
population of GC cycle back out of host cells to escape into the extracellular 
environment. The ability to escape from host cells is not strain-specific, since MS11 
mKC also appeared to escape from ME180 cells (Fig. 30A). Gentamicin was less 
efficient at killing extracellular GC associated with the Hec1B cell line during the 2 h 
treatment. Therefore, I was unable to determine if GC escaped from Hec1B cells since 
the high initial background level of GC in the supernatant prevented distinguishing 
escaping GC from extracellular GC replicating in the growth media (Fig. 30B). Since the 
data show that most GC escaped during the initial 2 h chase period, I wanted to determine 
the rate of GC escape from host cells. I collected supernatants at shorter intervals during 
the initial 2 h chase and found that the most rapid increase in GC escape occurred in the 
first 30 min of detection (Fig. 30C). Furthermore, the expression of Opa had little effect 
on GC escape during the initial chase period (Fig. 30C). I also ensured that washing the 
cells in growth media (following gentamicin treatment and prior to the beginning of the 
escape chase period) did not contribute to the background levels of extracellular GC after 
gentamicin killing (Fig. 30D).  
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Figure 30—Investigation of GC escape from the host cell intracellular environment 
after invasion. GC escape assays (panels A-D) and Bla reporter escape assays (panel E) 
were performed by incubating cells with:(A) FA1090 or MS11 mKC, (B-D) FA1090, or 
(E) FA1090 or FA1090 Φ(bla-iga’). Data in panel A = average (± SD) of 10 or 11 trials 
from six independent experiments; panel B = average (± SD) of 12 trials from seven 
independent experiments; panel C = one to three trials from a single experiment; panel D 
= average (± SD) of three trials from a single experiment and the t = 8 h supernatant is 
the final wash before adding IM for the chase period, panel E = single experiment and 
incubations with FA1090 served as gating control. ME180 cells were utilized in all trials 
(and Hec1B in panel B). GC were added to cells at a MOI of 1000 (panels A-C) and MOI 









Gentamicin = 500 µg/ml in panels A-C and 200 µg/ml in panel D-E.  
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 I utilized the Bla reporter assay to further determine if GC were exiting host cells. 
Host cells loaded with CCF2-AM that contain intracellular Bla
+
 GC should cleave the 
dye and fluoresce blue and cells that do not internalize Bla
+
 GC should not cleave the dye 
and fluoresce green. Invaded cells in the population that yield blue fluorescence at one 
time point would exhibit green fluorescence at a later time point if their internalized Bla
+
 
GC escape. I incubated ME180 cells with FA1090 Φ(bla-iga’) for 6 h, treated cells for 2 
h with gentamicin to kill extracellular GC and prevent escaping GC from re-entering host 
cells, and incubated cells in growth media for an additional 2 h and 4 h chase period. Our 
data show a large decline in the number of invaded ME180 cells at 6 h (~36%) compared 
to the number of cells with intracellular GC after gentamicin treatment at t = 8 h (~2%) 
(Fig. 30E), which supports the data in Figure 30C that escape is rapid. Taken together, 
these data indicate that GC can escape from within cervical epithelial cells and suggest 
that invaded GC may only reside in an intracellular location for a short time span before 
escaping into the extracellular milieu. 
 
GC escape by utilizing a host cell exocytosis pathway that can be inhibited by TA.  
 In order to understand the cellular processes that contribute to GC escape, ME180 
cells were treated with various cellular inhibitors after invasion. The actin polymerization 
inhibitors cytochalasin D and latrunculin B did not inhibit FA1090 escape during the 
initial 2 h chase period (Fig. 31A and Fig. 31B), indicating the actin microfilaments do 
not play a role in FA1090 exiting host cells. Disrupting microtubules with microtubule 
depolymerizing agent nocodazole also did not inhibit FA1090 escape (Fig. 31C).  
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 I modified the escape assay by treating cells with TA after the 6 h incubation 
instead of gentamicin. In Figure 17E, TA was shown to inhibit GC invasion. Thus, I 
reasoned that since TA inhibits vesicular fusions with the plasma membrane it may block 
escape. In cells treated with low or moderate concentrations of TA, FA1090 escape was 
not inhibited, but the moderate concentration did eliminate the background GC 
sometimes observed in the supernatants after gentamicin treatment (Fig. 31D and Fig. 
31E). The highest concentration of TA tested eliminated background FA1090 and 
blocked escape during the initial 2 h chase (Fig. 31E). Even after a 4 h chase period, only 
background levels of GC escaped into the supernatants from cells treated with high levels 
of TA (Fig. 31F). The high TA concentration also inhibited the escape of F62∆lgtD and 
F62∆lgtA (Fig. 31G), which demonstrated this inhibitory effect is not specific to FA1090. 
Alternatively, TA may not be blocking escape, but instead could be killing GC as they 
escape from host cells to prevent their recovery in the supernatants. To test this 
possibility, I incubated ME180 cells in high levels of TA for 2 h and then added back to 
the cells the number of FA1090 that appear to escape during a 2 h chase period from 
gentamicin- treated cells. During the 2 h chase period, the number of FA1090 in the 
supernatant increased indicating TA did not kill the added GC. TA inhibited escape rather 
than kill GC as they escape (Fig. 31H). TA fixes host cells without inhibiting intracellular 
functions and blocks vesicular fusion with the host cell membrane. Therefore, our data 
suggest GC escape from host cells by utilizing host cell exocytosis mechanism and TA 





Figure 31—Analysis of the GC escape mechanism. GC escape assays (panels A-G) 
and a GC escape control assay (panel H) were performed by incubating ME180 cells 
with: (A-F and H) FA1090 or (G) F62∆lgtD or F62∆lgtA. (A-C) The GC escape pathway 
cannot be blocked by cytoskeletal inhibitors (15 min pre-escape treatment and maintained 
throughout the chase period): (A) cytochalasin D (3 µM); data = average (± SD) of four 
to seven trials from three independent experiments, (B) latrunculin B (1 µM); data = one 
to three trials from a single experiment, (C) nocodazole (35 µM); data = an average of 
two trials from a single experiment. (D-H) GC escape from cervical epithelial cells via a 
host exocytosis mechanism that can be blocked by TA. Data in panel D = average (± SD) 
of four to eight trials from three independent experiments; panel E is representative of 
three independent experiments performed in triplicate; panel F = average (± SEM) of 
three independent experiments each performed in triplicate; panel G = average (± SD) of 
two independent experiments each performed in triplicate; panel H = average (± SD) of 
three trials from a single experiment. GC were added at a MOI of 1000 in panels A-D and 









Gentamicin = 200 µg/ml in panels A-G; TA = 0.5% in panels D, 0.2% or 0.2 % (90 min) 
+ 1% (30 min) in panels E, 0.2 % (90 min) + 1% (30 min) in panels F and G, 0.2% TA 








 Pathogens can utilize host processes to support their survival and transmission 
without eliciting a bactericidal immune response. The extent of GC ICS and persistence 
in a particular host may be contingent on a variety of factors, including the cell type 
invaded, the mechanism of invasion, the signaling pathways activated, and the specific 
innate defenses generated. It is thought that GC survive inside epithelial cells until they 
spread to other host tissues or are transmitted to a new host. GC ICS may contribute to 
the severity of tissue damage that occurs during disease (181, 261). The cellular 
interactions and factors that mediate the GC intracellular life cycle represents one of the 
least studied aspects of GC pathogenesis.     
 My data indicate that GC invasion of cervical epithelial cells yields three possible 
outcomes. GC are killed when bactericidal agents are present in the extracellular milieu. 
Under more favorable conditions, some GC survive within host cells and may avoid 
cellular killing strategies. Another subpopulation escapes from cells via an exocytotic 
pathway and may reinvade nearby cells, be transmitted to a new host, or interact with 
PMN’s to elicit pro-inflammatory responses.  
 Throughout this study, I used different modifications of the survival assay to 
monitor GC ICS and escape. My data show that continuous exposure of cells to cell-
impermeable bactericidal agents accelerated GC intracellular death compared to 
performing the assay with intermittent gentamicin or TA treatments. Data from the 
continuous treatment assays suggest the supposed “cell-impermeable” gentamicin and 
TA penetrate into cervical epithelial cells after prolonged exposure. Gray-Owen and 
colleagues also observed a decline in GC survival in CEACAM 3-expressing epithelial 
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cells and fibroblasts using the continuous treatment approach and gentamicin uptake into 
epithelial cells has been observed in other systems (21, 179). For example, researchers 
discovered that intestinal epithelial cells infected with Campylobacter jejuni (CJ) took up 
gentamicin at low levels during a continuous treatment assay and was responsible for 
killing a portion of the intracellular CJ (158). Overall, the intracellular killing attributed 
to gentamicin or TA permeability masks GC ICS in the continuous treatment survival 
assay and, thus, does not provide the most accurate measurement of GC ICS. 
 I wanted to determine which genes were needed for GC survival inside epithelial 
cells. To investigate the role of catalase in GC ICS, I deleted the GC catalase (katA) gene, 
a highly expressed cytoplasmic enzyme speculated to contribute to GC ICS (7, 310). I 
utilized the continuous treatment assay where cells were exposed to gentamicin 
throughout the survival chase period. The continuous treatment assay was employed in 
these analyses because I had not yet developed the intermittent survival assay at the time 
of this study. The potential penetration of gentamicin into host cells during the 
continuous treatment assay was expected to have a similar killing effect on both strains; 
therefore, any additional changes in ICS between them can be attributed to the affect of 
the catalase mutation. However, my results showed a similar rate of intracellular killing 
between FA1090 and FA1090∆katA, suggesting that catalase is not important for ICS. 
This is consistent with other published findings where a catalase mutant showed similar 
survival compared to wild-type GC in the estradiol-treated mouse model (265). These 
data indicate that catalase does not play a role in GC ICS in epithelial cells. Recent 
studies show factors other than catalase, such as the MntABC transporter, CcpA, and 
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Laz, play prominent roles in fighting oxidative stress (258, 285, 307), which further 
indicates that catalase is not essential for GC ICS. 
 In the intermittent survival assays, the GC-restrictive chase incubations were 
lifted by removal of the bactericidal agent after the initial treatment. My data show that 
GC can persist within cervical epithelial cells under these conditions or escape from host 
cells when treated with gentamicin or a low relative concentration of TA (i.e. escape-
permissive conditions). GC ICS appeared to decline at the beginning of the chase period 
under escape-permissive conditions. Other groups have also observed an initial lag or 
decline in FA1090 ICS after invasion into ME180 or T84 epithelial cells (51, 104). After 
the initial decline in GC ICS, my data show GC survival recovers over time in the 
intermittent assay in Figure 29A and Figure 29C suggesting GC may proliferate and/or 
escaping GC may re-enter into cells.  
 Treatment of cells with a high relative concentration of TA in Figure 29C (i.e. 
escape-restrictive conditions) blocked GC escape and restricted GC to intracellular 
locations where they appeared to survive at a stasis level. These data suggest the 
capability of epithelial cells to kill intracellular GC does not increase when a greater 
number are forced to remain inside host cells. In any case, it appears that GC can 
maintain a static or stationary level of ICS within epithelial cells over time. 
 The specific defense mechanisms that may kill some intracellular GC were not 
identified. Many invaded GC could die of starvation if unable to obtain an intracellular 
iron source since infected host cells could sequester this nutrient from the bacteria. 
Expression of the TonB-dependent iron transporter TdfF has been shown to be required 
for FA1090 survival in ME180 cells (104), suggesting GC that acquire iron could 
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represent the population that overcomes host intracellular defense and survive over time. 
Alternatively, GC subpopulations that signal and invade host cells via different 
mechanisms may enter into different subcellular compartments and realize different 
survival fates. As mentioned above, GC have been visualized in vacuoles or free in the 
cytoplasm in different cell types and entering into these different cellular locations may 
alter GC ICS. Timmerman, et al. display evidence of GC replication inside vacuoles and 
Weel, et al. show GC are destroyed inside some intracellular compartments (281, 297). 
These findings indicate that some, but not all, GC-infected cells develop vacuoles that 
mature into phagolysosomes and it appears some host cells may be more equipped to kill 
invaded GC than other cells. 
 GC re-emergence from host cells also represents a strategy for GC to persist in the 
host. My data from the gentamicin-based and Bla reporter-based escape assays showed 
that GC escape was rapid (30 min—2 h) suggesting GC cycled out of host cells soon after 
invasion. Therefore, the gentamicin-based escape assay may not be ideal for quantifying 
escape since many GC seem to emerge during the initial 2 h gentamicin treatment. The 
most rapid escaping GC would be killed prior to the chase period by gentamicin and 
would not be quantified in the escape pool. In addition, the late emerging GC during this 
gentamicin treatment period could represent the background extracellular GC sometimes 
observed in this assay. This subset of escaping GC would be extracellular prior to the 
chase period, but not exposed to the bactericidal agent long enough to be rendered 
nonviable. 
 I demonstrated that GC escape via a host exocytosis pathway blockable by TA. 
Since exocytosis occurs when intracellular vacuoles or vesicles fuse with the plasma 
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membrane, GC localized within intracellular compartments, not free in the cytoplasm, 
appear to be more probable escape candidates. Recently, Criss and Seifert demonstrated 
GC that invaded polarized T84 epithelial cells from the apical side could also exit 
through the apical membrane (51), but they did not identify the mechanism of GC re-
emergence. One potential mechanism for GC escape is the recycling endosome pathway, 
a route utilized by host cells to recycle receptors and cargo back to the cell surface (100). 
GC that remain bound to particular cell receptors after invasion or divert endosomes into 
the recycling track could be targeted for escape. Transferrin receptors and the ASGP-R 
undergo recycling. GC express transferrin binding proteins, TbpA and TbpB and bind to 
the ASGP-R via LnNT LOS (43, 48, 55, 165, 229, 255). GC that remain bound to the 
ASGP-R after invasion could recycle back to the plasma membrane. In theory, one could 
envision intracellular GC and cellular transferrin receptors both binding to transferrin 
molecules to compete for the iron source. Upon recycling, transferrin receptors, 
apotransferrin, and bound GC would cycle back to the plasma membrane to release both 
the apotransferrin and the bound GC to escape (55). GC could use many different 
receptors to carry out this recycling/escape strategy.  
 Escape, i.e. intracellular-extracellular cycling, may represent an important 
mechanism for GC persistence in the female reproductive tract. A subset of invaded GC 
could evade extracellular and intracellular host defenses by continual transitioning in and 
out of host cells. This subdued level of survival may contribute to the asymptomatic 
nature of GC disease in women and prevent GC from eliciting a strong innate immune 
response. Epithelial cells could provide GC with a location to sustain a small pool of 
protected organisms that persist in the host. These intracellular organisms are well 
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positioned to either transcytose into subepithelial tissues to propagate disease progression 
or escape into the extracellular milieu where they are localized for transmission to a new 
host or positioned to reinvade neighboring cells. In this study, I showed that some 
invaded GC can evade host cell killing mechanisms to maintain a surviving intracellular 
pool. Other GC escape back into the extracellular milieu using host cell exocytosis 
machinery. I found that the utilization of TA to block GC re-emergence in the escape and 
survival assays helped to uncover some details of the escape mechanism and uncouple 
the ICS and escape processes to better quantify GC ICS. The long-term fates of viable 
intracellular GC and re-emerging GC will require further study, but each subpopulation 
may contribute to the outcome of disease by affecting the magnitude of host cell 




 As a leading communicable disease and one of the most common STDs, 
gonorrhea continues to be a global public health issue known for its high morbidity. The 
disease is characterized by an intense neutrophil-mediated proinflammatory response in 
symptomatic individuals, yet many infected persons (especially women) do not produce 
recognizable symptoms and fail to seek treatment until the disease reaches greater 
severity. Infected hosts can generate innate immune responses to GC, but fail to mount a 
substantial adaptive immune response. Since GC do not create a protective antibody 
response, a cell-mediated response, or immunological memory, repeat infections of 
increasing severity are common. Furthermore, the rise in antibiotic-resistant GC along 
with the lack of a successful GC vaccine provides motivation for further GC research to 
discover new therapeutics and prevention methods. 
 To establish infection, GC must overcome mucosal epithelial cells and innate 
immune defenses. GC have been shown to adhere to, invade into, and survive within both 
phagocytic and nonphagocytic cells. However, correlating the impact of these events in 
GC pathogenesis with disease outcomes remains difficult. My work has focused on 
determining how pili, Opa, LOS, bacterial viability, etc. contribute to GC invasion and 
ICS by identifying host cell factors and processes (signaling molecules, actin dynamics, 
exocytosis, etc.) that GC target to accomplish these pathogenic events.  
 In order to identify potential host cell signaling molecules GC activate to initiate 
invasion, I incubated human cervical epidermal carcinoma cells (ME180 cells) with 
different GC variants expressing different combinations of pili, Opa, and/or LOS. I 
probed infected cell lysates for the phosphorylated forms of different kinases to 
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determine their activation status. The data produced in this study combined with findings 
in previous reports indicate that GC can activate a variety of signaling pathways prior to 
invasion [see (188, 209, 227) for reviews]. The combination of surface structures GC 
express, the type of host receptors bound, and the order of receptor binding can all 
influence the level of host cell activation and help determine if a cell will internalize GC. 
Since the GC surface undergoes high frequency PV and AV, most GC infections will 
involve a mixed population of GC expressing varied cell surfaces. Thus, GC possess the 
ability to induce different cellular responses leading to varied disease severity in women 
based on the specific GC-host cell interactions that occur within a population of cervical 
epithelial cells. For example, data from this work and previous reports indicate changes 
in LOS can impact host cell interactions and disease progression. If the majority of the 
infecting GC express the lacto-N-neotetraose LOS glycoform, then host cell JNK 
activation would be diminished. These cells would produce lower IL-8 levels and may 
avoid eliciting a proinflammatory immune response better than cells infected by a 
population of predominant lactosyl LOS-expressing GC. A previous study in our lab 
indicated LnNT LOS-expressing GC are more invasive into cervical epithelial cells 
indicating they can disseminate from the initial site of colonization (266). Therefore, in 
this example, altered expression of a single GC surface structure could change the level 
of symptoms produced during infection, which could influence the ability of GC to 
invade and migrate to secondary tissues. 
 In order to quantify GC invasion, I developed the β-lactamase reporter assay to 
measure the number of epithelial cells that internalize GC at the single cell level and also 
employed gentamicin and tannic acid-based protection assays. The level of GC invasion 
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into cervical epithelial cells may also influence the outcome of infection. Greater GC 
invasion into host tissues could propagate increased GC dissemination to additional 
anatomical sites and protect more GC from killing by phagocytes. While Opa represents a 
major invasin on the GC cell surface (176, 190), reports indicate other GC surface 
structures can contribute to invasion. The work described here indicate that GC can 
invade epithelial cells using Opa-independent mechanisms. Furthermore, GC not 
expressing Opa invaded a greater number of cells than Opa-expressing GC, which raises 
questions about Opa’s role as a primary invasin. While Opa may play a prominent role in 
establishing intimate adhesion between GC and some host cell types, its role in invasion 
may have been overestimated by the use of the gentamicin resistance assay. Regardless, 
the existence of Opa-independent invasion pathways demonstrates that GC express 
several different cell surface invasins that can orchestrate invasion mechanisms. GC 
viability was also shown to be necessary for invasion. Thus, in addition the physical 
interactions between GC ligands and cell receptors, invasion requires gonococcal 
responses to host cell cross-talk to generate invasion-promoting actions. Despite their 
multiple invasins and invasion strategies, my data also shows that invasive GC only enter 
a subpopulation of infected cells. Thus, cervical epithelial cells may possess mechanisms 
to resist invasion. Alternatively, GC may need to initiate enough interactions with a given 
host cell, possibly through microcolony formation, to generate a threshold level of 
signaling to trigger a bacterial internalization response in nonphagocytic cells. Thus, 
determining the signaling profiles and cellular response indicators that characterize an 
invasion-susceptible cell versus an invasion-resistant cell will be important focal points 
of future explorations. The β-lactamase reporter assay will serve as a useful technology 
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since it can be used to separate invasion-susceptible cells from invasion-resistant cells for 
further investigation. 
 The degree of intracellular survival of invasive GC can further influence disease 
outcomes. I developed a tannic acid-based survival assay to identify three intracellular 
fates of various invasive GC subpopulations: bacterial death, bacterial survival and 
transcytosis to subepithelial compartments, and bacterial escape to return to the 
extracellular milieu. The ability of GC to survive within phagocytes remains 
controversial. Thus, intracellular killing by epithelial cells may represent a primary 
mechanisms of GC clearance or at least serve an additional mechanism to complement 
phagocytic killing.  
Some GC are capable of surviving after internalization by cervical epithelial cells 
and they may represent a critical subpopulation for disseminated disease and chronic 
persistence in the human population. GC that establish an intracellular niche can avoid 
eliciting proinflammatory responses that could lead to bacterial clearance. My data reveal 
that GC maintain a low-level of persistence in epithelial cells and their lack of 
proliferation may be a critical adaptation in the GC intracellular life cycle for evading 
immune recognition. These GC would also be protected from extracellular immune 
defenses by the epithelial barrier. These factors could contribute to the ability of these 
bacteria to disseminate with minimal immune confrontation. Data from this study also 
indicate intracellular GC can escape from host cells via an exocytotic pathway. Escaping 
GC possess the added dimension of spreading to neighboring epithelial cells after re-
emergence to further compromise the epithelial barrier. These GC also represent a 
subpopulation ideally positioned from transmission to a new host due to their transient 
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extracellular location. Overall, I propose that intracellular GC are an important 
contributor to the high frequency of asymptomatic disease in women because they can 
persist at a low-level in the female reproductive tract and serve as a reservoir of GC 
disease.   
 GC establish infection by colonizing a localized host tissue site. Those GC that 
possess the virulence factors to spread into surrounding cells and progress into deeper 
tissues can cause divergent and more severe disease sequelae. Thus, determining the 
mechanisms of GC invasion, intracellular survival, and escape in cervical epithelial cells 
has important implications in our understanding of GC disease in women, including how 
to devise new treatment and prevention strategies for those infections that lead to morbid 
complications.  
 The work in this study has advanced our understanding of the invasion and post-
invasion stages of GC pathogenesis. I would like to proposal the following updated 
model of GC-epithelial cell interactions (Fig. 32). GC are able to associate with most 
epithelial cells in an infected population, yet only invade into a subset of these cells. The 
GC ligand-cell receptor interactions and downstream signaling pathways most likely 
differ between invasion susceptible and resistant cells. GC invade the susceptible 
subpopulation of epithelial cells via multiple entry pathways using one or more surface 
invasins and through additional cross-talk interactions with host cells that requires GC 
viability. The invasin(s) implemented by GC for entry appear to depend on the cell type 
encountered during infection. Invasion into ME180 cells can be Opa-independent and 
Opa expression reduced the invaded host cell subpopulation, but in other cell types, such 
as Chang epithelial cells, Opa facilitates invasion. In any case, GC trigger invasion by 
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eliciting overlapping signaling events to kinases, including MAPK, linked to actin 
cytoskeletal reorganization. The unique extended ERK activation by GC prior to invasion 
implicates ERK as an important GC invasion-associated kinase that may be activated 
through a GC-induced ErbB1 signaling pathway. Furthermore, GC trigger IL-8 
production in epithelial cells in part through JNK signaling. GC that diminish JNK 
activation in epithelial cells and thereby reduce IL-8 production could downgrade the 
innate immune response and help produce an asymptomatic infection. Once inside 
epithelial cells, GC can realize one of at least three intracellular fates. They can be killed 
by intracellular killing mechanisms that may involve phagolysosome maturation or 
bacterial starvation. GC that do survive can transcytose to subepithelial compartments 
where they can disseminate or possibly reinvade nearby cells through the basolateral 
membrane. In addition, surviving GC can escape into the extracellular lumen via a host 
exocytotic pathway where they can be transmitted to a subsequent host or reinvade 
neighboring cells to spread infection. Cycles of invasion and escape and a low-level of 
intracellular persistence in epithelial cells may help GC avoid immune recognition to 




Figure 32—Working model for GC infection of the cervical epithelium.  GC can 
adhere to most infected cervical epithelial cells and trigger invasion into a subpopulation 
of cells. Entry into epithelial cells may protect GC from phagocytes to help them avoid 
immune recognition and prevent symptom development. Invasion can be Opa-
independent, but requires pili expression, bacterial viability, F-actin recruitment, and 
cross-talk with host cells that includes signaling to kinases, such as the MAPK ERK. GC 
can also regulate the JNK signaling pathway to manipulate IL-8-driven immune 
responses. Internalized GC realize one of three possible intracellular fates: death, 
survival, and escape. Surviving bacteria can transcytose to the subepithelium and 
disseminate or reinvade neighboring cells to spread infection. Escaping bacteria can be 
transmitted to new hosts or also reinvade nearby cells. These mechanisms of persistence 
in host tissue may contribute to the high frequency of asymptomatic infections in women. 
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